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Engineering the repeats-in-toxin domain for biotechnology applications 
Oren Shur 
Repeat peptide domains are ubiquitous in nature. They consist of tandem repeats of a consensus 
sequence and are involved in a very wide array of different functions. The predictability of their 
sequence and, thus, their secondary structure has made them appealing scaffolds to bioengineers. 
A number of commonly found motifs have been subjected to bioengineering work aimed at 
consensus design. Such work focuses on identifying a modular repeat unit that can be multiplied 
as necessary to create a functional interface for applications such as creating novel biomolecular 
interactions or biomaterials. To be successful, a thorough understanding of the target motif must 
be obtained. One must understand what amino acids can be targeted for engineering and which 
are critical for proper folding. In this dissertation we describe our efforts to develop a new 
scaffold for biotechnology applications based on the beta roll forming repeats-in-toxin (RTX) 
domain. Unlike existing scaffolds, which tend to be static in structure, the RTX domain is a 
stimulus responsive domain which only forms a beta roll in the presence of calcium. It is for this 
reason that we have focused our efforts on this domain. The first three chapters of this 
dissertation describe our efforts to gain an in depth understanding of the RTX domains folding 
behavior and amenability to engineering. The final two chapters present two examples of using 
engineered RTX domains for two different biotechnology applications. 
RTX domains are known to only fold when flanked by a protein ―cap‖. In Chapter 2, we study 
this requirement in detail. A variety of different sized flanking groups are tested on an RTX 





different truncations of the natural flanking sequence that is found on this RTX domain within 
the CyaA protein. We show that only the C-terminal flanking sequence is required for calcium-
responsive folding. Then, alternative capping groups are tested to study whether or not the native 
flanking sequence is necessary or any cap is acceptable. We find that the maltose binding protein 
and certain fluorescent proteins can act as caps that enable folding, and further that these are only 
required on the C-terminus. 
For many biotechnology applications, the ability to tether a peptide on a solid surface is of value. 
Therefore, in Chapter 3 we investigate if the RTX domain can form a beta roll when 
immobilized on a solid surface. We use a quartz crystal microbalance (QCM) with RTX peptides 
immobilized on gold. By testing the C-terminally flanked RTX domain and RTX domains 
immobilized on either termini, we find that that a solid gold surface can also act as a cap that 
enables folding. Further, it is found that, unlike with protein caps, tether on either terminus can 
enable calcium-responsive folding. 
Having studied the capping requirements of the RTX domain in detail, Chapter 4 addresses the 
modularity and ordering of the actual RTX repeats. Both capped and uncapped RTX domains are 
synthesized consisting of three different lengths. Also, it is noted that there are both ―standard‖ 
and ―non-standard‖ RTX repeats, so we test the impact of orienting them in different positions 
relative to the flanking group. It is found that altering the number of RTX repeats still enables 
calcium-responsive beta roll formation, but with a slightly compromised conformation. On the 
other hand, we show that altering repeating ordering is catastrophic to beta roll function and only 





In Chapter 5, we make our first attempt at engineering novel functionality into the RTX domain. 
The amino acids that correspond to the beta sheet face are randomized and incorporate into two 
directed evolution display systems in order to try and select for streptavidin binding beta rolls. 
We explore both bacterial cell surface display and ribosome display. Using bacterial surface 
display, we show that the beta roll (both capped and uncapped) can be expressed on the cell 
surface, but significant problems are encountered with clonal selection of non-beta roll 
expressing cell such that this approach is abandoned. Using ribosome display, we identify a set 
of possible streptavidin binding beta rolls. One in particular is shown that may have a low 
micromolar binding affinity that is calcium-responsive. Finally, structural studies are performed 
on this clone to assess if it indeed forms a beta roll. 
In preparing for the work in Chapter 4, it was discovered that a ―consensus‖ designed RTX 
sequence undergoes calcium-responsive precipitation. Therefore, chapter 6 presents an effort to 
develop this into a useful technology for protein bioseparations. We show that three different 
proteins can be purified using this beta roll tag (BRT) and that the system can be coupled with a 
specific protease to purify the maltose binding protein. It is demonstrated that by altering the size 
of these BRTs, precipitation behavior can be modulated. 
Overall, in this dissertation we demonstrate the full cycle of developing a new scaffold for 
bioengineering. We begin by identifying an interesting naturally existing repeat domain. Then, 
we continued by characterizing, in detail, its folding behavior and tolerance to engineering. 
Finally, we conclude by showing two different applications that leverage our earlier knowledge 
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1 Introduction  
1.1 Scaffolds for bioengineering applications 
The engineering of novel protein-protein interactions has been a major focus of bioengineering 
from its inception. In most cases, the bioengineer has a fixed, target protein in mind and he or 
she must find a way to design another protein to adhere to the target. There are a variety of 
reasons such interactions may be desirable and they are addressed in more detail later. In 
principle, there are two approaches one could take to design this interaction. Option one would 
be to design the target-binding protein de novo. Option two would be to identify a naturally 
existing binding ―scaffold‖ and make targeted mutation to amino acids which have already been 
evolved for the express purpose of binding to targets. In either case, high affinity protein-protein 
interactions require precisely selected and oriented amino acids that can adhere to an epitope on 
the target. De novo design of proteins that properly fold is a challenge, let alone designing a 
protein that folds and binds to a target with affinity (although examples of computationally 
designed protein-protein interactions certainly exist, see [1]). For this reason, the use of scaffolds 
has been widely adopted by protein engineering and has been very successful. Many scaffolds 
are currently in use but the scaffold most widely used, by far, is the antibody. 
Antibodies were the first scaffolds to be used by biologists and bioengineers to create new and 
useful protein-protein interactions. The first example of a specific antibody being expressed was 
in 1975 by Kohler and Milstein.[2] However, this work simply demonstrated the feasibility of 
expressing an antibody of interest but was not yet an example of true bioengineering. Probably 





work demonstrated the feasibility of ―humanizing‖ antibodies.[3] These early works led to the 
refinement of hybridoma technology, whereby a laboratory animal is exposed to an antigen and 
through a now well established process, antibody can be made in large quantities. If these 
antibodies are desired for therapeutic applications, the key amino acids for binding can be 
identified and grafted into human antibodies, to minimize immunogenicity.  
More recently, methods have been developed to avoid lab animals and hybridoma technology 
(although it is still widely used). Such methods are based on the generation of antibody libraries 
which can be screened against target and enriched based on their binding. Mutagenesis steps can 
be added between screens in a manner that mimics the way the immune system raises new, 
specific antibodies. These techniques require a genotype-phenotype linkage such that the DNA 
sequence of a successful antibody can be determined. The first of such ―display‖ technologies 
developed was phage display.[4] In this method, an antibody library is displayed on the surface 
of filamentous phage and antibodies that stick to the target antigen will bring the phage with 
them. After selection, phage can be reamplified and selected as many times as required. Another 
display technique used is yeast display.[5] This technique operates on the same principle as 
phage display, but the library is on yeast cells instead. A range of other such display techniques 
exist and have been used with varying degrees of success. 
Antibodies have been immensely successful in therapeutics and biotechnology as a whole. The 
worldwide antibody market in 2008 was $27.4 billion and grew at a rate of 30.8% per year from 
2000 to 2008. Further, in 2008, there were 193 antibody based drugs in development, with 375 in 
clinical trials.[6] While traditional approaches have been used to develop many of these 
antibodies, display technologies have also been successful. The most notable example of an 





this success, there are some major challenges that antibodies present as a protein engineering 
scaffold. The greatest challenge is their requirement for disulfide bonds and glycosylation. 
Disulfide bonds effectively preclude any intracellular use as intracellular environments are 
typically reducing and the need for glycosylation significantly increases the cost and complexity 
of large scale production. Further, some antibodies are prone to aggregation, again complicating 
their large scale production and purification. For these reason, protein engineers have sought 
alternative scaffolds. 
A large number of alternative scaffolds have been explored and previously reviewed.[7] For this 
work, we will focus on repeat scaffolds. Repeat scaffolds are scaffolds that consist of tandem 
repeats of a consensus amino acid sequence. Repeat scaffolds have garnered much interest lately 
because they offer a number of properties which potentially make them a more attractive option 
than the alternative. Repeat scaffolds typically lack complicated tertiary structure and consist 
primarily of a predictable, repetitive secondary structure. This predictability allows for the size 
of the binding interface on the scaffold to be increased or decreased, as needed for the particular 
application. The use of such scaffolds for protein engineering applications was inspired by their 
wide usage in nature for protein-protein interactions. Some of the more thoroughly characterized 
natural scaffolds include leucine rich repeats [8], ankyrin repeats [9], and tetratricopeptide 
repeats (TPR) [10]. Of these, the ankyrin repeats (called design ankyrin repeats, or DARPins) 






1.2 Applications of binding proteins 
There are a number of motivations for why bioengineering focuses on designing binding proteins. 
These motivations have been summarized well previously.[7] Briefly, the major areas of 
applications for binding proteins (as summarized by Binz et al.) are as follows:  
1. Therapeutic applications – A binding protein can either block a target by simply inhibiting 
its function or, if it is an antibody, it can induce an immune response through the Fc region. 
2. Diagnostic applications – Binding proteins are useful for detection and sensing of target 
analytes. Typically, the binding protein is coupled to some signal transduction mechanism. 
For example, in an ELISA the binding protein is couple to an enzyme. 
3. Intracellular applications – In some cases, binding to a target protein intracellular can be 
used as a therapeutic mechanism or as a method for biosensing. 
4. Cocrystallization – Some proteins can be difficult to crystallize due to unstructured regions. 
A binding protein can target these regions and reduce disorder, thereby possibly increasing 
the likelihood of crystal formation. 
5. Chromatography – A binding protein can be incorporated into an affinity chromatography 
system. Ideally, there should also be a straightforward mechanism for release of the target. 
Different scaffolds are better or worse suited for specific applications. For many therapeutic 
applications, antibodies are clearly the ideal scaffold as they can both bind to a target to inhibit 
its disease function and they can elicit an immune response. On the other hand, for most other 
applications, the complexities in expressing large quantities of antibody do not justify their use. 
As an example, for chromatography, a simple unstructured binding peptide may be the ideal 
scaffold as one only needs intermediate binding affinity and the scaffold is not subject to any of 





All of the scaffolds described so far lack allosteric function. That is, they are always folded into 
the same conformation and will bind to their respective target if it is present. However, there are 
a number of applications where allosterically regulated target binding could be of particular use. 
Examples include drug delivery, biosensing, and chromatography. In drug delivery, for example, 
one can conceive of a situation where the inhibitory effects of a binder are only required in the 
presence of some other stimulus (e.g. altered pH or ionic strength). In this case, the binding 
protein would be far more useful if its function is only activated in the presence of this stimulus. 
In the case of chromatography, a ―smart‖ system can be set up whereby the chromatographic 
resin used displays an allosterically regulated binding peptide. When sample is loaded, the 
binding signal is on such that the scaffold binds its target and everything else is washed away. 
For elution, the allosteric ―switch‖ can be flipped and the target is released. Many 
chromatography system already function in such a manner (e.g. maltose binding protein or poly-
his tags), but in this situation one could specifically engineer the scaffold to bind to any protein, 
rather than fusing the target to the binding protein. 
1.3 The RTX domain 
As described above, a stimulus responsive, repeat protein binding scaffold would be of great 
benefit in certain applications. As has been done for other scaffolds, we can try and find 
inspiration in biology. Of course, binding scaffolds are quite common, and many of them have 
been reviewed above. The same is true for allosterically regulated proteins, which are very 
common. Likewise for allosterically regulated binding proteins. However, finding all of these 
properties in one scaffold is not simple. Therefore, another approach is to seek a biological 
scaffold which contains most of these properties and attempt to engineer in the missing ones. It is 





The repeats-in-toxin (RTX) domain is present in the C-terminal region of nearly all protein 
secreted by the bacterial type 1 secretion system (T1SS). The system enables the secretion of 
many proteases and toxins directly from the cytoplasm into the extracellular environment 
without exposure to the periplasm.[13] The RTX domain is unique in that it is intrinsically 
disordered in the absence of calcium and forms a beta roll (described later) in the presence of 
calcium. Since intracellular environments tend to have sub-nanomolar calcium concentrations 
and extracellular environments tend to be higher in calcium, this has led to the proposal that 
RTX domains fold as they are secreted from the cell.[14, 15] However, our interest in the RTX 
domain is not derived from its biological function, but rather the calcium-responsive nature of 
beta roll formation. 
Crystal structures have revealed the beta roll structure of folded RTX domains. The domain 
consists of tandem repeats of the consensus amino acid sequence GGXGXDXUX where X can 
be any amino acid and U is a hydrophobic residue. The beta roll is a helical structure, consisting 
of two oppositely facing parallel beta sheet faces. Each nine amino acid unit binds one calcium 
ion in the turn region (See Figure 1.1 and Figure 1.2). [16, 17] The folded beta roll consists of a 
hydrophobic core and is flanked by regions which are essential for its calcium responsive.[18] 
While the beta roll domain has no known natural binding partners, it does possess the trait of 
being a stimulus responsive, repeat motif. As mentioned above, in this work we propose to take 
the approach of engineering binding capabilities into this beta sheet face, while maintaining the 





 residues in each repeat which constitute the face are highly variable. 
Further, beta sheet faces are known, in some cases, to be involved in protein-protein interactions. 





proposed mechanism of binding beta rolls compared to binding LRR’s can be seen in Figure 
1.3.[19, 20] 
Prior to engaging in engineering efforts on the RTX domain, it is of value to review some of the 
past efforts that researchers have undertaken. There have been three notable examples of using 
RTX domains in protein engineering applications, although none have focused on engineering 
binding. The first notable example is the incorporate of the serralysin metalloprotease RTX 
domain into designed calcium-responsive network by Ringler and Schulz.[21] While the RTX 
domain itself was not modified, this work demonstrated the feasibility of incorporating the RTX 
domain into designed structures. The second two examples consist of attempts at creating 
synthetic beta roll forming RTX domains. These efforts were undertaken, first, by Lilie et al. and, 
second, by Scotter et al. [22, 23] While these works were successful in creating peptides that 
underwent a conformational change, neither was exactly as expected. The constructs by Lilie et 
al. only respond to lanthanum (not calcium) and those by Scotter et al. only respond to calcium 
in high (100 mM) calcium and polyethylene glycol (PEG) concentrations. While it is clear that 
there are significant challenges to engineering these domains, it does appear that with sufficient 
understanding of RTX behavior, the domain can be used for bioengineering applications. 
1.4 Goals  
In short, the goal of this work is to engineer the RTX domain for biotechnology applications. 
Particularly, we seek to engineer the domain to bind to target proteins in an allosterically 
regulated manner, controlled by the presence or absence of calcium. Given some of the previous 
challenges in engineering RTX domains summarized above, it is clear that successful 
engineering must be preceded by detailed characterization to provide a thorough understanding 





the RTX domain and two chapters describing applications of engineered RTX domains. The 
specific characterization and engineering goals of this work are listed below with their 
corresponding chapters. 
 
Goal 1:  Identify the minimum requirements for inducing beta roll formation in an RTX 
domain 
This goal is addressed in Chapter 2, where we explore both the minimal flanking requirements of 
RTX domains and their tolerance to alternative flanking groups. 
 
Goal 2: Explore the tolerance of RTX domains to surface immobilization 
In Chapter 3, we use a quartz crystal microbalance to study the behavior of RTX domains 
immobilized on a solid surface. We test calcium binding affinities and folding reversibility.  
 
Goal 3: Assess the modularity of RTX repeats and the importance of repeat ordering 
In Chapter 4, we conclude our characterization of RTX domains by studying the impact of 
increasing or decrease the number of repeats on calcium binding behavior. Further, we study the 
importance of different types of repeats in folding behavior. 
 





In Chapter 5, we use bacterial surface display and ribosome display in attempt to engineering 
allosterically regulated streptavidin binding beta rolls. We demonstrate the feasibility of this 
technique and identify two possible binding beta rolls. 
 
Goal 5: Explore other applications for the RTX domain 
The allosteric nature of RTX folding offers interesting options for other applications beyond 
binding. In Chapter 6, we show that the calcium-responsiveness of RTX domains can be used in 






Figure 1.1. Crystal structure of serralysin metalloprotease 
 







Figure 1.2. Crystal structure of folded RTX domain 
 
A focus on only the beta roll portion of the serralysin metalloprotease. The spheres are calcium 







Figure 1.3. Comparing beta roll to LRR binding 
 
At left is shown a beta roll with a hypothetic binding partner. At right, is shown a leucine rich 
repeat domain bound to its target. We see that both scaffolds form a similar potential binding 
interface and it is this similarity which leads us to hypothesize the beta roll may be used as a 





2 Role of flanking groups 
2.1 Minimal and alternative caps 
Note: A version of this chapter entitled ―Calcium-induced folding of a beta roll motif requires C-terminal entropic stabilization‖ appeared in the 
Journal of Molecular Biology, volume 400, issue 2, pages 244-256, July 2010 with co-authors Mark Blenner, Geza Szilvay, Donald Cropek and 
Scott Banta. 
OS designed experiments and DNA cloning strategy, prepared DNA constructs, purified protein, and conducted portions of tryptohan titrations 
and CD experiments and analysis. OS also performed secondary structure predictions to guide cap design. 
2.1.1 Abstract 
Beta roll motifs are associated with several proteins secreted by the type 1 secretion system 
(T1SS). Located just upstream of the C-terminal T1SS secretion signal, they are believed to act 
as calcium-induced switches that prevent folding before secretion. Bordetella pertussis adenylate 
cyclase (CyaA) toxin has five blocks of beta roll motifs (or repeats-in-toxin motifs) separated by 
linkers. The block V motif on its own has been reported to be non-responsive to calcium. Only 
when the N- and C-terminal linkers, or flanking groups, were fused did the motif bind calcium 
and fold. In an effort to understand the requirements for beta roll folding, we have truncated the 
N- and C-terminal flanks at several locations to determine the minimal essential sequences. 
Calcium-responsive beta roll folding occurred even in the absence of the natural N-terminal 
flank. The natural C-terminal flank could not be truncated without decreased calcium affinity and 
only partially truncated before losing calcium-responsiveness. Globular protein fusion at the C-
terminus likewise enabled calcium-induced folding but fusions solely at the N-terminus failed. 
This demonstrates that calcium-induced folding is an inherent property of the beta roll motif 
rather than the flanking groups. Given the disparate nature of the observed functional flanking 
groups, C-terminal fusions appear to confer calcium-responsiveness to the beta roll motif via a 





can enable beta roll folding. Increased calcium affinity was observed when the natural C-
terminal flank was used to enable calcium-induced folding, pointing to its cooperative 
participation in beta roll formation. This work indicates that a general principle of C-terminal 
entropic stabilization can enable stimulus-responsive repeat protein folding, while the C-terminal 
flank has a specific role in tuning calcium-responsive beta roll formation. These observations are 
in stark contrast to what has been reported for other repeat proteins. 
2.1.2 Introduction 
Modular repeat proteins are ubiquitous in nature and often mediate protein-protein interactions. 
Leucine rich repeats (LRRs), ankyrin repeat proteins (ARPs) and tricopeptide repeat proteins 
(TRPs) are among the best characterized repeat proteins [11, 20, 24]. Each repeat protein is 
characterized by a consensus repeating unit, defining the positions within the repeat that are 
relatively invariable.  These units define the structural elements of the specific repeat protein fold, 
as well as variable positions amenable to substitution [25] . These structural elements are 
stabilized via local short-range interactions, as opposed to globular proteins that often exhibit 
many cryptic long-range interactions along the folding pathway [24, 26]. A common feature for 
repeat proteins is tertiary stabilization by the formation of a hydrophobic core [27]. To stabilize 
this hydrophobic core, specialized flanking or capping groups are needed on both N- and C- 
termini to protect the hydrophobic core from solvation [20, 28]. Optimization of the capping 
groups has resulted in stable proteins with well defined tertiary structure  [29, 30].   
Bacterial Type 1 secretion systems (T1SS) are important in the transport of large proteins from 
the cytoplasm directly to the extracellular environment, without exposing the protein to the 
periplasm [31]. Proteins secreted through T1SS are unique in that the secretion signal is located 





of the secretion signal is typically a so-called Repeats-in-Toxin (RTX) domain. Recent work by 
Chenal et al. [15] has demonstrated that the RTX domain of adenylate cyclase (CyaA) from 
Bordetella pertussis, the causative agent of whooping cough, is an intrinsically disordered 
protein (IDP) at physiological intracellular calcium concentrations and becomes structured at 
higher calcium concentrations more typically found in the extracellular environment. Since the 
outer membrane protein of the T1SS has a channel 30 Å in diameter [33], it has been suggested 
that CyaA (>200 kDa) must be secreted in an unfolded conformation [15, 31]. The prevailing 
theory on the T1SS is that the entire RTX domain remains unfolded in the cytoplasm and 
throughout the secretion process, folding in the calcium rich extracellular environment [32, 34]. 
Only after this calcium-triggered RTX folding event can the catalytic domain of CyaA fold into 
its active toxic form [35].  
RTX domains are common to several families of proteins that use the T1SS, including 
extracellular proteases [36], extracellular lipases [37, 38], epimerases [39], and hemolytic toxins 
[18]. The RTX domain is composed of tandem repeating nonamers (9mers) of the sequence 
GXXGXDXUX where U is a large aliphatic amino acid (L, F, or I) residue, and X can be any 
residue [34, 36]. The number of RTX repeats in a given protein ranges from 5 to 45. These 
tandem repeats are often broken up into blocks of between 5 and 12 repeats, separated from one 
another by linker regions [18]. The RTX blocks, including flanking and repeat sequences, can 
fold independently of the surrounding blocks and are here referred to as RTX-motifs. 
Crystallographic data from an alkaline protease (PDB: 1SAT) [17] and an extracellular lipase 
(PSB: 2Z8X) [37] indicate the calcium-bound RTX-motif is composed of turns and -sheets 
forming a parallel beta helix termed a ―beta roll‖. The highly conserved aspartic acid is required 





bound to calcium, the RTX-repeats are folded, with GXXGXD forming a turn and XUX forming 
a beta strand. Two consecutive RTX-repeats form one turn of the beta roll structure, with amino 
acid U forming a hydrophobic core [17].  
The entire CyaA RTX domain has been reported to undergo calcium-responsive structure 
formation [15, 35]. Individual examination of the block V RTX-motif of CyaA was shown to 
fold with the entire natural N- and C-terminal flanking sequences, but not in their absence [18, 
41]. We have previously reported the restoration of the calcium-responsive behavior of the 
otherwise unresponsive block V RTX-repeats by the fusion of the protein FRET-pair, CFP and 
YFP [41]. In this study, we were interested in understanding more about the underlying 
mechanism of RTX-repeat folding and how that might impact our understanding of stimulus-
responsive repeat protein folding. To that end, we examined the minimal natural flanking 
sequence needed for calcium-responsive structure formation of block V RTX-repeats. 
Additionally, we have examined the effect of non-native fusion partners, such as maltose binding 
protein (MBP) and fluorescent proteins (CFP/YFP), on the calcium-responsive structure 
formation of the otherwise calcium-insensitive block V RTX-repeats. Last, we show that 
molecular crowding agent PEG can restore calcium-responsive folding as well. Taken together, 
our results point to a specific role for the natural C-terminal flank in tuning calcium-responsive 
beta roll formation, while a more general underlying entropy-dependent mechanism may be 
responsible for enabling calcium-responsive beta roll folding.   
2.1.3 Results 
The CyaA of B. pertussis contains a large C-terminal domain comprising five RTX-repeats, 
separated by linkers, or flanking residues. In this work, we examined the block V RTX-repeats 





based on the CyaA; Figure 2.1B). The natural N-terminal flanking residues span from 1488-1528, 
and the natural C-terminal flank spans from 1613-1680. Since the structure of N- and C-terminal 
flanks are not known, we have depicted them here schematically as straight-line extensions 
attached to the termini of the RTX-motif (Figure 2.1C). In the latter part of this work, non-native 
fusions were made to the RTX-repeats.    
Natural Flanking Residues Enable Calcium-Induced RTX Folding.  
Far-UV CD spectra and bis-ANS binding experiments shown in Figure 2.2A and Figure 2.2B 
indicate that the RTX-repeats on their own do not undergo calcium-induced secondary structure 
changes. Both calcium and calcium free CD spectra show a negative peak at approximately 198 
nm, indicative of unstructured residues. A subtle negative peak at approximately 215 nm is also 
observed, indicating a small amount of residual secondary structure. However, when the amino 
acids flanking the RTX-repeats are included, the far-UV CD spectrum (Figure 2.2C) shows a 
shift of the negative peak to approximately 218 nm and the appearance of the positive peak 
around 190 nm. This spectrum is indicative of increased -sheet secondary structure and is 
similar to the results of Bauche et al. [18]. Deconvolution of these spectra also indicates the gain 
of -sheet structure and the loss of unstructured residues (see Table 2.2).  Similarly, Figure 2.2D 
shows increased bis-ANS fluorescence with the addition of calcium, consistent with bis-ANS 
binding to organized hydrophobic regions on the protein that form either on the surface or within 
the resulting beta roll structure.  
C-terminal Flanking Residues Control Calcium-Induced RTX Folding. Given the important role 
of the natural flanking amino acids for the calcium-induced folding of the RTX-repeats, studying 





responsible for facilitating the disordered-to-ordered transition previously described. Since 
crystallographic data for the CyaA RTX domain are not available, truncations were made (based 
on secondary structure predictions [42]) in the N-terminal flank at position 1521, and in the C-
terminal flank at 1628, 1638, and 1653 (numbering based on the CyaA protein sequence). Far-
UV CD spectra of the block V RTX-repeats with truncated flanking groups were analyzed in the 
presence (10 mM CaCl2) and absence of calcium. Figure 2.3A shows that when both full length 
N-terminal and C-terminal flanking groups are present (RTX 1488-1680), a calcium-induced 
conformational change is observed in the CD spectra.  When the entire N-terminal flanking 
group was intact, two mutants with truncated C-terminal flanking groups (RTX 1488-1653, RTX 
1488-1638) still enabled calcium-induced folding (Figure 2.3B,C). These spectra had similar 
characteristic changes indicative of increased -sheet content. The RTX-repeats fused to the C-
terminal flanking group truncated at position 1628 (Figure 2.3D; RTX 1488-1628) or removed 
entirely (Figure 2.3E; RTX 1488-1612) no longer exhibited calcium-responsive behavior. When 
the entire C-terminal flanking group was preserved, any truncation of the N-terminal flank 
resulted in maintenance of the calcium-induced folding of the RTX-repeats (Figure 2.3F and H; 
RTX 1520-1680; RTX 1529-1680). When the C-terminal flank was truncated, truncation of the 
N-terminal flank no longer allowed calcium-responsive folding (Figure 2.3G; RTX 1520-1653). 
Deconvolution of these spectra indicated similar changes in -sheet content (see Supplementary 
Table S1) for fully flanked RTX-repeats as well as truncations. This strongly suggests the RTX-
repeats form beta roll structures, consistent with crystal structure data from RTX-repeat 
containing proteins [17, 36]. 
The calcium-responsive constructs with the largest overall truncations (Figure 2.3C and H) were 





possessed tryptophan residues in the C-terminal flank, calcium titration experiments could be 
performed by measuring changes in intrinsic tryptophan fluorescence. The increase in 
fluorescence was consistent with tryptophan residues moving into a more hydrophobic 
environment. Figure 2.4 indicates that the N-terminally truncated RTX-motif (RTX 1529-1680) 
possessed similar calcium binding affinity and binding cooperativity when compared to the fully 
flanked RTX-motif (RTX 1488-1680). Urea denaturation data for these two constructs showed 
both had similar stability (Figure S1). However, the mutant with a partial truncation to the C-
terminal flank (RTX 1488-1638) had diminished affinity for calcium as assessed by a fit to the 
Hill Equation (Table 2.1). Interestingly, both ―minimal‖ flanks have approximately the same 
number of residues.  
Fusion Proteins Enable Calcium-Induced RTX Folding Without Native Flanking Residues.   
Truncation experiments on the natural flanking groups have shown that the natural C-terminal 
flank can enhance calcium affinity and at least part of the flank is necessary for calcium-induced 
beta roll formation. Common to all calcium-responsive constructs are the RTX-repeats (RTX 
1529-1612) and residues 1612-1638 of the C-terminal flank, suggesting calcium-responsiveness 
is either an intrinsic property of the RTX-repeats or specific to the immediate C-terminal 
flanking residues. Given that the RTX folding is tolerant to truncation of either the natural C-
terminal or N-terminal flank, the question remained whether this effect was specific to native 
CyaA flanking regions or if other structures could be used. Initially, fluorescent proteins, CFP 
and YFP, were fused to the N- and C- termini of the RTX-motif, and calcium-induced folding 
was studied by FRET between the fluorescent proteins. For this system, an increase in FRET 
efficiency has been shown to be indicative of a decrease in CFP-YFP chromophore separation 





calcium-induced folding to the otherwise calcium-insensitive RTX-repeats (1529-1612). The 
change in FRET efficiency upon addition of 10 mM calcium was ~0.36, similar to the change in 
FRET efficiency observed for fluorescent proteins attached to the ends of an RTX-motif still 
possessing both natural N- and C-terminal flanking residues. Since the calcium-induced change 
in FRET efficiency is nearly identical, it seems likely that the change in FRET efficiency is 
reporting the folding of the RTX-repeats into a beta roll structure rather than changes in 
chromophore orientation.  
Since the fusion protein signal dominates the CD spectra, conformational for these constructs 
cannot be reliably observed using this technique (data not shown). Likewise, the RTX-repeats 
(RTX 1529-1612) lack tryptophan residues preventing the use of intrinsic tryptophan 
fluorescence. In order to verify the FRET results we therefore used bis-ANS binding to monitor 
calcium-induced changes in organized surface hydrophobicity of the RTX-repeats. For 
convenience, RTX 1488-1680 (Figure 2.2C) is now referred to as N-RTX-C, since it contains 
both N- and C- terminal flanks. Likewise, RTX 1488-1612 is now referred to as N-RTX and 
RTX 1529-1680 as RTX-C. The use of the notation ―RTX‖ refers only to the RTX-repeats 
themselves (RTX 1529-1612). As mentioned above, bis-ANS binding to bi-terminally flanked 
RTX (N-RTX-C) increased in response to calcium (Figure 2.6C). Likewise, a similar increase in 
bis-ANS binding was observed for RTX-C (Figure 2.6B). However, when the RTX-repeats were 
fused only to the natural N-terminal flank (N-RTX) no increase in bis-ANS binding was 
observed (Figure 2.6A), again suggesting it did not undergo calcium-induced folding. The 
unflanked RTX had little change in bis-ANS binding in the presence or absence of calcium 





The same FRET construct as described previously was made with G67S mutations in each 
fluorescent protein (CFP*-RTX-YFP*) to prevent fluorophore formation that would interfere 
with the bis-ANS measurements [43]. Similar to the natural flanking groups, the fusion of 
fluorescent protein mutants to both termini of the RTX-repeats (CFP*-RTX-YFP*) enabled a 
calcium-induced increase in bis-ANS binding (Figure 6F). Also similar to the natural flanking 
sequences, fusion of a fluorescent protein mutant to the C-terminus (RTX-YFP*) likewise 
enabled a calcium-induced increase in bis-ANS binding (Figure 6E), while N-terminal fusion 
(CFP*-RTX) had no such effect (Figure 2.6D). In order to determine the generality of this 
finding, we examined the calcium-induced folding of the RTX-repeats with fusions to maltose 
binding protein (MBP). Bi-terminal fusion, MBP-RTX-MBP, and C-terminal fusion, RTX-MBP, 
both exhibited increased bis-ANS binding in the presence of calcium while N-terminal fusion 
MBP-RTX was once again insensitive to calcium (Figure 2.6G-I).  
To complement the bis-ANS binding data, we performed terbium titration luminescence 
resonance energy transfer (LRET) experiments as well. While often used as a calcium analog, 
terbium affinities differ from calcium and do not, on their own, provide evidence of calcium 
binding. However, in combination with the CD, bis-ANS and FRET results, the terbium 
experiments offer further support of calcium-induced structural changes. Figure 2.7A–C show 
terbium titration curves that are consistent with the findings of bis-ANS experiments. In Figure 
2.7A, RTX-C and N-RTX-C both had similar terbium LRET titration curves. By comparison, the 
N-RTX titration curve had a lower maximum. Since the terbium binding curves for RTX-C and 
N-RTX-C are nearly identical, it means the contribution of the natural N-terminal flank is small. 
In Figure 2.7B and C, the terbium binding signal for the fusion proteins alone was subtracted 





resulting from the RTX-repeats. In both cases, the titration curve for the bi-terminal and C-
terminal fusion converged into similar curves indicating again that N-terminal fusion contributes 
little to terbium binding. The consistent demonstration that fusion to the C-terminus of the RTX 
is critical for calcium-induced beta roll formation suggests a polarity in folding, favoring 
initiation at the C-terminal end.  
PEG Restores Calcium-Induced RTX Folding. 
Polyethylene glycol (PEG) is often used as a molecular crowding agent to reduce the 
conformational freedom of proteins. We have shown that RTX (RTX 1529-1612) is unable to 
bind calcium without C-terminal fusion. CD spectra of RTX (Figure 2.8) with 100 mM CaCl2 
(broad dashed) were identical to CD spectra of RTX without CaCl2 (solid). Addition of 50% 
PEG 3350 (dotted) without calcium caused a change in the CD spectra, however it does not 
obtain characteristics of a folded beta roll (Figure 2.2C). In the presence of both 50% PEG and 
100 mM CaCl2 (narrow dashed) the CD spectra obtains characteristics similar to the folded beta 
roll.  
2.1.4 Discussion 
A variety of biophysical methods were used to investigate the calcium-induced folding of the 
block V RTX-repeats of CyaA. It has previously been shown that the block V RTX-repeats do 
not fold in response to calcium unless fused to its natural flanking residues, 1488-1528 on the N-
terminus and 1613-1680 on the C-terminus [18]. Several truncations were made to the natural 
flanking groups until calcium-responsive behavior was lost as determined by far-UV CD 
spectroscopy. Intrinsic tryptophan fluorescence measurements during calcium titrations revealed 





however, truncation of the entire N-terminal flank had no significant impact. Urea denaturation 
experiments confirm that N-RTX-C (RTX 1488-1680) and RTX-C (RTX 1529-1680) had 
similar stabilities. PEG could be used to confer calcium-responsive folding to the otherwise 
calcium-insensitive RTX. Bis-ANS and terbium fluorescence experiments were used where CD 
spectroscopy and tryptophan fluorescence could not be applied to show that C-terminal fusions 
of the RTX-repeats to well folded globular proteins (YFP* or MBP) likewise conferred calcium-
responsive folding; however, N-terminal fusions had little effect. These results taken together 
show that RTX folding is an intrinsic property of repeats attenuated by the C-terminal flank, 
suggesting folding of the RTX-repeats is highly dependent on the presence of a C-terminal flank. 
To investigate the role of native flanking residues in permitting calcium-induced RTX folding, 
we made several truncations to the flanks and measured changes in CD spectra to determine if 
calcium-induced folding was compromised by the truncation. The two calcium responsive 
mutants with the largest truncations were a partial C-terminal truncation (RTX 1488-1638; 
Figure 2.3C), and a complete N-terminal truncation (RTX 1529-1680; Figure 2.3H). While RTX 
1488-1638 and RTX 1529-1680 both enabled calcium-responsive RTX conformational change, 
truncation of the C-terminal flank reduced the calcium affinity (Figure 2.4). Further truncation 
ablated calcium responsive folding. This change in affinity suggests a specific role for the natural 
C-terminal flank for enhancing the calcium binding affinity. This result is not unexpected, as the 
cooperative folding of the RTX-repeats and natural flanking group have coevolved. Furthermore, 
our data indicate RTX 1488-1638 was calcium-responsive where RTX 1520-1653 was not, likely 
resulting from truncating the C-terminal flanking sequence at a position that no longer enables 





terminal flank does not play an important role in folding as observed in native flank truncation 
and non-native flank experiments.  
Like the RTX-motif, the native C-terminal flanking group is rich in aspartic acid residues and is 
highly charged, suggesting it is relatively unstructured without calcium [44, 45]. In fact, when 
compared with the other flanking groups separating RTX-blocks in CyaA, this is the only 
flanking group rich in aspartic acid (Figure S2). It is possible that the native C-terminal flanking 
sequence either participates in calcium-induced RTX folding in a concerted manner or the 
flanking group itself may bind calcium. Radioactive calcium binding studies indicate the block V 
RTX-motif (with native bi-terminal flanking sequences) bound ~7 calcium ions, the number 
expected based on nine RTX-repeats [18], however, this still does not definitively rule out C-
terminal flanking sequence calcium binding. Crystal structures of folded beta rolls show that 
calcium is bound between adjacent turns along the -helical axis [36, 37]. These structures also 
show that C-terminal flanking groups ―cap off‖ the beta roll by coordinating half calcium ions 
left exposed after the terminal turn and seal off the hydrophobic core. Further studies of the 
CyaA block V C-terminal flanking group are needed to fully elucidate its role in RTX folding 
and export through T1SS.  
Our study of the truncation of the native flanking groups indicated increased calcium affinity was 
possible with the full C-terminal flanking group, but how specific is the requirement for the 
natural C-terminal flank? We showed that partial truncation of the C-terminal flank (RTX 1488-
1638) still allows calcium to bind and cause RTX folding, albeit with compromised calcium 
affinity. Furthermore, we show that the FRET pair, CFP and YFP, can enable RTX folding. This 
suggests non-native flanks can enable calcium responsive RTX folding. Our results demonstrate 





to the C-terminus as we observed with the natural flank, but not to the N-terminus. The varied 
structures of the fusion proteins used ( /  MBP, -sheet YFP, and native flank) suggest other 
well-folded globular proteins could likewise enable calcium responsiveness. This is consistent 
with the successful employment of serralysin RTX-repeats as a calcium-switch to control the 
spatial separation of bi-terminally fused -galactosidase [21] while others have reported 
difficulty folding unflanked serralysin RTX-repeats [22, 23]. While we cannot definitively rule 
out the possibility that the RTX is binding calcium and folding into some non-native structure 
when fused to MBP or YFP*, we have ruled out multimer formation through size exclusion 
chromatography (Figure S3) confirming the sole presence of monomers in calcium-free and 
calcium containing buffers. Furthermore, changes in bis-ANS and terbium binding were similar 
for native and non-native flanks, suggesting they all undergo similar conformational change. 
Direct observation of decreased RTX flexibility upon fusion using a technique such as NMR 
would further bolster this explanation.  
Flanking or capping domains are known to be important for the folding and stability of LRR 
proteins [20, 46], which are dominated by short-range interactions between adjacent repeats, in 
contrast to globular proteins where long-range interactions can have a profound effect on the 
folding pathway [26]. These short range interactions are not strong enough to overcome the high 
entropic penalty associated with folding and, as such, require capping groups on both ends to 
lower the energy barrier and nucleate folding [47]. Our results indicate the capping effect 
appears to be important for the calcium-induced folding of the beta roll as well. It is important to 
note that for RTX-repeats, the unfolded state is really an intrinsically disordered calcium-free 
state (not a denatured state), and the folded state is the calcium-bound beta roll. Without a 





Since PEG, the native flanking sequence, and two unrelated proteins (YFP* and MBP) all enable 
calcium-induced RTX folding, it appears beta roll formation does not require any enthalpic 
interaction (salt bridges or hydrogen bonds) with specific residues or elements of secondary 
structure found in the flanks. Thus, the calcium-induced folding mechanism suggests RTX-
repeats can fold via an entropically driven mechanism. One possible explanation for this effect is 
a result of the RTX-repeats intrinsic disorder in calcium-poor environments [15]. This intrinsic 
disorder means that the RTX-repeats are flexible and have greater entropy than the calcium 
bound beta roll. Since RTX without C-terminal flanking groups cannot restore the calcium 
responsive RTX folding, the enthalpic contribution of calcium binding to RTX folding combined 
with the entropic contribution of the liberation of water from hydrophobic hydration [ref] is not 
large enough to overcome the entropic cost associated with the reduction in RTX flexibility 
associated with beta roll formation (DG > 0). If the entropy loss associated with beta formation 
could be lowered, it would be possible for calcium to induced RTX folding. We refer to this 
entropy reduction as entropic stabilization.  This entropy driven stabilization is consistent with a 
previous study of a synthetic beta roll motif formed by eight RTX-repeats and no capping groups. 
Only in the presence of 25% PEG 8000 and calcium did the RTX-repeats undergo calcium-
induced conformational change [22]. PEG is known to enhance molecular crowding and 
therefore reduce conformational freedom, which decreases the entropy of the protein [48-50]. 
Furthermore, molecular crowding has previously been shown to reduce the flexibility of some 
intrinsically disordered proteins [51-53], pointing to the importance of entropic stabilization as a 
mechanism for folding RTX-repeat proteins. We have confirmed this previous finding by 
showing that PEG induced calcium-dependent structure formation for the block V RTX- repeats 





In repeat proteins, the capping group position can have a profound effect on the folding pathway, 
helping to nucleate the folding of the rest of the repeats [26]. It is tempting to suggest that the 
flanking groups may act in a similar manner for the calcium-induced folding of the beta roll 
domain. Hill coefficients for cooperative calcium binding of the fully flanked RTX-motif were 
greater for tryptophan fluorescence titration data than for FRET data (Table 2.1). Since the 
tryptophan titration data reports conformational change near the C-terminus and the FRET data 
reports conformational change across the entire RTX-motif, this demonstrates greater binding 
cooperativity toward the C-terminus when compared with the average cooperativity across the 
entire block V RTX-motif. This difference in cooperativity distribution indicates once again the 
importance of the C-terminal repeats, and suggests directionality in beta roll folding from C-to-N 
terminus. If the calcium-induced folding of the RTX-repeats is principally controlled by the C-
terminal repeats, then entropic stabilization of only the C-terminal end, and not the N-terminus, 
would enable the RTX folding behavior we observe (Figures 2.4-2.7). 
The untethered flexible C-terminus of the calcium-free intrinsically disordered RTX would be 
highly flexible and thus have relatively high entropy. A folding nucleus would have to form at 
the C-terminal end to allow calcium-induced RTX folding. To form this ordered conformation, 
the RTX-repeats need to overcome this entropic barrier, specifically near the C-terminus. Fusion 
to inherently structured proteins would reduce the C-terminal mobility and the entropy of folding 
nucleus, thereby reducing the entropic penalty for folding. Several pieces of evidence exist that 
support the hypothesis of folding via entropic stabilization. Friebel et al. [54] studied the effect 
of tethering on the folding pathways of a -barrel protein. They found that tethering indeed 
affects the folding mechanism. Tethering at either terminus caused a reduction in the protein’s 





range contacts. They concluded that tethering could be used to expedite contact formation 
proximal to the tether. Furthermore, our hypothesis is supported by studies on constrained and 
linear peptides from phage display experiments [55]. Chen and coworkers found that constrained 
peptides had different ligand binding affinity compared to linear peptides due to differences in 
flexibility.  
While our results indicate a non-specific mechanism that can enable RTX folding is possible, 
potentially via entropic stabilization of the C-terminal RTX-repeats, the data for RTX folding 
with the natural C-terminal flanking sequence indicates a more specific mechanism is 
physiologically relevant. With increased affinity and greater positive cooperativity at the C-
terminus, the natural flanking sequence appears to tune the calcium responsiveness of the RTX. 
In Type 1 Secretion Systems, the RTX-motif is believed to remain unfolded at intracellular 
calcium concentrations (submicromolar) to help the protein remain unstructured until secreted 
into the extracellular environment [35, 56]. Once in the extracellular environment, the RTX-
motif is exposed to millimolar calcium concentrations, and the secreted protein folds into its 
active form [15, 35]. Recently it has been suggested that the calcium-induced RTX-motif 
structure formation can act, in a sense, as a ratchet, owing to its large size relative to the OMP 
[15]. Since the CyaA protein (and other RTX proteins) are secreted from their C-terminal end, 
folding of the RTX-motifs in the C-to-N direction is consistent and would offer the advantage of 
rapid RTX structural formation once exited from the OMP. N-to-C folding, on the other hand, 
would require the entire RTX-motif and N-terminal flank to be secreted in an unstructured form 
before folding could occur. While mechanistically there is no reason N-to-C folding should be 
impossible to achieve, the evolution of proteins exported through the T1SS would seem to favor 





RTX conformational change, the affinity and cooperativity were diminished (Figures 2.4-2.6; 
and data from Szilvay et al.[41]). Such changes in both affinity and cooperativity indicate a 
specific role of the natural C-terminal flank, increasing both the calcium binding affinity as well 
as enhancing positive calcium binding cooperativity. 
In summary, we have shown that the block V RTX-motif folds into a beta roll domain in a 
calcium-responsive manner that depends on the entropic stabilization of the C-terminal end.  
This is in stark contrast to the stabilization seen in other repeat proteins where specific capping 
groups are required on both ends of the protein. The responsive nature of the RTX-motif would 
seem to require less capping compared to other non-responsive repeat proteins. Our results are 
consistent with the prevailing T1SS theory that proteins are secreted from C-to-N terminus and 
folding also likely occurs from C-to-N terminus, allowing the folded beta roll motifs to act as a 
molecular ratchet to prevent the diffusion of CyaA back into the OMP. The block V RTX-repeats 
are an interesting example of how coupled binding and folding can be harnessed as a molecular 
switch to control an important biological process. The inherent molecular switching properties of 
the beta roll scaffold may be useful for controlling future orthogonally engineered protein 
functions [57, 58].  
2.1.5 Materials and Methods 
Materials. Plasmid pDLE9-CyaA [59] was a generous gift from Dr. Daniel Ladant (Institut 
Pasteur, Paris, France). Maltose binding protein expression & purification kit was purchased 
from New England Biolabs (Ipswich, MA). Unless otherwise stated, all enzymes were purchased 
from New England Biolabs and chemicals from Sigma-Aldrich. (St. Louis, MO). Isopropyl -D-





Cloning & Purification of RTX-Motif Mutants. The pDLE9-CyaA plasmid was transformed into 
5  Escherichia coli (New England Biolabs). RTX-motifs with truncated flanking regions were 
created using various combinations of oligonucleotide primers as outlined in the Supplementary 
Material. PCR primers contained unique restriction sites AvaI and HindIII for subsequent 
cloning into the pMAL-c4e expression plasmid (New England Biolabs). Expression was 
performed in 5  E. coli. Cultures were grown in LB media with 100 mg/mL ampicillin to OD600 
= 0.5. Expression was induced with 0.3 mM IPTG and grown for 3 h. Cells were harvested at 
6000g for 10 min, sonicated and clarified at 15,000g for 30 min. Clarified lysate was diluted 
five-fold and applied to a gravity flow column containing amylose resin (New England Biolabs) 
according to the manufacturer’s instructions. Maltose binding protein (MBP) fusions were eluted 
using 10 mM maltose. Eluted samples were then digested with 60 ng enterokinase (New England 
Biolabs) per liter of culture for at least 36 h at 4°C. After buffer exchange into 20 mM Bis-Tris, 
pH 6.0, 25 mM NaCl, ion exchange chromatography was performed using a 16/10 Q FF column 
(GE Healthcare, Piscataway, NJ) on an ÄKTA FPLC (GE Healthcare, Piscataway, NJ). 
Uncleaved MBP-fusions and cleaved beta rolls were coeluted at NaCl concentrations above 200 
mM. This mixture was further purified on a Superdex 200 prep grade Gel Filtration column (GE 
Healthcare) equilibrated with 50 mM Tris, pH 8, 200 mM NaCl or repurified on an amylose 
column. RTX proteins were at least 99% pure as determined by visual inspection of SDS-PAGE. 
Samples were desalted and concentrations were determined using absorption of light at 280 nm 
and calculated extinction coefficients [60].  
pET/C-CyaA
1488-1680
-Y (CBY) was constructed as previously described [41]. To examine bis-
ANS binding, a mutation was made to a residue essential for chromophore formation in both the 
CFP and YFP. Plasmid pET/C-CyaA
1488-1680





CFP cassette and a linker inserted to preserve both the frame and the restrictions sites (see 
Supplementary Material). QuikChange (Stratagene, La Jolla, CA) site-directed mutagenesis was 
performed using oligonucleotides described in the Supplementary Material. This mutation 
changed an essential glycine at position 67 [43] to a serine, maintaining the native -barrel 
structure without forming the chromophore. This plasmid, pET/CyaA
1488-1680
-Y* was used for 
the expression of CyaA
1488-1680
-YFP* (where * denotes a non-fluorescent mutant). Separately, 
plasmid pSET-CFP (Invitrogen, Carlsbad, CA) was mutated with oligonucleotides (see 
Supplementary Material) to produce pSET-CFP*. The mutated CFP* was PCR amplified with 
NdeI and BsrGI and cloned back into similarly digested pET/CyaA
1488-1680





 was made by inserting a 6xHis Tag and stop 
codon into a unique XhoI site immediately downstream of the RTX-repeats (see Supplementary 
Material). All mutants were purified as described previously [41].  
RTX-MBP was created by ligating the RTX sequence to the N-terminus of MBP into pMAL-c4e 
using the NdeI restriction site. The RTX-MBP was subsequently cloned into the pMAL-c4e 
using the AvaI and HindIII restriction sites to create MBP-RTX-MBP. All oligonucleotides are 
described in the Supplementary Material.  
CD Spectroscopy. Experiments were performed with a Jasco (Easton, MD) J-815 CD 
spectrometer with Peltier junction temperature control. Sample concentrations between 1–3 M 
were analyzed in a 0.01 cm quartz cuvette at 25ºC. Baseline spectra of 50 mM Tris, pH 8.0, 
containing either 0 or 10 mM CaCl2 was subtracted from the sample spectra. Spectral 
deconvolution was performed using CDPro software [61]. Each spectrum was deconvoluted 
using three different methods (SELCON3, CONTINLL, and CDSSTR), in each case with 4 





with their respective standard deviation. -helix and -sheet content is given as the sum of both 
ordered and disordered helix and sheet.  
Tryptophan Fluorescence Spectroscopy. Fluorescence measurements were performed with a 
Jasco J-815 CD spectrometer with Peltier junction temperature control and FMO-427S 
monochromator. Samples in 50 mM Tris, pH 8.0, were analyzed in a 1 cm quartz cuvette at 25ºC. 
Changes in intrinsic tryptophan fluorescence were monitored by measuring the emission 
spectrum between 300 and 420 nm (excitation at 294 nm) and are reported at the 340 nm 
emission peak maximum. Fluorescence measurements were performed at least five times. 
Calcium chloride was used to titrate the samples to determine the effect of calcium induced 
structural changes. Calcium titration data were fit to the Hill Equation using Origin 8.0 
(OriginLab, Northampton, MA).   
bis-ANS Binding Fluorescence Spectroscopy. 4,4’-dianilino-1,1’-binaphthyl-5,5’-disulfonic acid 
(bis-ANS) binding to surface exposed hydrophobic patches enabled the monitoring of structural 
changes in RTX-motifs [62]. This technique was mainly applied to constructs lacking the natural 
C-terminal flanking region that contains the conformationally sensitive tryptophan residues. The 
applicability of the bis-ANS binding experiment was verified by comparison of results from 
tryptophan containing constructs. Changes in bis-ANS binding were monitored by measuring the 
emission spectrum between 420 nm and 600 nm (excitation at 390 nm). 250 nM protein samples 
in 50 mM Tris (pH 8.0) were pre-equilibrated with either 0 or 10 mM calcium (and 10 mM 
maltose for the MBP fusions) at 25ºC before introduction of 1 g/mL bis-ANS. Signal from bis-
ANS binding to the fusion protein (either CFP* or MBP) was subtracted from the fluorescence 





Urea Denaturation CD Spectroscopy. CD spectra were collected for samples as stated previously 
in a 0.01 cm quartz cuvette with varying concentrations of urea and either 0 or 10 mM CaCl2. 
Denaturation was monitored by measuring CD spectra between 200 and 250 nm. Data are 
presented at 220 nm. Reversibility was confirmed by dilution of denatured samples and 
measuring the resulting CD spectra. Data were fit to a single unfolding transition with linear 
baselines, though unfolding intermediates cannot be ruled out. The fit is intended to guide the 
readers eye.  
Förster Resonance Energy Transfer (FRET) Efficiency Experiments. FRET experiments were 
done by exciting CFP donor fluorophore at 420 nm and measuring acceptor emission at 527 nm. 
Experiments were performed on a SpectraMax M2 (Molecular Devices, Sunnyvale, CA) 
spectrophotometer. Titrations were done with 1 M protein at 25ºC. Origin 8.0 software was 
used to fit the data to the Hill Equation. FRET efficiency analysis was performed as described 
previously [41].   
Terbium Förster Resonance Energy Transfer. Terbium has been widely used to probe calcium 
binding sites, owing to its similar ionic radius and favorable spectral properties [63-65]. Terbium 
binding can be measured by Förster resonance energy transfer (FRET) from excited tyrosine 
residues in close proximity to a bound terbium ion [63-65]. Changes in terbium binding were 
monitored by measuring the emission at 545 nm (excitation at 282 nm) on a SpectraMax M2 
spectrophotometer. Protein samples (1 M) in 20 mM PIPES (pH 6.8), 120 mM NaCl and 10 
mM KCl were equilibrated with various concentrations of terbium chloride in 96 well plates 
(Costar, Lowell, MA) for 30 min at 25ºC. Fluorescence measurements were performed at least 





PEG CD Spectroscopy. CD spectra were collected for samples as stated previously in a 0.01 cm 
quartz cuvette. 50% PEG8000 and 100 mM CaCl2 were needed to observe beta roll-like CD 
spectra. Buffer baseline spectra were subtracted from the data. Data collected in the presence of 
PEG absorbed light too strongly to produce reliable data below 208 nm, preventing 
deconvolution of the CD spectra. 
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2.1.7 Figures and Tables 
Figure 2.1 Structural Organization of CyaA. 
 
(A) CyaA is a large protein with an N-terminal catalytic domain and C-terminal hemolytic 
domain. A large portion of the hemolytic domain is comprised of RTX-repeats that are organized 
into five blocks (I-V) separated by linkers, or flanking sequences. SS denotes the location of the 
secretion signal. (B) The primary amino acid sequence of the block V RTX-motif is written out, 
highlighting the RTX-repeats and their flanking sequences. The numbers indicate the amino acid 
position in the parent CyaA.  (C) Schematic representation of the block V RTX-motif. The 
straight line segments represent the N- and C-terminal flanks. Hatch marks along the lines denote 







Figure 2.2 Flanked vs. unflanked RTX domain 
 
CD spectra of unflanked (A) RTX 1529-1612 and flanked (C) RTX 1488-1680 in the presence 
(—) and absence (---) of 10 mM calcium, demonstrate flanking residues are needed for calcium-
induced RTX folding. These results are consistent with bis-ANS binding results for the same two 







Figure 2.3 CD Spectra of RTX-Repeats Flank Mutants. 
 
Purified mutants were analyzed using CD spectroscopy, in the presence (—) and absence (---) of 
10 mM calcium. Where conformational change was induced by 10 mM calcium, the CD spectra 
do not overlap each other. RTX 1488-1680 (A), RTX 1488-1653 (B), RTX 1488-1638 (C), RTX 
1520-1680 (F), and RTX 1529-1680 (H) all had different CD spectra in the presence of calcium. 
RTX 1488-1628 (D), and RTX 1488-1612 (E), and, RTX 1520-1653 (G) had similar CD spectra 
regardless of the presence of calcium. The calcium-responsive constructs with fewest flanking 
amino acids were RTX 1488-1638 and RTX 1529-1680. CD data are presented as mean residue 
ellipticity (MRE). The cartoons shown in each spectra are meant to aid the reader in identifying 








Figure 2.4 Calcium Titration of RTX-Motif Flank Mutants. 
 
Purified mutants of RTX 1488-1680 (), RTX 1529-1680 (), and RTX 1488-1638 () all 
demonstrated calcium-induced changes in intrinsic tryptophan fluorescence consistent with 
conformational change. The curves refer to data fit to the Hill Equation and parameters are 







Figure 2.5 Non-native Capping Groups Enable RTX-Repeats Folding. 
 
When RTX 1529-1612 (), (which does not undergo calcium-responsive folding in 10 mM 
Ca
2+
), is fused between CFP and YFP (CFP-RTX-YFP), a calcium-induced increase in FRET 
efficiency is observed. For comparison, RTX 1488-1680 () is fused between CFP and YFP 
(CFP-N-RTX-C-YFP) and a calcium-induced increase in FRET efficiency is also observed. The 
EFRET at zero Ca
2+







Figure 2.6 C-terminal Fusions Enable Calcium-Induced Folding of RTX-Repeats. 
 
RTX 1529-1612 was fused to its natural flanking sequences (A-C), to CFP/YFP (D-F), and to 
MBP (G-I) on its N-terminus (A,D,G), its C-terminus (B,E,H), and on both termini (C,F,I). 
Fusions to the N-terminus resulted in no difference in the bis-ANS binding in the presence (—) 
and absence (---) of 10 mM calcium, while calcium-responsive bis-ANS binding occurred when 










 titration experiments revealed that C-terminal fusions () of (A) natural flanking residues, 
(B) CFP*/YFP*, and  (C) MBP all had similar Tb
3+
 binding affinity to concomitant N- and C- 
terminal fusions (). N-terminal fusions () had lower Tb
3+
 fluorescence. The terbium binding 







Figure 2.8 PEG Enables Calcium-Responsive RTX Folding. 
 
CD spectra of unflanked RTX in calcium and PEG free buffer (solid), and RTX in 100 mM 
CaCl2 (broad dashed) had spectra indicative of unstructured protein. RTX in 50% PEG 3350 
(dotted) had a CD spectra different than either PEG-free sample. Including 100 mM CaCl2 and 






Table 2.1 Summary of Calcium Binding Affinities and Hill Coefficients 
 KD ( M) nH R
2
 
Tryptophan Fluorescence   
    RTX 1488-1680 263 ± 4 5.97 ± 0.5 0.992 
    RTX 1529-1680 194 ± 2 4.69 ± 0.2 0.997 
    RTX 1488-1638 923 ± 9 8.92 ± 0.8 0.993 
FRET   
    RTX 1488-1680 189 ± 13 2.33 ± 0.3 0.989 
    RTX 1529-1612 2035 ± 110             1.16 ± 0.1 0.999 
Errors indicated are standard error values based on nonlinear regression.  








2.1.8 Supplemental Methods 
Oligonucleotides used for truncation mutants. 
Each of the truncated mutants was made using the PCR primers (5’ to 3’) that correspond to their 
starting and final amino acid position. 
1488 F: TATTTTTATCTCGGGGATGACGATGACAAGGGCCAGGGCCGGGGCCTC 
1520 F: TATTTTTATCTCGGGGATGACGATGACAAGGTGTTGCGCAATATCGAGAACGCC 
1529 F: TATTTTTATCTCGGGGATGACGATGACAAGGGCAGCGCGCGTGATGACGTGCTG 
1612 R: ATAATTAAAAAGCTTTTAGCGGATGGTGTCATGGCCGCCGCC 
1628 R: ATAATTAAAAAGCTTTTAGGTGCCGAGAATGCGGATCTCCAG 
1638 R: ATAATTAAAAAGCTTTTAGCGATACCAGTCGTGCACGGTAAGTGC 
1653 R: ATAATTAAAAAGCTTTTACGCCTGGTTGGCGGCATGGATGATTTC 
1680 R: ATAATTAAAAAGCTTTTAGTCCGGATACTGCGCCATTGCCTC 
 
Oligonucleotides used for CFP and YFP G67S mutants: 
CFP G67S F: CCCTCGTGACCACCCTGACCTGGAGCGTGCAGTGCTTCAGCCGC  
and its compliment. 
YFP G67S F: CCTCGTGACCACCTTCGGCTACAGCCTGCAGTGCTTCGCCCGC  
and its compliment. 
NdeI BsrGI Linker-F: TATGGGCGGTTCCGA 
NdeI BsrGI Linker-R: GTAGTCGGAACCGCCCA 
XhoI 6xHis Stop-F: TCGAACACCACCACCACCACTGATAGG 
XhoI 6xHis Stop-R: TCGACCTATCAGTGGTGGTGGTGGTGGTGT 
 













Table 2.2 Deconvolution of CD Spectra. 
Sample  Helix Sheet Turn Unstructured 
RTX 1488-1680  0.075 0.316 0.225 0.375 
RTX 1488-1680 Ca
2+
 0.072 0.382 0.217 0.318 
RTX 1488-1653  0.062 0.312 0.224 0.377 
RTX 1488-1653 Ca
2+
 0.067 0.386 0.227 0.322 
RTX 1488-1638  0.095 0.303 0.224 0.366 
RTX 1488-1638 Ca
2+
 0.100 0.377 0.232 0.290 
RTX 1488-1628  0.071 0.295 0.228 0.408 
RTX 1488-1628 Ca
2+
 0.069 0.296 0.231 0.401 
RTX 1488-1612  0.073 0.288 0.226 0.402 
RTX 1488-1612 Ca
2+
 0.070 0.292 0.230 0.400 
RTX 1520-1680  0.068 0.298 0.227 0.394 
RTX 1520-1680 Ca
2+
 0.058 0.373 0.213 0.347 
RTX 1520-1653  0.040 0.415 0.201 0.343 
RTX 1520-1653 Ca
2+
 0.040 0.427 0.214 0.320 
RTX 1529-1680  0.093 0.291 0.232 0.386 
RTX 1529-1680 Ca
2+
 0.086 0.340 0.222 0.353 
RTX 1529-1612  0.057 0.276 0.234 0.427 
RTX 1529-1612 Ca
2+









Figure S1. Urea denaturation of RTX constructs.  
 
(A) N-RTX-C, and (B) RTX-C in the presence ( ■ ) or absence ( ● ) of 10mM CaCl2. Data are fit 
to a single unfolding transition with linear baselines, though unfolding intermediates have not 
been ruled out. The G and m for N-RTX-C are G = -22.8 kJ/mol and m = 5.4 kJ/mol*M. The 







Figure S2. Percentage Aspartic Acid in CyaA RTX Flanking Groups.  
 





Figure S3. Size Exclusion Chromatography.  
 
Size exclusion chromatography performed on (A) N-RTX-C, (B) RTX, (C) MBP-RTX, and (D) 
RTX-MBP without (solid trace) and with 10 mM Ca2+ (dashed trace). The absorbance at 280 
nm was normalized to minima and maxima for individual traces. The shift in elution volume 
seen in (A) is consistent with a decrease in hydrodynamic radius observed when N-RTX-C folds. 
RTX-MBP is also expected to fold in the presence of calcuim (D) but the large size of the MBP 
compared to RTX  prevents a significant shift in the elution volume.  The lack of appearance of 









2.2  FRET studies 
Note: A version of this chapter entitled ―A FRET-based method for probing the conformational behavior of an intrinsically disordered repeat 
domain from Bordetella pertussis adenylate cyclase‖ appeared in Biochemistry, volume 48, issue 47, pages 11273-11282, October 2009 with co-
authors Geza Szilvay, Mark Blenner, Donald Cropek and Scott Banta. 
OS performed protein purification and CD experiments and analysis of alanine and proline mutants. OS also performed folding reversibility 
studies with Trp fluorescence. 
2.2.1 Abstract 
A better understanding of the conformational changes exhibited by intrinsically disordered 
proteins is necessary as we continue to unravel their myriad biological functions. In repeats in 
toxin (RTX) domains, calcium binding triggers the natively unstructured domain to adopt a beta 
roll structure. Here we present an in vitro Förster resonance energy transfer (FRET)-based 
method for the investigation of the conformational behavior of an RTX domain from the 
Bordetella pertussis adenylate cyclase consisting of nine repeat units. Equilibrium and stopped-
flow FRET between fluorescent proteins, attached to the termini of the domain, were measured 
to analyze the end-to-end distance changes in the RTX domain. The method was complemented 
with circular dichroism spectroscopy, tryptophan fluorescence, and bis-ANS dye binding. High 
ionic strength was observed to decrease the calcium affinity of the RTX domain.  A truncation 
and single amino acid mutations yielded insights into the structural determinants of beta roll 
formation. Mutating the conserved Asp residue in one of the nine repeats significantly reduced 
the affinity of the domains for calcium ions. Removal of the sequences flanking the repeat 
domain prevented folding, but replacing them with fluorescent proteins restored conformational 
behavior, suggesting an entropic stabilization. The FRET-based method is a useful technique that 
complements other low-resolution techniques for investigating the dynamic conformational 






The exploration of intrinsically disordered proteins (IDPs) has greatly broadened our view on 
protein structure – function relations. According to our current understanding, biologically 
relevant function can arise either from an unstructured (disordered), molten globule, or structured 
protein conformation [66, 67]. Most known IDPs adopt a structured form upon interaction with a 
binding partner [68]. The adenylate cyclase toxin (CyaA) protein from Bordetella pertussis (the 
etiologic agent of pertussis or ―whooping cough‖) has an approximately 700 amino acid long C-
terminal part that is natively disordered in the absence of calcium ions [69]. This segment has 
five domains that are each composed of tandemly repeated nonapeptides called repeats in toxins 
(RTX), named so since these motifs are often found in secreted bacterial toxins or virulence 
factors [70]. Domains formed by tandemly arranged repeated RTX motifs are found in secreted 
proteins from gram-negative bacteria, such as in hemolysins, lipases, zinc proteases, nodulation 
proteins and cyclolysins [71-75]. The RTX motifs have a general consensus sequence of 
GGXGXDXUX where U denotes a large hydrophobic amino acid and X represents any amino 
acid. X-ray crystal structures of proteins containing RTX domains show that in the presence of 
calcium, the domain forms a right-handed beta helical structure, the beta roll, where calcium ions 
are bound between turns (GGXGXD) that connect adjacent beta strands (XUX) [72, 73, 76] 
(Figure 2.9A).  
The C-terminal part of CyaA that contains the five RTX domains has been shown to bind 
calcium ions reversibly with low affinity [77, 78]. Thus it has been suggested that in the bacterial 
cytosol, where calcium is scarce (nanomolar concentration [79]), the unstructured domain 
facilitates passage through the type I secretion system [69]. After secretion into an extracellular 





form beta roll structures that are characteristic for the RTX domains. This Ca
2+
-dependent 
conformational change has been suggested to be an allosteric switch that causes a transformation 
of the CyaA into a biologically active form [78, 80, 81]. In the active form, CyaA can bind to a 
target cell surface and form a pore with its hydrophobic domain. Subsequent translocation of the 
CyaA into the cell causes uncontrolled cyclic AMP synthesis leading to cell death. 
 A general structural understanding of the behavior of RTX domains is emerging, although there 
are still features that need to be explained. The X-ray crystal or NMR structures of some proteins 
containing RTX domains in their calcium-bound state are available but a structure of the CyaA 
RTX domains has not been reported. Understanding the conformational changes that take place 
in the RTX domains is important to elucidate the mechanism of the calcium dependent secretion 
and activation of CyaA and other similar toxins. Furthermore, this will aid the development of 
efficient preventive and therapeutic strategies against B. pertussis infection.  
The conformational behavior of IDPs or disordered peptides has been proposed to be of potential 
use in the development of protein switches [82-85]. These proteins or peptides can function as 
stimulus-responsive elements that can modulate the properties of engineered systems, e.g., by 
changing cross-linking size in materials or attenuating protein function [21, 82, 86]. Several 
research groups are working to better understand the function of control elements occurring in 
natural proteins and to utilize them as stimulus-responsive components in engineered systems.  
To study the conformational changes of IDPs, and specifically the last RTX domain in CyaA, we 
have engineered a genetically encoded Förster resonance energy transfer (FRET) reporter 
(Figure 2.9B and C). In the fusion protein, the RTX domain is inserted between two fluorescent 





The method is a useful way to study the conformational changes in protein domains under 
various conditions. The results were compared with circular dichroism (CD) and fluorescence 
spectroscopy studies.  
2.2.3 Materials and Methods 
2.2.3.1 Plasmid constructs  
To generate the FRET constructs, the genes for cyan fluorescent protein (CFP), an RTX domain, 
and yellow fluorescent protein (YFP) were assembled sequentially into the vector pET-20b(+) 
(Novagen, Gibbstown, NJ, USA), upstream of a His6-tag encoding segment. The details of the 
recombinant DNA work are available as Supporting Information. Also, the construction of the 
CFP and YFP expression vectors pET/CFP and pET/YFP, the non-fluorescent fusion protein C*-
BR(S)-Y* expression vector pET/C*-CyaA
1488-1680
-Y*, non fluorescent CFP expression vector 
pET/CFP*, the maltose binding protein – RTX domain fusions, and site-directed mutagenesis is 
described in the Supporting Information.  
2.2.3.2 Protein expression and purification 
Proteins were expressed in Escherichia coli BL21(DE3) cells (Invitrogen, Carlsbad, CA, USA). 
C-BR(L)-Y, C-BR(S)-Y, their mutants, and YFP control protein expressing cells were induced at 
mid-log growth phase with 0.04 mM isopropyl -D-1thiogalactopyranoside. Expression was 
continued for 16 h at 20 C. Using these conditions YFP and its fusion partners were expressed in 
soluble form but expression at 37 C for 4 h resulted in protein accumulation in inclusion bodies. 
CFP expression cultures were induced with 0.4 mM isopropyl -D-1thiogalactopyranoside at 
37 C for 4 h. The amount of expressed soluble CFP seemed to be approximately equal at 37 C 





HCl buffer at pH 8 supplemented with 10 mM CaCl2, 20 mM imidazole and a protease inhibitor 
cocktail (Complete Mini, EDTA free (Roche, Indianapolis, IN, USA)) and lysed using an 
ultrasonicator tip. The target proteins were purified using HiTrap Ni-affinity chromatography 
(GE Healthcare, Piscataway, NJ, USA), concentrated using Amicon 15 ultrafiltration cartridges 
(Millipore, Billerica, MA, USA) and subsequently applied to a 16/60 Superdex 200 preparative 
grade gel filtration chromatography column (GE Healthcare) equilibrated with 50 mM Tris-HCl 
buffer at pH 8 containing 200 mM sodium chloride. Fractions containing protein were pooled 
and exchanged into 50 mM Tris-HCl buffer at pH 8 by ultrafiltration. Samples analyzed by SDS-
PAGE showed at least 95% purity. Protein concentrations were determined 
spectrophotometrically from CFP absorption using the published molar extinction coefficient 
[87]. The resulting concentrations corresponded well to the values determined from the YFP 
absorption and its molar extinction coefficient [87]. 
The expression and purification of BR(L), BR(S), BR(L)-D/A, and BR(L)-D/P were carried out 
using the pMAL expression system (New England Biolabs, Ipswich, MA, USA) according to the 
manufacturer’s protocol. Briefly, the protein was expressed as a fusion to maltose binding 
protein (MBP), the clarified bacterial lysate was applied to an amylose column, washed, and the 
MBP fusion protein was eluted with maltose. Subsequently enterokinase was used to cleave the 
MBP from its fusion partner. The proteins were finally purified from MBP and enterokinase by 
anion exchange chromatography on a Hi Prep 16/10 Q FF column (GE Healthcare) and size 
exclusion chromatography on a Hi Load 16/60 Superdex 75 column (GE Healthcare). SDS-





2.2.3.3 Fluorescence spectroscopy and quantitation of FRET efficiency 
Fluorescence spectroscopy was performed using a SpectraMax M2 (Molecular Devices, 
Sunnyvale, CA, USA) spectrophotometer. Tryptophan fluorescence was measured by excitation 
at 295 nm and emission at 340 nm. FRET analysis was done by exciting the donor fluorophore at 
420 nm and recording the emission spectrum. The FRET efficiency (FRET E) (the fraction of 
excitation energy transferred from the donor (CFP) to the acceptor (YFP)) was observed as the 
increase in acceptor emission at 527 nm, and calculated using the method described by Clegg [88] 
and utilized earlier in protein-protein interactions [89]. The method has several benefits as 
compared to the often used donor quenching method [88]. Small amounts of free donor in the 
sample (such as from degraded fusion protein) does not affect the calculated FRET E. 
Furthermore, the method uses the directly excited acceptor fluorescence as an internal control for 
concentration thus accounting for any variation in protein concentration across samples.  
According to the method [88], the fluorescence contribution of the acceptor was extracted from 
the emission spectrum by subtracting a normalized fluorescence spectrum of a donor-only 
sample from the measured sample. The resulting spectrum contains the acceptor fluorescence 
arising from FRET and directly excited acceptor. This spectrum was then divided by the 
fluorescence of the acceptor when excited directly at 490 nm, where only the acceptor is excited. 










      (1) 
where ( ) denotes the extinction coefficients of CFP and YFP at wavelength  [88] and ( ) 





measure both the FRET E and the fluorescence of the directly excited acceptor, the quantum 
yield 
YFP








(490) 0.0193. The apparent inter-chromophore distance r was calculated from the 





         (2)  
where the published Förster distance R0 of 4.9 nm [90] was used and assuming random relative 
orientation of donor and acceptor (orientation factor K
2
-value set as 2/3).  
Titrations were performed at 1 M protein concentration with CaCl2, NaCl, (NH4)2SO4 or MgCl2, 
in 50 mM Tris-HCl buffer at pH 8.0. The Origin 8.0 (OriginLab, Northampton, MA, USA) 
software was used to fit the Hill model to the titration curve data and retrieve the best-fit values 
for apparent KD and Hill coefficients. 
Fluorescence of the dye 4,4'-bis(1-anilinonaphthalene 8-sulfonate) (bis-ANS, Sigma, St. Louis, 
MO, USA) at 1.6 µM in the presence of 250 nM protein was measured with a Jasco J-815 
spectrometer by exciting the sample at 390 nm and scanning the emission spectra from 420 to 
600 nm.  
2.2.3.4 Comparison of FRET derived dimensions with theoretical polymer models 
The continuous worm like chain (WLC) model was used to describe a random coil structure 
between the FPs [91]. In this model, the average end-to-end distance of a polymer is described 
by rigid segments characterized by the persistence length lp. The mean square end-to-end 










       (3) 
The contour length, lc, for a polypeptide chain was defined as 0.38 nm per amino acid. In 
addition to the RTX inserts (195 or 86 amino acids, including a 2 amino acid linker), 11 amino 
acids in CFP and 3 in YFP that link the FP terminus to structured parts of the FP, were estimated 
as unstructured based on X-ray crystal structures (PDB IDs 1CV7 and 1YFP). Furthermore, for 
simplicity, the chromophore – FP surface distance of 1.5 nm and 2.3 nm for CFP and YFP, 
respectively, was approximated as flexible. Thus, the lc between chromophores for C-BR(L)-Y 
and C-BR(S)-Y was estimated as 83 nm and 42 nm, respectively. For the model of a self-
avoiding walk of a freely jointed Gaussian chain formed by N number of links each having a 
length of a = 0.38 nm (lc = aN), the mean end-to-end distance was described as r = aN
3/5
 [92].  
2.2.3.5 Stopped-flow FRET 
Folding kinetics of C-BR(L)-Y were measured as the change in FRET acceptor fluorescence in 
time with a Jasco J-815 spectrometer equipped with a fluorescence monochromator (FMO-
427S/15) (Jasco Inc., Easton, MD, USA) and a stopped-flow apparatus (SFM-20) with a 2 mm 
light path cuvette (dead time ~10 ms) (Bio-Logic, Claix, France). Samples were excited at 420 
nm and emission of the acceptor was monitored at 527 nm. The rates of calcium-induced 
fluorescence change were measured by rapid mixing of 4 µM protein and 0 – 1 mM CaCl2 in 50 
mM Tris buffer at pH 8. Unfolding rates were measured by rapid mixing of protein pre-incubated 
with 0 – 10 mM CaCl2 and a 5 – 20-fold molar excess of ethylene glycol tetraacetic acid (EGTA). 
The EGTA concentrations used did not have an observed effect on the unfolding rates. Single 
exponential curves were fit to the data using Origin 8 (OriginLab) to determine the values of the 





2.2.3.6 Circular dichroism spectroscopy 
Far-UV circular dichroism (CD) spectroscopy was performed with a Jasco J-815 CD 
spectrometer equipped with a Peltier temperature control in a 0.01 cm quartz cuvette. Samples 
were scanned in 50 mM Tris-HCl buffer at pH 8 from 250 nm to 190 nm in continuous mode, 
with a scan speed of 50 nm/min, response time of 2 s, and by accumulating 5 scans at 25 C. 
Secondary structure contents were estimated using the program CDPro [93]. 
2.2.4 Results 
The beta roll domain chosen for this study was the fifth RTX domain block (residues 1488 – 
1680), of CyaA from B. pertussis (Uniprot ID P15318). This sequence includes the N- and C-
terminal non-RTX sequences that flank the core nine repeat RTX domain and were previously 
shown to be required for the calcium-responsive conformational change [78]. Residues 1488 – 
1528 and 1613 – 1680, upstream and downstream of the RTX domain, are here referred to as 
flanking sequences (Figure 2.9B). The protein was termed CyaA
1488–1680
 by Bauche et al. [78] 
and is referred here to as BR(L) for simplicity (―L‖ for long). The fusion protein where the BR(L) 
was inserted between the FPs was named C-BR(L)-Y, where C and Y refer to CFP and YFP, 
respectively. The core RTX domain sequence without the flanking sequences comprising the 
amino acids 1529 – 1612, was similarly inserted between the FPs, yielding C-BR(S)-Y (―S‖ for 
short). All used RTX domain constructs used in this study are summarized in Table S1 
(Supporting Information). 
2.2.4.1 The calcium-free conformation of the CyaA RTX domain 
FRET taking place between the FPs was observed as a reduction in CFP (donor) fluorescence 
and increase in YFP (acceptor) fluorescence when exciting the donor at 420 nm (Figure 2.10A). 





that corresponds to an average inter-FP distance of about 6.6 ±0.3 nm, when assuming random 
orientation of donor and acceptor. Similarly, the initial FRET E for the shorter RTX domain C-
BR(S)-Y was 0.22 ±0.01, corresponding to an average inter-FP distance of 6.1 ±0.1 nm. As 
expected, an equimolar mixture of free CFP and YFP had a very low FRET E value of 0.012 
±0.001 (Figure 2.10A and B inset). 
In order to gain understanding of the calcium-free conformation, the inter-FP distances obtained 
by FRET were compared with the dimensions of theoretical flexible polymers. According to the 
Gaussian self-avoiding walk model, an ideally flexible chain with a length corresponding to that 
of BR(L) and BR(S) (and including all linker sequences as described in Materials and Methods) 
has an average length of 9.6 nm and 6.4 nm, respectively (Table 1).  The FRET distance 
measurements for the C-BR(S)-Y insert (6.1 nm) agreed well with a polypeptide that behaves as 
a Gaussian chain (6.4 nm). The C-BR(L)-Y insert, however, has more compact dimensions (6.6 
nm) than a corresponding Gaussian chain (9.6 nm).  
The WLC model was then used to describe the flexibility of the RTX domains. This model 
describes the conformation distribution of a semi-flexible polymer where chain segment 
direction has a persistent memory characterized by the persistence length, lp. The persistence 
length values for C-BR(L)-Y and C-BR(S)-Y were calculated using Equation 3 and the apparent 
FP separation distances obtained by FRET and were determined to be 0.26 nm and 0.45 nm, 
respectively (Table 1). The value for lp has previously been determined to be about 0.5 – 0.7 nm 
for large IDPs, 0.4 – 0.45 nm for flexible polypeptide linkers, and 0.3 nm for protein loop 
structures [91, 94, 95]. The lp value for C-BR(S)-Y thus corresponds to a flexible or disordered 





2.2.4.2 Calcium-induced FRET change 
The addition of 10 mM CaCl2 to C-BR(L)-Y caused a rapid reduction in the CFP fluorescence 
and an increase in the YFP fluorescence as shown in Figure 2.10A. The calculated FRET E in 10 
mM CaCl2 was approximately 0.57 ±0.09. This calcium-dependent change in FRET E from 0.15 
to 0.57 was attributed to a change in RTX domain end-to-end distance and thus folding of the 
RTX domain. The fluorescence emission spectrum of the control sample containing a 1:1 ratio of 
free CFP and YFP did not change upon CaCl2 addition (Figure 2.10A and B). The calcium-
induced FRET E for C-BR(S)-Y increased from 0.22 ±0.01 to about 0.56 ±0.06 (Figure 2.10B), 
and thus both RTX domains reached the same FRET E values that correspond to apparent 
average FP separations of 4.7 ±0.3 nm and 4.7 ±0.2 nm for C-BR(L)-Y and C-BR(S)-Y, 
respectively (Table 2.3).  
To compare the FRET derived dimensions of the calcium-bound state with the size of a 
theoretical beta roll structure, the rough dimensions of potential beta roll structures were 
estimated from available X-ray crystal structures (see Supporting Information). The total inter-
chromophore distance for a theoretical beta roll structure formed by all amino acids between the 
FPs in C-BR(L)-Y (193 amino acid RTX insert) and in C-BR(S)-Y (84 amino acid RTX insert) 
would be roughly 7.5 nm and 4.8 nm, respectively. Thus, the FRET derived apparent distance 
value for calcium-bound C-BR(S)-Y (4.7 nm) corresponds well to the size of the theoretical 
inter-FP distance when the insert assumes an all beta roll structure. As the calcium-bound 
structure of C-BR(L)-Y had very similar FRET dimensions (4.7 nm) but possesses the additional 
non-RTX flanking regions, these flanking regions possibly adopt a compact conformation that 





possible that folding brings the two FPs to close proximity so that they can interact in a similar 
way both in C-BR(L)-Y and in C-BR(S)-Y.  
2.2.4.3 Calcium-binding affinity and kinetics as measured by FRET  
The Ca
2+
-induced folding of C-BR(L)-Y, its mutants and C-BR(S)-Y was studied by equilibrium 
titration experiments (Figure 2.10B). The Hill model was fitted to the data using non-linear 
regression and the obtained parameters are summarized in Table 2. The calcium-dependent 
FRET E change in C-BR(L)-Y was clearly sigmoidal in shape having a Hill coefficient of 2.4 
and an apparent KD of 190 µM for Ca
2+
. The data show that the affinity for Ca
2+
 is relatively low 
and folding is cooperative. Calcium titrations with C-BR(S)-Y showed that this protein had an 
even lower affinity having an apparent KD of 2.0 mM for calcium. Moreover, C-BR(S)-Y was 
almost non-cooperative with a Hill coefficient of 1.16. 
To investigate the role of the Asp residues in the CyaA RTX domain conformational change, the 
Asp residue in the fifth RTX nonapeptide repeat was mutated to an Ala or a Pro residue resulting 
in C-BR(L)-Y-D/A and C-BR(L)-Y-D/P. Both mutations significantly reduced the calcium 
affinity of the domain to about 850 µM (pair-wise Student’s t-test, p<0.05) (Figure 2.10B, Table 
2.4). Furthermore, the Hill coefficients of both mutants were about 1.2, indicating an almost non-
cooperative calcium binding. The mutants and wild-type constructs reached approximately the 
same FRET E value at 10 mM Ca
2+
 concentration (Figure 2.10B, inset).  
To gain insight into the folding rates of the RTX domains, the fast kinetics of the FRET change 
of C-BR(L)-Y were followed using stopped-flow fluorescence spectroscopy. Empirically, the 
fluorescence change rate was a mono-exponential process as the fluorescence traces were well fit 





constant of the conformational change as a function of calcium concentration has a sigmoidal 
shape, suggesting that the folding is a multi-step reaction that cannot be modeled with simple 
bimolecular rate equations (Figure 2.10C). The unfolding of the calcium bound RTX in calcium-
free conditions (EGTA as a Ca
2+
 sink) is a unimolecular process that occurred at a constant rate 
of koff = 0.33 s
-1
 over the studied calcium concentration range. By applying the apparent KD for 




 can be 
calculated (where KD = koff/kon). As this is an apparent rate constant, however, it should be taken 
only as an overall value for the ensemble of the individual binding sites. As a whole, the 
preliminary kinetic results presented here indicate that the FRET method can potentially be 
applied to study the beta roll folding mechanism in detail.  
2.2.4.4 Calcium-induced changes in Trp fluorescence 
The fluorescence of the Trp amino acid side chain is sensitive to the polarity of its local 
environment and thus Trp fluorescence can be used to study structural changes in proteins that 
take place near Trp residues. The domain BR(L) has two Trp residues in its C-terminal flanking 
sequence (Figure 2.9B) that upon conformation change increase in fluorescence intensity. 
Because of the linear nature of the beta roll structure, the FRET and Trp fluorescence methods 
will report conformational changes of different parts of the protein. While the FRET 
measurements probe the average conformation of the whole protein, the Trp fluorescence 
emphasizes the C-terminal part of the protein. A combination of the two methods is very 
valuable as variation in the calcium binding properties along the length of the protein can be 
discerned. In CaCl2 titration experiments with C-BR(L)-Y, a sigmoidal increase in the Trp 
fluorescence was observed and an apparent KD of 160 µM and a Hill-coefficient of 4.2 was 





curve obtained with the FRET method (Fig. 2B). The calcium affinities of the Ala and Pro 
mutants were lower than that of the wild-type. However, the maximum change in Trp 
fluorescence was not affected by the mutations. The dissociation constants and Hill coefficients 
determined using both Trp fluorescence and FRET are compared in Table 2.4. The BR(S) protein 
does not contain any Trp residues as they are present only in the C-terminal flanking region, and 
thus there was no change in Trp fluorescence upon calcium addition (data not shown).  
2.2.4.5 RTX conformational changes in different environments 
The Ca
2+
-dependent FRET E change of C-BR(L)-Y was studied in various NaCl concentrations 
to explore the effect of ionic strength on the conformational change. The resulting calcium 
titration curves showed that with an increasing ionic strength, more CaCl2 was needed to elicit 
the FRET response (Figure 2.11). The apparent dissociation constants increased as a function of 
ionic strength, from 0.19 mM in the absence of NaCl to 1.4 mM at 200 mM NaCl. The same 
ionic strength effect was also observed in Trp fluorescence measurements (data not shown).  
Titrations were also performed with NaCl, (NH4)2SO4, and MgCl2 to explore the effect of 
different salts on C-BR(L)-Y conformation (Fig. S2, Supporting Information). None of the tested 
salts affected the FRET E of equimolar mixtures of CFP and YFP. The FRET E and Trp 
fluorescence of C-BR(L)-Y increased only slightly as a function of ionic strength when titrated 
with NaCl or (NH4)2SO4 (Fig. S2A and S2B). The stronger hydrophobic interactions at high salt 
concentrations may cause the C-BR(L)-Y to adopt a slightly more compact unfolded state 
conformation.  
Titration with MgCl2 caused an increase in FRET at high MgCl2 concentrations, however, the 





fluorescence was not increased by the addition of MgCl2 and, moreover, the Ca
2+
-titration Trp 
fluorescence curve was not affected by the presence of magnesium (data not shown). The effect 
of MgCl2 on the FRET curve was identical with all tested proteins (C-BR(L)-Y, C-BR(S)-Y and 
C-BR(L)-Y-D/A) , demonstrating that the Mg
2+
-induced FRET E increase is independent of the 
sequence between FPs. Furthermore, Mg
2+
 did not cause a change in the studied RTX domain 
CD spectra as discussed below. Thus it is likely that MgCl2 at high concentrations can cause a 
decrease in inter-FP distance by FP association or eliciting an alternative RTX conformation.  
2.2.4.6 Reversibility of the calcium-induced conformational change 
The chelating agent EGTA was able to reverse the calcium-induced increase in FRET E and Trp 
fluorescence in C-BR(L)-Y. Furthermore, by sequential additions of CaCl2 and EGTA, the 
unstructured/folded transition was observable at least four times (Figure 2.12). In the later rounds, 
the FRET E and Trp fluorescence values were likely affected by the accumulating ionic strength. 
As suggested by the NaCl titration experiments, the high ionic strength present towards the end 
of the experiment can cause small changes in protein conformation. 
2.2.4.7 Calcium-induced conformational changes observed with CD spectroscopy 
Conformational changes in RTX domains flanked with FPs could not be reliably studied with 
CD because the FPs, which are rich in beta sheets exhibited a dominating contribution to the CD 
spectrum. Therefore, CD spectroscopy was performed only on non-fused RTX domains lacking 
the FPs.  
The addition of 10 mM CaCl2 to the RTX domain BR(L) caused a significant change in the CD 
spectrum corresponding to a 7% increase in beta sheet content (Figure 2.13). Addition of Ca
2+
 to 





spectra of the mutants BR(L)-D/A and BR(L)-D/P in the absence of Ca
2+
 was very similar to the 
spectrum of the wild type protein. Upon CaCl2 addition, a qualitative change in CD spectrum 
was observed. However, upon deconvolution of the spectra, no significant secondary structure 
changes were observed. Addition of up to 10 mM MgCl2 or NaCl did not change the CD spectra 
of any of the RTX domains (data not shown). 
2.2.4.8 Calcium-induced conformational changes observed by bis-ANS fluorescence 
Based on the FRET experiments, the C-BR(S)-Y conformation was calcium responsive but CD 
spectroscopy showed that BR(S) conformation was not. Due to the lack of Trp residues in the 
uncapped variant BR(S), it was not possible to follow Trp fluorescence and the presence of the 
FPs in C-BR(S)-Y hindered CD spectroscopy experiments as discussed above. Thus, an 
orthogonal method for studying the conformational changes in the C-BR(S)-Y protein was 
desired to complement the FRET measurements. The fluorescent dye bis-ANS is often used as a 
reporter for changes in protein conformation as its fluorescence properties change upon binding 
to extended hydrophobic patches. As the fluorescence of the FPs interfered with the bis-ANS 
fluorescence spectroscopy, a non-fluorescent mutant of C-BR(S)-Y, C*-BR(S)-Y*, was 
generated where an essential Gly residue involved in the chromophore maturation was mutated 
to a Ser residue in both FPs [96] (see Supporting Information).  
The bis-ANS binding to the non-fluorescent proteins C*-BR(S)-Y*, CFP* and BR(S) was 
measured in the presence and absence of CaCl2 (Figure 2.14). Addition of 10 mM CaCl2 to the 
non-fluorescent C*-BR(S)-Y* resulted in a 3.2 fold increase in the maximum fluorescence of 
bis-ANS, accompanied by a peak shift from 495 nm to 475 nm, indicative of a conformational 
change (Figure 2.14). NaCl at 10 mM had no significant effect on the bis-ANS fluorescence. 





in bis-ANS fluorescence indicating a lack of conformational change. In a control sample with 
two molar equivalents of non-fluorescent CFP*, only a small fluorescence increase of 1.7 fold 
was observed with no change in peak wavelength.  
2.2.5 Discussion 
2.2.5.1 Design of the FRET based conformational change reporter 
FRET is a convenient and well-known method for the study of changes in distances between 
molecules or between parts of molecules [97] and thus it has also been termed as the 
―spectroscopic ruler‖ [98]. Using a suitable energy transfer donor and acceptor chromophore pair, 
the FRET efficiency (FRET E) depends on the donor – acceptor distance and relative orientation. 
To study the conformational changes in RTX domains, we engineered a genetically encoded 
FRET reporter that utilizes the distance dependent changes in energy transfer from CFP to YFP. 
In the fusion protein, the studied RTX domains were sandwiched between the two FPs (Figure 
2.9C) [99]. Similar FRET constructs have previously been used to report the conformational 
changes in structured proteins, often with the goal of engineering intracellular sensors [99-102]. 
The conformation ensemble of disordered proteins has been examined with FRET between FPs 
[94], and chemically linked small-molecule fluorophores have been used to study conformational 
changes in IDPs [103]. The present study shows that the genetically encoded FRET reporter 
system is a suitable method for the study of IDPs and their ligand-induced conformational 
changes. The advantages of this method over other low-resolution structural methods such as CD 
spectroscopy are that other components in the sample such as other proteins, buffer components 
or impurities do not complicate the measurements. Furthermore, no chemical fluorophore 





The FRET-based reporter can be used to study the conformations and structural dynamics of a 
CyaA RTX domain by measuring the apparent distance between the flanking FPs (Figure 2.9C). 
The studied RTX domain is predicted to form a calcium-binding beta roll –like structure based 





-induced increase in beta sheet content strongly support the structural prediction. Using 
the genetically encoded FRET constructs, we were able to explore the calcium-free and calcium-
bound conformations, and furthermore, study the structural and environmental factors affecting 
the conformational change dynamics.  
2.2.5.2 The unstructured conformations of the RTX domains 
In the absence of calcium, the FRET derived average inter-chromophore distance of C-BR(L)-Y 
was smaller than if the protein behaved as an ideal Gaussian chain-like polymer. Furthermore, 
the WLC model predicted that the persistence length was shorter than what is typical for IDPs, 
suggesting that some residual structure is present in this sequence. Also, the calcium-free 
conformation of BR(L) has been previously shown to possess residual structure as addition of 
denaturant was required for complete unfolding [78]. The C-BR(S)-Y, however, had a 
conformation that corresponded to a polymer behaving like a Gaussian flexible chain. Moreover, 
the WLC model predicted a persistence length that is typical for IDPs. The finding suggests that 
the conserved RTX sequence, BR(S), is mostly unstructured in the absence of calcium and the 
protein parts flanking this core sequence (found in BR(L)) have at least some residual structure. 
Recently, it has been shown that the about 700 amino acid long C-terminal half of CyaA is 
unstructured in the absence of calcium [69]. Our results show that there is variation in the extent 
of structure along the CyaA C-terminal part in the absence of Ca
2+
. The studied fifth RTX 





pH, mostly due to a high number of Asp residues, which probably cause electrostatic repulsion 
along the chain and perhaps effectively keeps the domain unstructured [104].  
2.2.5.3 Calcium-induced conformational change in C-BR(L)-Y 
Addition of Ca
2+
-ions to the unfolded RTX domain causes the equilibrium to shift towards the 
folded beta roll state. When Ca
2+
-ions bind to the RTX domain, they can compensate for the 
negative charge and thus enable folding into the beta roll conformation. The Ca
2+
-ions are an 
important structural part of the beta roll as the polypeptide chain folds around the cations. The 
structure is also stabilized by hydrogen bonding in the beta sheets and by hydrophobic 
interactions between the two beta sheets (Figure 2.9). Introducing calcium to C-BR(L)-Y causes 
a fast conformational change as observed by a decrease in the average FP distance using FRET 
and increase in Trp fluorescence (Figure 2.10). Correspondingly, a conformational change and 
an increase in beta sheet content were observed with CD spectroscopy in BR(L) (Figure 2.13). 
Our data is consistent with a previous related study where the conformational change of BR(L) 
was studied using CD, Trp fluorescence and limited proteolysis [78]. 
2.2.5.4  Role of the natural and artificial flanking groups in beta roll conformational 
change 
The importance of the flanking sequences for the RTX folding has previously been shown in 
CyaA [78]. Consistent with previous reports, our studies using CD spectroscopy showed that the 
sequences flanking the RTX domain in BR(L) were necessary for a Ca
2+
-induced conformational 
change as the BR(S) lacking those sequences was not responsive to Ca
2+
 (Figure 2.13). 
Surprisingly, when the RTX domain was studied with FRET using the C-BR(S)-Y construct, a 
significant calcium-induced conformational change was observed that resulted in approximately 







-binding was, however, reduced as compared to the C-BR(L)-Y. Also, a conformational 
change was seen in C*-BR(S)-Y*, but not in BR(S), by bis-ANS binding experiments (Fig. 6). 
Taken together, the results indicate that the FPs at both termini are able to restore the Ca
2+
 
dependent beta roll structure formation ability of BR(S), though a higher Ca
2+
 concentration is 
needed. These natural endcaps do not seem to have a specific role in the beta roll structure 
formation but may act as passive structural caps. It is possible that the large FP endcaps reduce 
the entropy of the unfolded state and thus, in the presence of calcium, drive the equilibrium 
towards the folded state. In the folded state, the caps can potentially prevent fraying by providing 
interactions at the beta roll ends and, moreover, shield the hydrophobic core.  
The need for capping groups may be a general requirement for repeat proteins. Engineered caps 
have been designed for some repeat proteins based on their natural caps [47, 105, 106], but the 
possibility for non-related protein domains to act as artificial caps in repeat proteins has not been 
addressed before. It remains to be seen if non-native capping groups can also be employed in 
other repeat proteins and, conversely, if proteins other than the FPs used here can function as 
capping groups. Further structural studies of the roles of the caps should provide insight to how 
the allosteric calcium-binding signal is translated through RTX folding to the rest of the protein.  
Protein domains are known to be able to affect the folding of their fusion partners [107]. Thus, it 
seems that the FP based FRET method is particularly suitable for the study of protein fragments 
as the fragments are in a more native like environment as opposed to studies in isolation from 
other protein domains. Conversely, it is likely that conformational studies of whole proteins 





2.2.5.5 The calcium-bound structure of C-BR(L)-Y and C-BR(S)-Y 
The dimensions obtained by FRET for the C-BR(S)-Y in its Ca
2+
-bound form correspond well to 
a conformation where the RTX domain has adopted a 4.5 turn beta roll conformation (Table 2.3). 
The dimension for C-BR(L)-Y on the other hand is only slightly longer suggesting that the 
flanking regions form a compact structure. Also, as these flanking regions lack the consensus 
RTX sequence it is likely that they do not form a calcium-dependent beta roll structure. Addition 
of calcium, however, causes the C-terminal flanking region to fold as suggested by the observed 
increase in Trp fluorescence.  
2.2.5.6 Calcium ion affinity of the RTX domains 
The affinity of C-BR(L)-Y for Ca
2+
 is relatively low with an apparent KD of 190 M, according 
to FRET E and 160 M according to Trp fluorescence (Figure 2.10 and Table 2.4). That the two 
independent methods result in similar values demonstrates that they report about the same 
conformational change. The Ca
2+
-affinity of C-BR(L)-Y was observed to decrease with 
increased ionic strength (Figure 2.11). It is likely that due to the ionic nature of the Ca
2+
 – Asp 
residue interaction, Na
+
-ions at sufficiently high concentrations can shield this interaction and 
thus reduce the RTX affinity for Ca
2+
. The BR(L) has previously been shown to bind about 6 – 7 




 and an apparent affinity in the mid-micromolar range [78], which is 
consistent with our data. Furthermore, the Ca
2+
 affinity of the -haemolysin from Escherichia 
coli was determined to be about 110 M [71]. However, the entire C-terminal RTX cluster of 
CyaA was shown to have a slightly lower overall Ca
2+
 affinity of about 600 M [77].  
The low Ca
2+
-affinity of C-BR(L)-Y was also evident in the fact that chelating agents readily 












 irreversibly [108, 109]. The low calcium affinity of beta rolls has been attributed to 
keeping the protein unstructured in the cytosol which would facilitate secretion through the T1 
channel [69]. Also, Ca
2+
 binding usually activates the protein functions. Thus, the Ca
2+
-binding 
in RTX domains seems to be an allosteric safety switch to prevent activation of potentially 
detrimental toxin activity in the bacterial cytosol. 
2.2.5.7 Cooperativity in calcium-induced RTX conformational change 
The Ca
2+
-induced conformational change had a cooperative character as shown by both FRET 
and Trp measurements (Figure 2.10,Table 2.4). The structural basis for the Ca
2+
 binding 
cooperativity lies in the elongated structure of this linear repeat-protein. According to published 
X-ray crystal structures of beta rolls, a calcium-binding site is formed between two adjacent 
turns by backbone oxygens and carboxyl groups of two Asp residues. Further, each turn 
coordinates two adjacent Ca
2+
 ions (Figure 2.9A). Cooperativity arises because binding of one 
ion causes the formation of half of the binding site for the next ion (along the helical axis). In 
addition, ion binding in one side of the domain very likely increases the possibility for the turns 
on the opposite side (perpendicular to the helical axis) to form and bind an ion. Due to the 
extended beta roll structure, the binding of each Ca
2+
-ion only increases the affinity of an 
adjacent binding site and thus the mechanism of cooperativity is probably mostly sequential in 
nature. The finding that the macroscopic calcium affinity near the Trp residues and across the 
whole protein are very similar suggests that the individual binding sites are alike, which is 
consistent with the repetitive structure. The higher Hill coefficient for the C-terminal side than 
across the whole domain, however, indicates that the cooperativity is translated to neighboring 





important from the folding point of view. This could be a factor why the flanking sequences have 
been shown to be important [78]. In support of this view, the folding of repeat proteins have 
often been observed to be nucleated at one end of the protein and then to proceed directionally 
along the protein towards the other end [26].  
2.2.5.8 Role of a central conserved Asp residue on the RTX conformational change 
Asp residues are highly conserved in the sixth position in RTX motifs and only occasionally 
substituted by Asn residues. To study the significance of a single Asp residue and its effect on 
folding cooperativity we mutated a central Asp residue in C-BR(L)-Y and BR(L) to an Ala or 
Pro residue. The mutants lack the carboxyl group of the Asp residue and, furthermore, the Pro 
mutant is more constricted in its backbone flexibility. 
Both mutations reduced the apparent Ca
2+
 affinity and cooperativity as observed by FRET and 
Trp fluorescence (Figure 2.10). However, the affinity and cooperativity of the C-terminal side 
was much less affected as observed with Trp fluorescence, probably because the Trp residues are 
distant from the mutation site. The reduction in the overall apparent Ca
2+
 affinity was very 
pronounced considering that only one nonapeptide repeat out of nine was mutated. The mutation 
creates a non-responsive site in the protein that effectively prevents crosstalk between each side 
of the mutation and thus reduces the cooperativity. Analysis of the same mutants without the FPs 
using CD spectroscopy showed that both the D/A and D/P mutants had a reduced ability to 
undergo Ca
2+
-induced conformational change when compared to the wild-type RTX domain 
(Figure 2.13). Similarly, mutating two Asp residues in a beta roll domain of a bacterial lipase 
PML variant has been reported to significantly impair Ca
2+
 binding [110]. It was also shown that 





2.2.5.9 FRET as a tool to study conformational changes in RTX domains  
The developed FP based FRET method was successfully used to study the conformational 
behavior of a CyaA RTX domain. The method proved to be a valuable addition to the presently 
available toolbox for structural analysis of conformational changes in intrinsically disordered 
domains. By combining the FRET method with CD and fluorescence spectroscopy, we could 
study both the unstructured and structured conformations, and the dynamics of the structural 
change. Furthermore, the construct could also potentially be used for the engineering of protein 






2.2.6 Figures and Tables 
Table 2.3 Inter-chromophore distances determined by FRET  











































 Contour length (lc) between the chromophores of the FPs, calculated as described in Materials 
and Methods. 
b
 Average end-to-end distance of a theoretical Gaussian chain with the contour 
length lc. 
c
 The persistence length lp was calculated using the WLC model where the inter-
chromophore distance was obtained from FRET measurements as described in Materials and 
Methods. 
d
 The WLC model is not applicable as such to the structured state because the lc of a 
structured protein is defined by the structure and not by the extended chain length. The values 
given in parenthesis are calculated using the lc of a fully extended chain solely to indicate that the 
values are smaller than those of the calcium-free conformation. 
e









Table 2.4 Hill equation for RTX domains using FRET 










C-BR(L)-Y 190  10 2.40  0.29 160  3 4.23  0.30 
C-BR(L)-Y-D/A 860  60 1.19  0.07 290  20 3.39  0.68 
C-BR(L)-Y-D/P 850  70 1.20  0.09 310  10 3.23  0.41 





 Determined in 50 mM Tris-HCl buffer at pH 8.0 and 25 C. Values (mean ± SEM) are obtained 
from best fits of the Hill equation to the data. 
b






Figure 2.9 The RTX domains and the genetically encoded FRET reporter. 
 
 (A) Beta roll structure of the Ca2+-bound state of an RTX domain from the Serratia marcescens 
serralysin enzyme (PDB ID: 1SAT) [111]. Ca2+-ions are shown as spheres and the side chains of 
the conserved Asp residues are highlighted. Beta strands, each formed by three amino acids, are 
shown as arrows. Currently there is no protein structure available of a CyaA beta roll. However, 
based on sequence homology, the RTX domains of CyaA are predicted to adopt similar beta roll 
folds. (B) The sequence of the fifth RTX domain (named here BR(S), amino acids 1529 – 1612) 
and its flanking regions (BR(L), amino acids 1488 – 1680) of CyaA from Bordetella pertussis. 
The conserved nonapeptide RTX domain is shown in the middle, and the conserved Asp residues 
involved in Ca2+-binding are highlighted. The flanking regions are indicated and Trp residues 
(1621 and 1645) are underlined. The Asp1570 residue mutated in this work is marked with a box. 
(C) Schematic image of the C-BR(L)-Y fusion protein construct showing the Ca2+-dependent 
beta roll structure formation that alters the distance between the FRET pair CFP and YFP (not 






Figure 2.10 Conformational change as observed by FRET and trp fluorescence 
 
(A) Emission spectra of 1 M C-BR(L)-Y in the absence (solid line) and presence (dashed line) 
of 10 mM CaCl2 when excited at 420 nm. An increase in FRET E was seen as a decrease in CFP 
fluorescence (475 nm) and an increase in YFP (527 nm) fluorescence. Addition of CaCl2 did not 
affect the emission spectra of a mixture of 1 M CFP and 1 M YFP (dash-dot-dotted line, no 
CaCl2 and dotted line, CaCl2 added). (B) The dependence of FRET E on CaCl2 concentration. C-
BR(L)-Y (squares), C-BR(S)-Y (triangles) and the mutants C-BR(L)-Y-D/A (circles), and C-
BR(L)-Y-D/P (diamonds) shown as a relative change in FRET E. The data with apparent FRET 
E values are shown in inset. The mixture of 1 M CFP and 1 M YFP had no change in 
calculated FRET E as a function of CaCl2 (inset, star symbols). The lines are best fits of the Hill 
equation as described in Materials and Methods. (C) Rapid kinetics of C-BR(L)-Y folding 
(squares) and unfolding (circles) at indicated CaCl2 concentrations was measured using FRET as 
described in Materials and Methods. Error bars represent standard errors (n≥3). Representative 
fluorescence time-course traces are shown in Fig. S1. (D) Relative tryptophan fluorescence upon 
CaCl2 addition in C-BR(L)-Y (squares), and mutants C-BR(L)-Y-D/A (circles), and C-BR(L)-Y-







Figure 2.11 Effect of ionic strength on RTX calcium binding 
 




-induced change to FRET E in 
buffer supplemented with 0 – 200 mM NaCl. The lines are best fits to the data with KD values of 











-induced increase in FRET E (black) and Trp fluorescence (white) is reversed with 
EGTA. Repeated conformational changes were induced in the same sample by sequential 
additions of CaCl2 and EGTA. The indicated concentrations are calculated as free CaCl2 








Figure 2.13 CD spectra of RTX domains and mutants 
 
CD spectra of RTX domains in the presence (dashed lines) and absence of CaCl2 (solid lines). 
CaCl2 induces a conformational change in BR(L) (A) but not in BR(S) (B). The mutants BR(L)-







Figure 2.14 Conformational change measured by bis-ANS binding 
 
(A), CFP* (B), and non-fluorescent C*-BR(S)-Y* (C). Bis-ANS fluorescence spectra are shown 
in the absence (solid lines) and presence (dashed lines) of 10 mM CaCl2. The data for two molar 






2.2.7 Supplementary information 
2.2.7.1 Construction of the fluorescent protein-RTX domain fusions for FRET 
experiments 
The gene encoding the enhanced cyan fluorescent protein (CFP) was amplified with polymerase 
chain reaction (PCR) from the plasmid pSET-CFP (Invitrogen, Carlsbad, CA, USA) using the 
oligos 5’-AGCATCACATATGGTGAGCAAGGGCGAGGA-3’ and 5’-
AGCTCATATGCTTGTACAGCTCGTCCATGCC-3’,  thereby introducing NdeI restriction 
sites in both termini (all oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA, USA)). The CFP gene was then inserted as an NdeI –cut (New England Biolabs,  
Ipswich, MA, USA) fragment into NdeI and antarctic phosphatase (New England Biolabs) 
treated pET-20b-series vector pET/SerBR (Blenner M.,  et al., unpublished results) to form 
pET/CFP-SerBR. Site directed mutagenesis (QuikChange  –kit, Stratagene, La Jolla, CA, USA) 
utilizing the primers 5’-GACGAGCTGTACAAGGGCGGCTCTGGTAA-3’ and its 
complementary sequence was used to remove the NdeI-site and the amino acid linker sequence 
HisMet after the CFP to yield pET/CFP-SerBRII. 
The enhanced yellow fluorescent protein (YFP) from the plasmid pEYFP-C1 (Clontech, 
Mountain View, CA, USA) was similarly amplified using the oligos 5’-
TTCGTTCTCGAGATGGTGAGCAAGGGCGAGGAGCTGT-3’ and 5’-
TTACACCTCGAGCTTGTACAGCTCGTCCATGCCGAG-3’ containing flanking XhoI –sites, 
digested with XhoI (New England Biolabs) and inserted into a similarly cut pET/CFP-SerBRΙI 
plasmid to yield pET/CFP-SerBRII-YFP. To make the XhoI  –site between SerBR and YFP 
unique the XhoI  –site between YFP and the  His6 –tag  wasremoved by site directed 





CTCTCGGCATGGACGAGCTGTATAAGGGCGAGCACCACCACCACCACC-3’ and its 
complementary primer and yielding pET/CFP-SerBRII-YFPII.  
The plasmid  pTRCyaAΔ1-1489Δ1682-1706[18](kindly donated by Dr. Ladant, Institute Pasteur, 
Paris, France) was used as a template to amplify the gene fragment CyaA1488-1680 with the 
oligos 5’-TAATATAATGTACAAGGGCCCGGGCCGGGGCCTC-3’, and 5’-
GCGCCGCGCTCGAGGTCCGGATACTGCGCCATTGCCTC-3’ that were flanked by BsrGI 
and XhoI –sites upstream and downstream, respectively. The plasmid pET/CFPSerBRII-YFPII 
was then digested with BsrGI and XhoI to remove the SerBR linker sequence and concomitantly 
ligated with similarly treated CyaA 1488-1680 PCR-fragment yielding the plasmid pET/C-
CyaA1488-1680- Y. In this plasmid, the CyaA1488-1680 gene between the fluorescent proteins 
(FPs) corresponds to the insert in pTRCyaAΔ1-1489Δ1682-1706 described in Bauche et al. and 
encodes for the repeats in toxin (RTX) domain and the flanking regions[18]. 
The plasmid pET/C-CyaA 1529-1612-Y was constructed identically except that the oligos 5’-
TAATATAATGTACAAGGGCAGCGCGCGTGATGACGTGCTG-3’ and 5’-
GCGCCGCGCTCGAGGCGGATGGTGTCATGGCCGCCGCC-3’ were used for amplification 
of only the conserved RTX domain (amino acids 1529  – 1612) without flanking sequences from 
the pTRCyaAΔ1-1489Δ1682-1706 –template. The insert between the FPs in pET/C-CyaA1529-
1612-Y corresponds to the insert in pTRCyaAΔ1-1527Δ1613-1706 in Bauche et al.[18] 
For constructing the plasmids for CFP and YFP expression, the corresponding genes were 
amplified from the above-mentioned templates with the oligos 5’-
AGCATCACATATGGTGAGCAAGGGCGAGGA-3’ and 5’-





were ligated into the similarly treated linearized pET-20(b)+ resulting in the 3 plasmids 
pET/CFP and pET/YFP. The insertions yielded constructs with the FPs tagged with a His6 –tag.  
All coding sequences in this work were analyzed after each plasmid construction and 
mutagenesis by DNA sequencing (Genewiz, South Plainfield, NJ, USA).  
2.2.7.2 Construction and expression of non-fluorescent mutants of fluorescent 
proteins fusions 
Fluorescence of the CFP and YFP in C-BR(S)-Y strongly interfered with the measurements of 
bis-ANS fluorescence and, moreover, photobleaching the FPs turned out to be inefficient. During 
the folding and maturation of FPs, the residues Ser65, Tyr66 and Gly67 (numbering from green 
fluorescent protein) undergo an intramolecular cyclization reaction to form the chromophore 
[112, 113]. Since a mutation in the residue G67 has been shown to prevent the chromophore 
formation but retain the beta barrel structure [43], we mutated G67 in both FPs of C-BR(S)-Y to 
Ser residues, yielding C*-BR(S)-Y*. Site directed mutagenesis (QuikChange kit, Stratagene) 
was performed using the oligos 5’-
CCCTCGTGACCACCCTGACCTGGAGCGTGCAGTGCTTCAGCCGC-3’ (for CFP) and 5’-
CCTCGTGACCACCTTCGGCTACAGCCTGCAGTGCTTCGCCCGC-3’ (for YFP) and their 
respective complementary sequences. For a control sample, the CFP was similarly mutated to a 
non-fluorescent variant, yielding CFP*. Protein expression and purification were done identically 
as for the C-BR(S)-Y. Spectral analysis showed that chromophore formation was obstructed as 





2.2.7.3 Construction of MBP-RTX fusions for BR(L) and BR(S) expression 
Maltose binding protein – RTX domain fusions were constructed using the AvaI and HindIII 
(New England Biolabs) cloning sites in the pMAL-c4e vector (New England Biolabs). The gene 
fragment encoding for the CyaA amino acids 1488 – 1680 (named BR(L)) was PCR amplified 
from pTRCyaAΔ1-1489Δ1682-1706 using the oligonucleotides 5’-
TATTTTTATCTCGGGGATGACGATGACAAGGGCCAGGGCCGGGGCCTC-3’ and 5’-
ATAATTAAAAAGCTTTTAGTCCGGATACTGCGCCATTGCCTC-3’. Similarly, for  the 
gene fragment encoding for CyaA amino acids 1529 – 1612 (named BR(S)) was cloned using the 
oligonucleotides 5’-
TATTTTTATCTCGGGGATGACGATGACAAGGGCAGCGCGCGTGATGACGTGCTG-3’ 
and 5’-ATAATTAAAAAGCTTTTAGCGGATGGTGTCATGGCCGCCGCC-3’.  
2.2.7.4 Mutagenesis of a conserved Asp residue in the RTX domain 
Site-directed mutagenesis (QuikChange –kit, Stratagene) was used to mutate the conserved Asp 
residue in the centermost RTX repeat to Ala and Pro residues in CyaA1488-1680 to generate the 
mutants pET/C-CyA1488-1680-Y/D1570A and pET/C-CyA1488-1680-Y/D1570P, using the 
oligos 5’-GACGAGGGCTCGGCGCTGCTCAGCGGCG-3’ and  5’-
CGACGAGGGCTCGCCGCTGCTCAGCGGCG-3’, respectively, and their complementary 
sequences. The plasmids described encode the mutant proteins termed CBR(L)-Y-D/A and C-
BR(L)-Y-D/P, respectively. The above described oligos were also used to generate the same 





2.2.7.5 Estimation of the dimensions of a beta roll formed by the CyaA fragment in 
CBR(L)-Y and C-BR(S)-Y 
To estimate the dimensions of the RTX domains studied in this work, the RTX domain from 
Serratia marcescens serralysin (formed by five nonapeptide repeats) X-ray crystal structure [16] 
was used to obtain the dimensions of a single turn. In a beta roll structure, the pitch along a 
complete beta helical turn (18 residues) is 4.5 Å and thus the average translation (per amino acid) 
along the helical axis is 0.25 Å. For estimation of the CFP –YFP inter-chromophore distance, the 
segments joining the CyaA fragment to the FP chromophores were assumed to have Gaussian 
chain like properties and were determined to have a total average length of 2.7 nm. Thus, the 
total inter-chromophore distance for a theoretical beta roll structure formed by the CyaA 
fragment in C-BR(L)-Y (193 amino acid RTX insert) and in C-BR(S)-Y (84 amino acid RTX 













3 Surface immobilization 
Note: A version of this chapter entitled ―Monitoring the conformational changes of an intrinsically disordered peptide using a quartz crystal 
microbalance‖ appeared in Protein Science, volume 20, issue 5, pages 925-930, May 2011. 
OS purified all proteins and performed experiments with assistance from JW. OS wrote the manuscript. 
3.1  Abstract 
Intrinsically disordered peptides (IDPs) have recently garnered much interest due to their role in 
biological processes such as molecular recognition, and their ability to undergo stimulus-
responsive conformational changes. The block V repeats-in-toxin (RTX) motif of the Bordetella 
pertussis adenylate cyclase is an example of an IDP that undergoes a transition from a disordered 
state to an ordered beta roll conformation in the presence of calcium ions. In solution, a C-
terminal capping domain is necessary for this transition to occur.  In order to further explore the 
conformational behavior and folding requirements of this IDP, we have cysteine modified three 
previously characterized constructs, allowing for attachment to the gold surface of a quartz 
crystal microbalance (QCM). We demonstrate that, while immobilized, the C-terminally capped 
peptide exhibits similar calcium-binding properties to what have been observed in solution. In 
addition, immobilization on the solid surface appears to enable calcium-responsiveness in the 
uncapped peptides, in contrast to the behavior observed in solution. This work demonstrates the 
power of QCM as a tool to study the conformational changes of IDPs immobilized on surfaces 
and has implications for a range of potential applications where IDPs may be engineered and 
utilized including protein purification, biosensors, and other bionanotechnology applications.  
3.2 Introduction 
Intrinsically disordered peptides (IDPs) are of interest as they play critical roles in biological 





from a disordered to an ordered state upon interaction with a binding partner or a change in 
environment.[44, 114, 115] Examples of IDP’s include certain domains of p53, pKID, 
neurofilament H and others.[116-119] The ability to control the transition between different 
structural states presents an opportunity for their utilization in applications such as protein 
purification, biosensors, development of ―smart‖ therapeutics, and other bionanotechnologies.[58, 
120]  For example, the elastin-like peptides undergo a change in structure upon changes in 
temperature, and have been employed in applications including protein purification and 
temperature-controlled binding.[121, 122] The ability to switch between a disordered and an 
ordered structure with an intrinsic binding site may be useful in biosensor development where 
the ability to modulate binding is desired.  Specifically, if an IDP with stimulus-dependent 
binding were immobilized in a functional form on a surface, this surface could be used as a 
substrate for the controlled binding (and perhaps release) of a target analyte. To this end, we are 
exploring the use of IDPs as potential scaffolds for engineered biomolecular recognition.   
The repeats-in-toxin (RTX) peptide motif is found in certain secreted bacterial proteins.[13, 14] 
The domain is intrinsically disordered in the absence of calcium, but forms a beta roll structure 
in the presence of calcium ions.[15] Previous work has characterized the end-capping 
requirements for calcium-responsive folding of block V of the RTX domain from the adenylate 
cyclase of Bordetella pertussis and a C-terminal capping domain has been found to be essential 
for calcium responsiveness.[123, 124] In the presence of calcium, aspartate residues in each 
repeat bind calcium and a beta roll structure is formed.[16, 125] Folding appears to occur with 
the highest affinity and cooperativity when the native C-terminal sequence is present, but has 
also been shown to occur when other well-folded domains are fused to the C-terminus. Caps may 





C-terminal cap also acts as a nucleator of a polarized folding process which proceeds from C- to 
N- terminus in the presence of calcium. [123] This is similar to what has been observed in other 
repeat proteins, such as the leucine rich repeats of internalin B, which fold in an N-terminally 
polarized fashion.[26] Since multiple, unrelated proteins enable folding of the beta roll, we 
previously proposed that folding is enabled via entropic stabilization of the C-terminus. [123] 
Further, we reasoned that alternative non-protein caps, including a solid surface, may be capable 
of enabling calcium-responsive structure formation. 
IDPs are a promising scaffold for engineering biomolecular recognition and will likely find 
utility in a variety of applications. However, study of surface immobilized IDPs is difficult due 
to the incompatibility of most spectroscopic characterization techniques with such an 
environment. The quartz crystal microbalance (QCM) is a sensitive and versatile tool that has 
been applied to detect biomolecular interactions and conformational changes in peptides and 
proteins.[126, 127] For example, the calcium-induced conformational change of calmodulin has 
been studied by QCM, where it was shown that the dehydration process and increased rigidity of 
the protein upon calcium binding was detectable as an increase in frequency.[128] Considering 
the significant conformational change of the RTX domain in response to calcium, we 
hypothesized that this change would be detectable by QCM and that its behavior would depend 
on the N- or C-terminal orientation of the peptide due to previous experiments where such 
dependencies have been observed.[54]  Here, we use QCM to study conformational changes of 
capped and uncapped RTX peptides and explore the ability of a surface to act as an entropic cap, 





3.3  Discussion 
We first sought to confirm that three cysteine-modified RTX constructs (Figure 3.1a) behaved, in 
solution, the same as previously characterized non-cysteine-modified constructs [123] and that 
the presence of salt did not alter the behavior of the peptides, because a higher salt environment 
was required for QCM experiments. The uncapped cys-RTX and RTX-cys constructs showed no 
change in secondary structure by circular dichroism (CD) in up to 100 mM CaCl2, while the C-
terminally capped cys-RTX-C construct exhibited an increase in secondary structure between 0 
mM and 10 mM CaCl2, similar to what has previously been observed. [123] Therefore, calcium 
titrations were performed with this C-terminally capped construct while following the CD signal 
at 220 nm to monitor β-sheet formation (Figure 3.2a). Data were fit to the Hill equation, yielding 
a KD of 1340 μM and a Hill coefficient of 3.26 (Table 3.1), similar to previous observations.[123]  
cys-RTX-C possesses a pair of tryptophan residues in the C-terminal cap which can be used to 
track conformational changes in this region of the peptide. Therefore, an additional calcium 
titration was performed while tracking tryptophan fluorescence (Figure 3.2a). A KD of 147 μM 
and a Hill coefficient of 1.43 were obtained (Table 3.1). In this case, while the Hill coefficient is 
low, cooperativity is a less meaningful parameter because the tryptophan signal is likely only 
reporting the conformational behavior of the cap. From these results, it seems that the C-terminal 
region of the peptide undergoes a conformational change at a concentration which is far lower 
than for the overall peptide. This suggests that the C-terminal region is the first to respond to 
calcium. The KD obtained by tryptophan fluorescence is nearly identical to those we have 
previously reported, despite the higher salt concentration.[123] Using a FRET construct, we 
previously reported a salt dependency on the binding affinity of the RTX-C construct.[129] The 





fluorescence suggests that the RTX region is primarily responsible for the salt dependency of the 
binding affinity. 
Next, we sought to determine if calcium-dependent conformational changes of the RTX domain 
could be detected by QCM. Therefore, we examined the cys-RTX-C construct, which was shown 
to respond to calcium in solution. This peptide was expected to undergo a significant and easily 
detectable conformation change and was tested in calcium-free and calcium-rich solution. The 
frequency change upon immobilization to the gold modified QCM crystal corresponds to a mass 
loading comparable to what has been observed in previous work, as computed by the Sauerbrey 
equation.[127] Upon addition of 10 mM CaCl2, a change in both frequency (12 Hz) and 
resistance (-1 ohm) was observed (Figure 3.1b). According to our previous work, using a 
manufacturer provided relationship, a 1 ohm resistance change contributes about 2 Hz to the total 
frequency change.[127] Therefore, most of the frequency change (~10 Hz) is due to a loss of 
mass at the surface, suggesting that a dehydration process likely takes place upon beta roll 
formation. After switching to calcium-free buffer, a return to baseline was observed. This 
demonstrates that calcium binding is readily reversible, in agreement with previous results.  The 
folding and unfolding process, as indicated by a return to a stable baseline frequency and 
resistance signal, can be repeated at least twice in the QCM system (not shown). This is similar 
to the repeated folding and unfolding of the beta roll reported in solution.[129] To determine 
whether the change is specific to calcium or an ionic effect, the experiment was repeated using 
10 mM MgCl2.  No change in resistance and only a small (~2 Hz) change in frequency was 
observed (Figure 3.1b), possibly due to cation replacement. This supports the conclusion that the 
signal change is due to beta roll formation and is consistent with the observation of calcium-





Next, we test the uncapped cys-RTX and RTX-cys constructs. We hypothesized that cys-RTX 
would not be calcium responsive, since immobilization occurs on the N-terminus, while RTX-
cys could be responsive, due to an entropic stabilization effect by the mass of the surface at the 
C-terminus.  Again, the frequency change observed upon incubation of these constructs with the 
QCM surface indicates robust attachment (not shown). Interestingly, upon exposure to calcium, a 
frequency increase was observed for both peptides (5 Hz for cys-RTX and 7 Hz for RTX-cys). 
This effect was found to be specific to calcium and did not occur with magnesium. However, no 
significant change in resistance was observed for either construct. The calcium specificity of the 
frequency change suggests beta roll structure formation, while the lack of a resistance change 
may be due to the fact that these peptides are smaller in size and, therefore, do not undergo as 
significant a conformational change. Also, the frequency change cannot be attributed to non-
specific interactions with the QCM surface because this would result in a drop in frequency (due 
to mass gain), as was observed in testing of the system without an immobilized peptide (not 
shown). 
Together, these results suggest that the surface of the QCM crystal provides the entropic 
stabilization required for beta roll formation independent of which terminus is immobilized. 
Protein domains are very different end-capping groups compared to a solid surface and it is 
likely that the surface provides substantially more entropic stabilization. Also, the peptides are 
closely packed on the surface in comparison to the solution phase, providing additional 
confinement on the entropy of the peptides. This is analogous to the scenario where the peptide 
is in a high concentration PEG solution. It has previously been reported that in 50% PEG and 
100 mM CaCl2, the uncapped RTX peptide undergoes a CD-detectable conformational change. 





tethering situations, one cannot determine whether the final folded structure is the same as that 
achieved with the native capping group. 
To further understand the folding process, we performed calcium titrations on all three 
immobilized constructs (Figure 3.2b). The calculated Hill coefficients (n) and dissociation 
constants (KD) for binding are summarized in Table 3.1. The uncapped constructs, while capable 
of undergoing a conformational change when immobilized, possess lower binding affinities as 
compared to cys-RTX-C. Further, the Hill coefficients are both lower than that of the capped 
construct, suggesting an alternative folding mechanism.  
These results suggest that the native C-terminal cap of the RTX domain performs two important 
functions: (1) it provides entropic stabilization to allow for folding in solution and (2) it acts as a 
nucleator of folding, allowing for cooperative calcium binding. The fact that the uncapped 
constructs respond to calcium, but with lower affinity and cooperativity, suggests that the solid 
substrate, and perhaps alternative protein caps reported previously[123], achieve the first 
function but not the second function as well as the native cap. It is also possible that beta roll 
formation proceeds through different folding mechanisms. Specifically, when the native cap is 
present, folding proceeds in a polarized fashion, beginning from the C-terminus. However, when 
the native cap is replaced by a globular protein or solid surface, calcium ions bind, but the 
binding may not occur in a specific cooperative order. 
The increase in calcium affinity of the immobilized construct, as compared to solution, is likely 
due to additional surface entropic stabilization of the peptide, while the decrease in cooperativity 





cooperative folding, while requiring entropic stabilization, also requires some additional 
flexibility in the RTX region.  
Here, we have demonstrated that a solid substrate can be used to entropically stabilize an RTX 
peptide and allow for calcium-responsive folding which is not observed in solution. Further, we 
have demonstrated the utility of QCM in studying conformational changes in immobilized 
peptides and have obtained further insight into the folding mechanisms of RTX domains. We 
demonstrate that the native capping group likely plays two roles, entropic stabilization and 
folding nucleation. Non-native caps can provide entropic stabilization, but not necessarily 
folding nucleation, resulting in reduced cooperativity. These results should provide more insight 
for future efforts to immobilize IDPs on solid surfaces for a variety of applications. 
3.4  Materials and Methods 
The RTX and RTX-C constructs reported previously were used as templates for preparation of 
the cysteine-modified constructs.[123] Cysteine residues were introduced on the N-terminus of 
the RTX-C construct using the Quikchange site-directed mutagenesis kit (Stratagene, Santa Clara, 
CA) to create cys-RTX-C. The same protocol was used to create the cys-RTX and RTX-cys 
constructs. Expression and purification of the three constructs followed a previously described 
protocol. [123] 
QCM experiments were performed as previously described.[127] All experiments were carried 
out in TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.4). Calcium chloride and magnesium 
chloride were used as the calcium and magnesium ion sources, respectively, and added as 
indicated. Cysteine backfilling was performed after immobilization of the peptide on the QCM 





CD experiments were performed using a J-815 CD spectrometer (Jasco, Inc., Easton, MD) 
equipped with a Peltier junction temperature control. Protein concentrations of 75-100 μM were 
analyzed in a 0.01 cm path length quartz cuvette at 20°C. Fluorescence measurements were 
performed in the same machine equipped with a FMO-427S fluorescence monochromator. 
Protein concentrations of 1 μM in a 1 cm path length quartz cuvette were excited at 280 nm and 
the fluorescence signal was followed at 340 nm.  
All titration data were fitted to the Hill equation using Origin 8.0 (OriginLab, Northampton, MA). 
Fraction folded was determined by scaling all data to the endpoints of the titrations. Errors are 
reported as standard deviation. 
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3.6 Figures and tables 
Figure 3.1. QCM testing of beta rolls: Experimental schematic and sample results. 
 
(a) Sequence of RTX and suspected calcium-bound conformation. cys-RTX-C consists of a cys 
residue at the N-terminus and includes the gray capping sequence at the C terminus. cys-RTX 
and RTX-cys possess cys residues at the N- and C-termini, respectively. (b) Frequency and 






Figure 3.2. Calcium titrations of cysteine beta roll fusions. 
(a) Titrations of cys-RTX-C with varying concentrations of calcium performed by measuring 
changes in tryptophan fluorescence, CD signal at 220 nm, and QCM. (b) Calcium titrations of 






Table 3.1. Properties of cysteine beta roll mutants. 
Construct Technique KD, μM Hill coefficient, n 
cys-RTX QCM 5140 ± 160 1.45 ± 0.06 
RTX-cys QCM 4190 ± 390 0.94 ± 0.05 
cys-RTX-C QCM 728 ± 9 2.29 ± 0.06 
cys-RTX-C CD 1340 ± 60 3.26 ± 0.38 
cys-RTX-C Trp Fluorescence 147 ± 5 1.43 ± 0.06 
Dissociation constants (KD) and Hill coefficients (n) for the three constructs as determined by 







4 Exploring the modularity of RTX domains 
Note: A version of this chapter entitled ―Rearranging and Concatenating a Native RTX Domain to Understand Sequence Modularity‖ has been 
submitted to Protein Engineering, Design, and Selection as of June 2012. 
OS conceived of and performed all experiments. OS wrote the manuscript. 
4.1 Abstract  
The use of repetitive peptide sequences forming predictable secondary structures has been a key 
paradigm in recent efforts to engineer biomolecular recognition. The modularity and 
predictability of these scaffolds enables precise identification and mutation of the active interface, 
providing a level of control which non-repetitive scaffolds often lack. However, the majority of 
these scaffolds are well-folded stable structures.  If the structures had a stimulus-responsive 
character, this would enable the allosteric regulation of their function. The calcium-responsive 
beta roll forming repeats-in-toxin (RTX) domain potentially offers both of these properties. To 
further develop this scaffold, we have synthesized a set of RTX peptides to determine whether 
RTX repeats are modular, allowing for their concatenation and rearrangement. Additionally, we 
perform a comparison on a set of known RTX containing proteins to better understand the 
relationship between RTX size and sequence in these structures. These results should help in 
guiding use of the RTX domain as a scaffold for future protein engineering efforts. 
4.2 Introduction 
Repeat proteins have proven to be valuable scaffolds to protein engineers. These scaffolds 
possess two properties which make them different than globular proteins: (1) they are dominated 
by short range, repetitive interactions, and (2) they tend to be highly modular. [130] These two 
properties have enabled researchers to perform detailed folding studies as well as to engineering 
novel biomolecular recognition functionality into these proteins. Examples of repeat proteins 





rich repeats, and WD repeats. [131-134] In addition to the characterization of folding 
mechanisms and behavior, some of these motifs have been used to generate novel binding 
interactions with varying degrees of success. Examples include the use of designed ankyrin 
repeats (DARPins) to produce nanomolar (and subnanomolar) binders and the use of 
tetratricopeptides to produce micromolar binders.  [11, 135, 136] 
Effectively leveraging repeat proteins (and in some cases, any scaffold) for bioengineering 
applications requires a fairly detailed understanding of the behavior of the scaffold. Particularly, 
one must understand (1) what constitutes the modular unit of the repeat scaffold, (2) what 
positions on the scaffold are amenable to mutation without disrupting structure, and (3) any other 
requirements that are necessary for proper expression and folding of the scaffold. Each of these 
areas has been explored to differing extents for the previously reported repeat scaffolds. A 
number of approaches to understanding repeat protein folding exist and have recently been 
reviewed. [137] The selection of engineerable positions in a scaffold can often be based upon 
where protein-protein interactions occur naturally, as in the cases for DARPins. [11] Modularity 
and consensus design typically depends upon analyzing naturally existing sequences to guide 
identification of a consensus sequence. Such approaches have been used effectively to generate 
consensus ankyrin repeats, leucine rich repeats, armadillo repeats and others. [30, 138, 139] 
Finally, many repeat scaffolds have been shown to require capping groups on their termini in 
order to enable folding, as in the case for leucine rich repeats and DARPins.[25, 131] Each of 
these three areas is critical and one is not likely to succeed at engineering a scaffold without 
considering each one in detail. 
Of the many repeat scaffolds that have been targeted for engineering efforts, a less commonly 





the engineering and use of stimulus responsive peptides exist and have been previously reviewed. 
[140] The most frequently cited examples of engineered stimulus-responsive peptides are the 
elastin-like peptides. [141] Towards combining the available knowledge of repeat scaffolds and 
stimulus responsive systems, we have sought to identify a repeat protein which also possesses 
stimulus-responsiveness. This would enable the design of an allosterically-regulated repeat 
scaffold which would operate similar to some of the previously described protein switches used 
for biomolecular recognition. [142] As a possible solution to this goal, we have identified the 
beta roll-forming repeats-in-toxin (RTX) domain. RTX domains are found in the C-terminal 
regions of proteins secreted through the bacterial type I secretion system. [31] These proteins are 
thought to be unstructured prior to secretion, and only fold into the beta roll when the RTX 
domain enters the calcium-rich extracellular region. This is based on in vitro observations where 
the RTX domain is intrinsically disordered in the absence of calcium, and forms the beta roll 
conformation in the presence of calcium. [32, 143] At the primary sequence level, RTX domains 
consist of tandem repeats of the nine amino acid consensus sequence GGXGXDXUX where U is 
a large aliphatic amino acid and X can be any amino acid. These domains fold into a flattened 
helical structure consisting of two oppositely oriented parallel beta sheet faces interspersed with 
a turn region that binds a calcium ion (see ―9-in‖, Figure 4.1). [34, 144] 
A few attempts have been made at engineering synthetic beta roll forming domains, based on the 
consensus sequence. A synthetic beta roll forming peptide made by consensus design was 
reported by Lilie et al. However, the peptide only functioned in very high concentrations of both 
poly-ethylene glycol (PEG) and calcium. [22] Subsequently, Scotter et al. designed synthetic 
beta roll peptides as well. However, these peptides form filaments and only in response to 





elucidated part of the reason that these approaches were not as successful. It has been shown that 
capping groups are necessary to achieve proper calcium-responsive behavior in the block V RTX 
domain from the adenylate cyclase (CyaA) of B. pertussis. [18] Further, it has been found that 
only the C-terminal capping group is required and that this group can be substituted with a 
globular protein or a solid surface and still retain calcium-responsive folding.[123, 146, 147] 
Finally, using the insights provided by characterization experiments, a beta roll domain has been 
rationally engineered with a leucine-decorated face so that it forms protein-protein interactions 
only in the presence of calcium, enabling the formation of hydrogels. [148]  
Of the three requirements for successfully characterizing a repeat scaffold outlined above, the 
RTX domain has been reasonably well characterized regarding which positions are amenable to 
engineering and what the requirements are for folding. As mentioned, it has been established that 
a C-terminal cap is required for folding and, based on the hydrogel work, the face of the beta roll 
is fairly tolerant of mutation. However, less has been done to explore modularity.   Efforts to 
generate synthetic beta rolls by consensus design have, thus far, not been particularly 
successfully.   
To begin to explore modular design, we began by simply identifying the most frequent amino 
acids at each position for an RTX repeat (GGAGNDTLY) and concatenating multiple copies of 
this synthetic sequence to the C-terminal cap of the CyaA RTX domain. Rather unexpectedly, it 
was found that concatenations of this sequence are prone to calcium-responsive insolubility. 
While this finding turned out to be valuable for protein purification applications (Submitted to 
Biotechniques, June 2012), it is not beneficial for the goal of this work. Therefore, we thought 
that an appropriate next step towards identifying a modular RTX unit was to create variants of a 





characterized the CyaA block V domain in its native nine RTX repeat form (called ―9-in‖ or 
―9C-in‖ in this work, C for native capping sequence). Here, we present a systematic study of the 
modularity of the natural RTX repeats from the CyaA block V domain and couple these results 
with analysis of naturally existing beta roll sequences.  
4.3 Materials and Methods 
All chemicals were obtained from Sigma Aldrich (St. Louis, MO) unless otherwise stated. 
Analysis of natural RTX sequences. In order to identify RTX domains, UniProt 
(http://www.uniprot.org) was searched for hemolysin type calcium binding (HTCB) regions 
(ExPASy accession number: PS00330), this being a motif defined in the PROSITE database. 
[149] 58 hits were found (proteins marked as ―reviewed‖ by UniProt). Of these, some entries 
were repetitive and were removed. This left 41 proteins for further analysis. These sequences 
were then manually processed in order to identify the number of consecutive repeats in each 
RTX domain as well as the total number of RTX domains. A stretch of nine amino acids within a 
protein was considered an RTX unit if it met the following three criteria: (1) The sixth amino 
acid was an aspartic acid for calcium binding, (2)the first, second, or fourth amino acid was 
glycine to form the flexible turn region, (3) the eighth amino acid was hydrophobic. Examples of 
some notable RTX domains we studied can be seen in the supplementary materials. 
In addition to these requirements, we identified situations in which an RTX domain exists, but 
there are deviations from the nine amino acid pattern. These are cases where two nine amino acid 
sequences match the above requirements but are separated by a sequence which does not. We 
identified three different scenarios where this is the case and dealt with them as indicated in 





previous repeat and marked as non-standard), (2) There are between nine and seventeen amino 
acids between the repeats and an aspartic acid is present in the sequence (counted as a separate 
repeat), (3) there are between nine and seventeen amino acids but an aspartic acid is not present 
(RTX domain is considered terminated). It should be noted that, by this definition, the final C-
terminal RTX repeat will always be nine amino acids long (never non-standard) and no repeat 
can be shorter than nine amino acids, as it will then be considered part of the previous repeat. For 
the purposes of consistency with previously published work, we allowed one exception to these 
criteria. By the method described above, the first nine amino acids of the C-terminal cap of the 
CyaA RTX domain would be considered a repeat. However, we have kept it as part of the 
capping region.[123]  
Native vs. non-native ordering. The constructs generated in this work are classified as either 





 out of the nine repeats. When these repeats are in their normal position 
relative to the C-terminal cap, a construct is referred to as natively ordered. When these repeats 
are absent from a construct, or present in a different location, the construct is referred to as non-
natively ordered. 
Concatenation scheme and DNA preparation. A recursive ligation strategy was used to generate 
each of the RTX constructs, similarly to previously described schemes. [150, 151] Essentially, 
each subunit of the final gene was introduced into the expression vector sequentially. The 
expression vector used was the pMAL_c4E vector from New England Biolabs (NEB). The 
vector was modified by adding in a BseRI oriented such that additional units of RTX (or cap) 
DNA could be cloned in without leaving any artifacts of the ligation process. This procedure can 





protocol can be found in the supplementary materials. Using this scheme, twelve RTX constructs 
were synthesized as well as the CyaA C-terminal cap in isolation. These constructs were named 
based on their length (5, 9, or 17 repeats), ordering (in or out of native order), and presence of 
native C-terminal cap. The thirteen constructs were named as follows and their sequences: 5-in, 
5-out, 9-in, 9-out, 17-in, 17-out, 5C-in, 5C-out, 9C-in, 9C-out, 17C-in, 17C-out , C. The 
sequence of the RTX domain can be seen in Table 4.1. The arrangement of the different RTX 
repeats in each of the constructs made is shown in Table 4.2. Predicted structured of the 
uncapped versions of these constructs can be seen in Figure 4.1. Predictions are based on 
homology models as previously described. [148] 
Due to purification issues, constructs 5C-in and 9C-out were subsequently cloned into the pMAL 
vector modified by cloning in an intein at a position downstream of the maltose binding protein 
(MBP), replacing the enterokinase site and producing the pMAL_intein vector. The intein was 
obtained from the pET-EI/OPH vector from the Wood group. [152] Cloning of these beta rolls 
was accomplished using a 5’ KpnI site and a 3’ HindIII.  
Protein purification with MBP-enterokinase construct. All constructs, except 5C-in and 9C-out 
were purified as previously described. [123] Briefly, RTX protein fused to MBP was expressed 
in OmniMaxT1 cells by induction with 0.3 mM IPTG and 2 hours subsequent expression at 37 C. 
(Invitrogen). Cells were lysed by sonication, and clarified lysate was run over an amylose 
column (NEB). After washing, fusion protein was eluted with maltose and cleaved with 
enterokinase as per manufacturer’s protocol (NEB). The cleavage product was run over a HiPrep 
Q FF 16/60 ion exchange column (GE Healthcare) to separate MBP from uncleaved fusion and 
beta roll using a gradient from 20 mM to 500 mM sodium chloride. While this effectively 





purification was required. The fusion/beta roll mixture was then run back over the amylose resin 
and flow through was collected and, if necessary, run over a HiLoad 16/60 SuperDex 200 size 
exclusion chromatography column in 20 mM tris HCl and 200 mM NaCl (GE Healthcare). The 
final product was concentrated and diafiltered into 50 mM Tris-HCl, pH 7.5 for characterization 
and purity was confirmed via SDS-PAGE.  
Protein purification with MBP-intein construct. Constructs 5C-in and 9C-out were found to be 
resistant to cleavage by enterokinase. Therefore, they were cloned into the intein-modified 
pMAL vector described above. Fusion protein was expressed as described above. After applying 
the clarified lysate to the amylose column and washing, the column was incubated overnight at 
37 C in cleavage buffer (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4H2, 1.76 mM KH2PO4, 
40 mM Bis-Tris, 2 mM EDTA, pH 6.2). The product of the cleavage reaction was then washed 
out from the column and concentrated. The concentrate was run over the Q ion exchange column 
to remove MBP and a pure peak of beta roll protein was obtained. This was concentrated and 
diafilitered into 50 mM Tris-HCl, pH 7.5 for subsequent characterization.  
CD spectroscopy and tryptophan fluorescence measurements. CD data was collected on a J-815 
CD spectrometer (Jasco, Easton, MD) equipped with a Peltier junction temperature controller. 
All CD scans were performed from 250 to 190 nm in a 0.01 cm path-length cuvette (Helma, 
Müllheim, Germany) with a protein concentration of 100 uM and five replicates. Intrinsic 
tryptophan fluorescence data was collected with a FMO-427S fluorescence monochromator. 
Protein concentrations of 1 uM were used in a 1 cm path length quartz cuvette (Helma). Samples 
were excited at 280 nm and the fluorescence was measured at 340 nm. For all characterization, 
samples were in 50 mM Tris-HCl, pH 7.5 with calcium chloride added at the indicated 





algorithm was used with reference set SDP42. Fraction of plateau values were determined by 
scaling all measurements to the maximum change in tryptophan fluorescence observed. 
Calcium titration curve fitting. All dissociation constant (KD) and Hill coefficient values (n) were 
determined by fitting titration data to the Hill equation with SigmaPlot. Errors reported are 
standard error. 
4.4 Results 
For the purposes of convenience, throughout this manuscript we refer to the block V RTX 
domain from the adenylate cyclase toxin of B. pertussis as ―the RTX domain‖. However, it 
should be noted that statements in this work regarding the RTX domain apply specifically to the 
domain tested and, not necessarily to all RTX domains. When claims are made about all RTX 
domains, it is noted. 
Natural variability in RTX lengths. As a guideline for determining the sizes of RTX constructs to 
be tested, the sizes of naturally existing RTX domains were cataloged (Figure 4.2).The smallest 
RTX domains observed consist of three tandem repeats and one example of an RTX domain 
consisting of seventeen repeats was observed. Based on these results, it was chosen to test RTX 
constructs of five, nine and seventeen repeats. Nine was chosen as it is near the middle of the 
range, and is a size that has been previously tested.[18, 123, 129] Seventeen was chosen as it 
represents possibly an upper size limit for RTX domains. Finally, five was chosen as we 
suspected that any RTX domain shorter than five repeats would not be larger enough to form a 
face useful in bioengineering applications. Samples RTX proteins used to assemble this data can 





Construct behavior in absence of C-terminal capping group. Previous work with the RTX 
domain has verified the need for a C-terminal capping group to enable folding. [18, 123] We first 
sought to confirm that this was also true for the uncapped versions of the constructs made in this 
work. It was found that constructs 5-in and 5-out were susceptible to proteolytic degradation 
during expression and, therefore, were omitted from characterization. Constructs 9-out, 17-in, 
and 17-out were tested in 0 mM and 100 mM calcium using circular dichroism (Figure 4.3). As 
can be seen, all three constructs show no response to calcium, analogous to previous 
observations for 9-in.  
It is thought that the folding of RTX domains into beta rolls is an entropically driven process 
whereby reducing the entropy of the terminus enables folding. This has been observed both using 
proteins and solid substrates as caps for RTX domains. [146] An alternative method for reducing 
the entropy of these biomolecules is through the addition of a molecular crowding agent, such as 
PEG.[48, 50] It has been previously observed that the presence of high calcium concentrations 
and concentrations of PEG between 25% and 50% can, in some cases, induce folding of RTX 
domains which do not normally fold. [22]  Most relevant to this work is the past observation that 
9-in undergoes a conformational change in the presence of 50% PEG and 100 mM calcium. We 
sought to replicate this result with the three uncapped constructs (Figure 4.3). No change was 
observed for 9-out in the presence of 50% PEG with or without calcium. It was observed that in 
the presence of 50% PEG and 100 mM calcium, both 17-in and 17-out precipitated out of 
solution. Therefore, CD spectra were taken in 25% PEG. No change was observed for 17-out and 
a slight change was observed for 17-in, although this change is not like what has been previously 
observed for 9-in and is not indicative of beta roll formation. The observation that both 17 repeat 





observations that a synthetically designed RTX domain of the same length also precipitates in 
calcium (although no PEG is required). (Submitted to Biotechniques, June 2012)  
Behavior of C-terminal capping group. Past efforts to characterize the RTX domain have been 
hampered by a lack of structural data on the natural C-terminal capping group. CD data has been 
recently reported for this capping group, demonstrating that it is not calcium responsive at 
biologically relevant concentrations. [153] We sought to confirm this result as well as study the 
conformation of the cap at significantly higher calcium concentrations. Resulting CD spectra for 
0, 10, and 400 mM calcium chloride can be seen in Figure 4.4. It can be seen that no significant 
conformational change is observed in 10 mM calcium. However, at a much higher calcium 
concentration a modest change in conformation was observed. Deconvolution suggests that this 
change is driven by an 8.6% gain in helical content and a 4.5% change in sheet content. 
Circular dichroism of six capped constructs. Having observed that the uncapped RTX constructs 
do not undergo calcium-responsive conformational changes, we focused on the six capped 
constructs. It was seen that the three constructs with natively ordered repeats underwent their full 
conformational change by 10 mM calcium, whereas the non-natively ordered constructs required 
significantly higher calcium concentrations (Figure 4.5). 9C-in is the native construct, and the 
same that we have previously characterized. [123] It is clear from the spectra that this construct 
undergoes the most significant calcium responsive conformational change. However, the other 
two natively ordered constructs are also calcium responsive. On the other hand, the non-natively 
ordered constructs 5C-out and 9C-out exhibit a poorer affinity for calcium, demonstrating the 
importance of the proper position of non-standard repeats. 17C-out reaches the same CD spectra 





RTX repeats can be overcome to induce beta roll formation, but requires far higher calcium 
concentrations. 
In order to provide a more quantitative analysis of the CD spectra obtained for these six 
constructs (as well as the C-terminal cap), deconvolutions were performed to identify the 
percentage of sheet and disordered structure in each (Table 4.3). By comparing the increase in 
sheet content at a given concentration to the change for the cap, we can determine if the RTX 
region is contributing sheet content due to beta roll formation. In the case of the natively ordered 
constructs, it was found that all three constructs contain higher proportions of sheet than the cap, 
suggesting beta roll formation in all three. However, for the non-natively ordered constructs, we 
see that only 17C-out shows higher sheet content than the cap. 
Calcium titration of six capped constructs. There are two tryptophan residues present in the C-
terminal cap of the RTX domain and these have been previously used to track calcium binding of 
the RTX domain (marked in bold in Table 4.1). Therefore, we performed calcium titrations of all 
six constructs and the cap while tracking intrinsic tryptophan fluorescence (Figure 4.6). While 
CD suggested minimal, if any, beta roll formation in 5C-out and 9C-out, titrations were still 
performed as tryptophan fluorescence tracks different aspects of conformational change, which 
might be missed by CD. These results were fit to the Hill equation in order to obtain the 
dissociation constant and Hill coefficient (Table 4.4). It can be seen that, like CD, the natively 
ordered constructs perform far better in response to calcium. It is also observed that 9C-in shows 
a slightly higher affinity for calcium than both 5C-in and 17C-in. However, it is not clear why 
9C-in would show a slightly reduced cooperativity than the other two natively ordered constructs. 
The non-natively ordered constructs show calcium responsiveness and cooperativity roughly 





magnitude and calcium binding is no longer cooperative, one of the signature features of beta roll 
folding. 
Relationship between non-standard RTX repeats and RTX length. Having observed that the 
ordering of RTX repeats is essential for the native high-affinity calcium-responsive 
conformational change, we sought to obtain further insight from the database of natural RTX 
sequences which we identified. Specifically, we calculated at which repeats relative to the N- or 
C-terminal end non-standard repeats were the most frequent (Figure 4.7A). What we see is that 
non-standard repeats (that is, repeats longer than nine amino acids) are far more frequently 
concentrated towards the C-terminus of RTX domains than the N-terminus. This might help to 
explain why moving the non-standard repeats away from the C-terminus was so destructive in 
the three non-natively ordered constructs tested above. Next, we determined the probability that 
a given RTX domain would have a non-standard repeat within its sequence as a function of the 
total number of consecutive repeats present (Figure 4.7B). There is also a clear correlation 
between RTX domain length and the probability of a non-standard repeat. We see that there is a 
transition in the range of RTX domains of 5-7 repeats where below this size non-standard repeats 
are typically not present and above this size, non-standard repeats are nearly always present.  
4.5 Discussion 
There are three major properties of the RTX domain which can be targeted for engineering: (1) 
the face of the beta roll formed, (2) the capping groups on the RTX domain, and (3) the number 
and ordering of the RTX repeats. Past efforts have demonstrated that the face and the capping 
groups can tolerate a significant degree of variation. For example, the recently described 
hydrogel forming beta roll and past work fusing the RTX domain to surfaces and fluorescent 





repeats and their ordering has not been as extensively studied.  A better understanding of the 
modularity of the repeating unit is critical as this scaffold is developed for future protein 
engineering efforts.  Therefore, the focus of this work was to study the modularity of RTX 
repeats by constructing a set of synthetic RTX domains, varying both the number of RTX repeats 
and their ordering. 
A set of RTX containing proteins from the UniProt database was identified. This library 
contained proteins which are commonly associated with RTX domains including epimerases, 
hemolysins, proteases, and secreted toxins. By processing these sequences to identify RTX 
sequences, we found that the longest stretch of tandem RTX sequences found is seventeen, in the 
leukotoxin of A.  actinomycetemcomitans (P16462). This result guided our decision in 
synthesizing the constructs of three different sizes: 5, 9, and 17 tandem repeats. Additionally, it 
was observed that non-standard repeats tended to intersperse RTX sequences (non-standard 
repeats are marked with asterisks in Table 4.1). To assess the importance of these repeats, the 
orientation of the two non-standard repeats in the RTX domain was varied to create both 
―natively‖ and ―non-natively‖ ordered constructs. Finally, all of the constructs were tested both 
with and without their natural C-terminal capping group. In the past, this capping group has been 
shown to be required to induce beta roll formation.[123] However, it was thought that additional 
repeats may reduce or eliminate the need for this cap. The construct 9C-in was included for 
comparison and is the same protein that has been tested in previous work. [123] 
As expected, the uncapped versions of these constructs were not calcium responsive (Figure 4.3). 
The observation that 9-out does not undergo a conformational change in the presence of calcium 
and PEG is in contrast to the previously tested 9-in, which does. This suggests that repeat 





mechanism for both 9-in (with PEG) and 9C-in might be the same although further study is 
needed to confirm this. 17-in and 17-out both precipitated in the same PEG concentration. It is 
not clear why this occurred, but it is not the first time that synthetic RTX domains of this size 
have been found to be insoluble under certain conditions. (Submitted to Biotechniques, June 
2012) Unfortunately, we were unable to test 5-in and 5-out as they were found to be highly 
susceptible to proteolytic degradation. However, one would expect that these constructs would 
most likely not possess any calcium responsiveness as we have observed for the uncapped RTX 
domain from the metalloprotease of S. marcescens (unpublished observations). 
The similar CD spectra coupled with the very different dissociation constant and Hill coefficient 
indicate that 17C-in and 17C-out follow alternative folding pathways. The first pathway is the 
cooperative, high affinity pathway demonstrated by the three natively ordered constructs. In this 
pathway, calcium binds at the interface between the RTX repeats and the cap and then additional 
calcium ions bind in a polarized fashion towards the N-terminus. This is likely similar to the 
folding mechanism which has been demonstrated for leucine rich repeats (although, of course, 
that mechanism is not ion dependent). [131] On the other hand, for the non-natively ordered 
17C-out construct, the folding pathway is more nonspecific. In this method, calcium ions bind 
throughout the protein until eventually it is fully folded and in the same conformation as 17C-in. 
For this reason, significantly more calcium is required and there is a lack of cooperativity. This 
alternative folding mechanism has been previously proposed in cases where there is an 
alternative cap on the RTX domain. [146] 
Upon further analysis of the RTX library, it was observed that a significant proportion of other 
RTX domains possess a concentration of non-standard repeats towards their C-terminus. In light 





our present observations that moving these repeats eliminates cooperative folding, it seems likely 
that non-standard repeats play a key role in driving cooperative folding. Since the native C-
terminal capping group is also essential for cooperative folding, there is probably a precise 
tuning that takes place between these non-standard repeats and the cap. Therefore, for future 
engineering efforts, this means that there may be value in further studying the structure and 
behavior of the cap in isolation.  
While non-standard repeats are mostly found at the C-terminus, in the case of the seventeen 
repeat RTX domain of the leukotoxin, there are, in fact, nonstandard repeats at the N-terminus 
and not at the C-terminus (see supplementary material). This presents the possibility that the 
leukotoxin RTX domain may fold in the opposite direction as the adenylate cyclase toxin and 
indicates that there is clearly a need for further investigation of other RTX domains beyond just 
the adenylate cyclase toxin domain. The leukotoxin, in fact, may offer a promising scaffold from 
which to seek to obtain better folding, longer RTX domains. Of note is that the leukotoxin may 
be an exception to most RTX proteins, in that it is cell associated as opposed to secreted. [154] 
Together, these observations suggest that perhaps a rethinking of the concept of an RTX domain 
capping group is required. That is, while they may bind calcium and possess RTX-like character, 
non-standard repeats located near the terminus may be better defined as part of the capping 
region. Perhaps this ―pre-capping‖ region is equally as important as the capping region. Further 
investigation will be necessary to confirm this hypothesis. 
Overall, our results provide additional guidance for efforts to engineer RTX domains. For 
applications where a larger (or smaller) beta roll face is required, the number of repeats can 
safely be altered. However, care must be taken to keep the non-standard repeats in their natural 





significant a conformational change as 9C-in, it is clear that there is a unique tuning between the 
C-terminal cap and the nine natively ordered RTX domain repeats. We believe that to further 
optimize the RTX domain as a repeat scaffold, further efforts will be required to identify the 





4.6 Figures  
Figure 4.1 Constructs tested in this manuscript 
 
Predicted structure of each of the RTX constructs synthesized, N-terminus at top and C-terminus 
at bottom. The non-standard repeats are shaded in black. The C-terminal cap is fused at the C-
terminus in the capped constructs. Homology models were generated with SWISS-MODEL 
(Swiss Institute of Bioinformatics) using an extracellular lipase from Pseudomonas sp. MIS38 







Figure 4.2. Histogram of RTX sizes.  
 






Figure 4.3 CD on uncapped constructs.  
 
Samples were tested with 0 mM calcium chloride (solid black lines), 100 mM calcium chloride 
(long dashed dark gray lines), 0 mM calcium chloride with 50% PEG (dashed medium gray 






Figure 4.4 CD on the C-terminal capping group.  
 







Figure 4.5 CD on capped constructs.  
 
Natively ordered constructs (5C-in, 9C-in, and 17C-in) were tested at 0 mM and 10 mM calcium 
chloride (solid and dashed lines, respectively). Non-natively ordered constructs (5C-out, 9C-out, 







Figure 4.6 Calcium titrations of six capped constructs and cap.  
 
Values shown are fraction of plateau of the tryptophan signal measured. Constructs are as 
follows: 5C-in(  ), 9C-in (  ), 17C-in (  ), 5C-out ( ), 9C-out (  ), 17C-out(  ), and C-






Figure 4.7 Positioning and probabilities of non-standard repeats in RTX domains.  
 
(a) Frequency of non-standard repeats by distance from N-terminus (black bars) or C-terminus 
(gray bars), the asterisk indicates that this value is, by definition, zero. (b) Probability of a non-







Table 4.1 Sequence of the block V RTX domain from CyaA  
Repeat Sequence 
1 GSARDDVLI  
2 GDAGANVLN  
3 GLAGNDVLS  
4 GGAGDDVLL  
5 GDEGSDLLS  
6 GDAGNDDLF  







The C-terminal cap is labeled as ―cap‖. Non-standard repeats are marked with an asterisk and the 
tryptophan residues are marked in bold. 
 
 
Table 4.2 Concatenation strategy 
Native ordering   Non-native ordering   
Construct Concatenated Units Construct Concatenated Units 
5-in 5-9 5-out 1-5 
9-in 1-9 9-out 6-9, 1-5 
17-in 1-4, 1-4, 1-9 17-out 1-9, 1-4, 1-5 
5C-in 6-9, C 5C-out 1-5, C 
9C-in 1-9, C 9C-out 6-9, 1-5, C 
17C-in 1-4, 1-4, 1-9, C 17C-out 1-9, 1-4, 1-5, C 
The second and fourth columns identify which repeats were included in the particular construct 
and in which order. Individual DNA fragments for each unit were concatenated as described in 







Table 4.3 Deconvolution of capped constructs and cap 
 
Δ 
Sheet Δ Unstructured 
5C-in 7.30% -14.50% 
9C-in 14.30% -40.30% 
17C-in 10.50% -18.00% 
   Cap, 10 mM 2.00% -10.80% 
   5C-out -1.10% -1.10% 
9C-out 4.30% -6.70% 
17C-out 11.70% -20.70% 
   Cap, 400 mM 4.50% -19.00% 
Natively ordered constructs were all measured at 10 mM calcium chloride. Non-natively ordered 
constructs were measured at 400 mM calcium chloride. Corresponding deconvolution for the cap 
at the respective concentrations are shown. 
 
 
Table 4.4 Calcium binding properties of capped constructs 
 
KD, mM n 
5C-in 0.361 ± 0.02 1.81 ± 0.13 
9C-in 0.130 ± 0.006 1.38 ± 0.07 
17C-in 0.281 ± 0.03 1.77 ± 0.32 
   5C-out 210 ± 106 0.521 ± 0.06 
9C-out 18.5 ± 1.81 0.678 ± 0.07 
17C-
out 33.7 ± 21.6 0.597 ± 0.21 
Dissociation constants (KD) and Hill coefficients (n) for each of the constructs are shown. Errors 






4.8 Supplementary Information 
4.8.1 Concatenation strategy and primers 
The protocol for generating the six constructs in this work begins by using the pMAL-1529-1682 
vector from Blenner et al (JMB, 2010) as a template. All of the primers used are listed in table 
S1. 
Overall, the following scheme is used. The first unit is added by PCR amplification to introduce 
a 5’ AvaI site and a 3’ HindIII site, which is preceded by a stop codon followed by a BseRI site. 
The BseRI site is oriented such that the cleavage site is within the gene prior to the stop codon 
when cut. For subsequent units, the unit to be inserted is amplified with a 5’ BtsCI site and a 3’ 
HindIII site, and the product is digested. This product also contains a BseRI prior to the HindIII 
site. The vector is then cut with BseRI and HindIII. BseRI and BtsCI are isochizomers, which 
allows for ligation. The ligated product now consists of the second unit appended to the first unit, 
with no artifacts of the cloning process. Further, the inclusion of a BseRI site in the second unit, 
yields a vector which can now have a third unit appended using the same procedure that was 
used for the second. 
For the six constructs, each required PCR reaction is one row in table S2. For example, the 5C-in 
construct required only one PCR pairing the Ade5 entero AvaI F primer with the AdeC HindIII 
R primer. However, in the case of 17C-in, three reactions were required as shown. For the 
synthesiz of these constructs, each row corresponds to a single ligation into the starting pMAL-
c4E vector from NEB. The vector is cut with AvaI and HindIII for the first reaction of each 





were cut with AvaI and HindIII for the first reaction and cut with BtsCI and HindIII for 
subsequent reactions. 








Forward Primers Sequence (5’ to 3’) 
AvaI entero F ATAAAATTCTCGGGGATGACGATGACAAG 
Ade1 GC BtsCI F AATATAAAGGATGGCGGCAGCGCGCGTGAT 
Ade 1 TG BtsCI F AATATAAAGGATGTGGGCAGCGCGCGTGAT 
Ade5 entero AvaI ATAATATACTCGGGGATGACGATGACAAGGGCGACGAGGGCTCG 
Ade6 entero AvaI ATAATATACTCGGGGATGACGATGACAAGGGCGATGCGGGCAAC 
Ade6 BtsCI F AATATAAAGGATGGCGGCGATGCGGGCAAC 
AdeC entero AvaI ATTAAAAACTCGGGGATGATGATGACAAGATCAACGCGGGGGCG 
AdeC BtsCI F AATATAAAGGATGGCATCAACGCGGGGGCG 
Ade5 KpnI F ATTAAATAACCGGTACCGGGCGACGAGGGCTCG 
Ade6 KpnI F ATTAAATAACCGGTACCGGGCGATGCGGGCAAC 
  
Reverse Primers  
Ade4 BseRI R ATATTATAAAGCTTGAGGAGTATTATTACAGCAGCACATCGTCGCC 
Ade5 BseRI R ATATTATAAAGCTTGAGGAGTATTATTAGCTGAGCAGGTCCGAGCC 
Ade9 BseRI R ATATTATAAAGCTTGAGGAGTATTATTAGCGGATGGTGTCATGGCC 
AdeC HindIII R TTTTTAATAAGCTTTTAGTCCGGATACTGCGCCATTG 
 
Table S2. 
Construct Primers Template Product 
5C-in Ade5 entero AvaI F, AdeC HindIII R pMAL-1529-1682 5C-in 
9C-in AvaI entero F, AdeC HindIII R pMAL-1529-1682 9C-in 
17C-in AvaI entero F, ade4 BseRI R pMAL-1529-1682 1-4 
 Ade1 TG BtsCI F, ade4 BseRI R pMAL-1529-1682 1-4,1-4 
 Ade1 TG BtsCI F, AdeC HindIII R pMAL-1529-1682 17C-in 
5C-out AvaI entero F, Ade5 BseRI, R pMAL-1529-1682 5-out 
 AdeC BtsCI F, AdeC HindIII R pMAL-1529-1682 5C-out 
9C-out Ade6 entero AvaI F, Ade9 BseRI R pMAL-1529-1682 9-out 
 Ade1 GC BtsCI F, AdeC HindIII R pMAL-5C-out 9C-out 
17C-out AvaI entero F, Ade9 BseRI R pMAL-1529-1682 9-in 
 Ade1 GC BtsCI F, Ade4 BseRI R pMAL-1529-1682 13-out 







4.8.2 Representatives for variously sized RTX domains 
The longest RTX domain that we found consisted of 17 tandem RTX repeats as defined in the 




















A few cases of 3 repeat RTX domains were also observed. One of these was in the chromosomal 





While the block V RTX domain of the adenylate cyclase toxin has two non-standard repeats, we 
did find cases of 9 repeat RTX domains that consisted exclusively of 9 amino acid repeats. This 




















5 Engineering RTX domains for biomolecular recognition 
Note: A version of this chapter will be included in a future manuscript. 
OS conceived of and performed all experiments. 
5.1 Introduction 
5.1.1 Biomolecular recognition engineering  
In protein engineering, the most frequently used scaffolds used for the engineering of 
biomolecular recognition are antibodies and antibody fragments. Antibodies have been 
successfully designed that can bind targets with extremely high affinity. For example, an 
antibody has been engineered to bind fluorescein with a dissociation constant of 0.3 nM and, 
more recently, antibodies binding fluorescein with a KD of 48 femtomolar.[155, 156] The 
primary approach used for achieving high affinity binders is directed evolution (addressed in 
more detail below). However, this approach is not simply interesting for its ability to achieve 
very high binding affinity. Directed evolution has been used to improve many properties of 
antibodies for therapeutic applications including improved activity, stability, reduced 
immunogenicity, and more.[157]  
While antibodies have been quite successful, they possess some significant drawbacks. As 
described by Binz et al., ―antibodies have ―relatively low expression yields, a tendency to 
aggregate and dependence on disulfide bonds for stability.‖ [25]  For these reasons, efforts have 
been made to explore alternative scaffolds. Many different scaffolds have been explored, with 
varying degrees of success.[7] Like antibodies, many of the scaffolds have rigid, well-folded 
binding sites which can be a limitation. Therefore, repeat proteins have been considered as an 





structure, with sequence units which are modular. This allows for the binding interface to be 
increased or decreased in size as needed.  Two particularly successful examples of repeat 
proteins used for engineered biomolecular recognition include designed ankyrin repeats 
(DARPins) to produce nanomolar (and subnanomolar) binders and tetratricopeptides to produce 
micromolar binders.  [11, 135, 136] 
One property that both antibodies and the previously described repeat proteins lack is stimulus 
responsiveness. For therapeutic applications, tight binding to target is often what is required. If a 
therapeutic protein functions by inhibiting an enzyme, for example, it can simply bind the 
enzyme to inhibit it and then be cleared from the body after some time. However, there are other 
applications where the ability to reversibly bind a target is useful. Applications for stimulus 
responsive peptides have been previously summarized and include chromatography, 
environmentally responsive biomaterials, bioseparations, and biosensors.[58] However, a 
stimulus-responsive modular repeat scaffold that can be used for biomolecular recognition has 
not yet been reported. The RTX domain is explored here as a possible answer to this requirement. 




 residues are 
highly variable. In Figure 5.1, the frequency of amino acids at each of the nine positions for an 








 residues are fairly well defined. This 
is to be expected as flexible residues are required in the turn between repeats and the aspartic 




 residues face outwards. 
Therefore, we can reasonably expect that so long as these residues do not significantly harm the 





The high variability of these two residues is of interest and we hypothesized that these residues 
would make an ideal scaffold onto which to insert randomized amino acids for directed evolution 
experiments. In fact, this argument is further supported by the recently published findings that 
these residues can be mutated to all leucines in order to form a beta roll hydrogel and, more 





of each repeat are highlighted with side chains showing. Another reason that we expected that 
the beta roll face might make an ideal engineered binding interface is its similarity to the leucine 
rich repeat (LRR) domain. LRRs are motifs that fold into a structure with an extended beta sheet 
face, that is similar to the beta roll face and all LRRs are thought to be involved in protein-
protein interactions through this face.[19] The difference with the beta roll, however, is the lack 
of stimulus responsiveness in these domains. 
5.1.2 Directed evolution  
In order to evolve and/or engineer novel binding functionality in the beta roll (or any 
biomolecule, for that matter), there are two broad approaches that can be taken. First, a targeted 
approach can be taken whereby one attempts to engineer the binding face to interact with the 
target using available knowledge about the binding site and what residues are likely to interact. 
This is typically referred to as ―rational‖ protein engineering. For de novo binding interactions, 
this can often be a nearly insurmountable challenge. However in cases were some knowledge is 
available about the desired interaction, this can be a successful approach. For example, in the 
case of the beta roll hydrogel mentioned above, it was previously known that leucine zipper 
domains can aggregate together through the association of their hydrophobic leucine faces.[158] 
Therefore, it was possible to graft a leucine face onto the beta roll with the hope that similar 





alternative approach is to ―evolve‖ the desired binding interaction. This can be achieved in a 
method quite similar to the human immune system. Directed evolution is an approach that has 
been widely used to create novel binding behavior[159], alter enzyme specificity[160], stability 
[161] and more. Essentially, the amino acids desired to be involved in binding are randomized in 
order to create a library of mutant proteins. So, for example, the face of a beta roll (such as in 
Figure 5.2) which has eight exposed amino acids is randomized. If each of these positions can be 





different beta rolls could be generated. In the case of the beta roll, we can create this library at 
the DNA level by synthesizing oligonucleotides which are randomized at the positions which 
code for the face (more details below). 
Once the DNA library of beta roll mutants has been generated, the library must be express as a 
protein. At this point, the library is exposed to the target to which we would like to engineer 
binding in order to sort out proteins that bind from those that do not bind. There are a few 
methods of achieving this which will be discussed in more detail later. The selected library can 
then be re-amplified and exposed to further selections in order to enrich for those mutants that 
bind strongest. Additionally, since it is usually not feasible to express the entire sequence space 
of the library being screened at once, additional mutagenesis steps can be included to add more 
diversity to the library. This process is called affinity maturation and this mutagenesis can be 
achieved using a variety of techniques such as DNA shuffling[162], error prone PCR[163], and 
more targeted methods. The guiding principle here is that over multiple rounds of selections 
coupled with affinity maturation, natural evolution can be mimicked in order to identify beta roll 





responsiveness, one could selectively include or omit calcium during selections in order to 
control the structure of the RTX domains.  
For directed evolution experiments, we cannot simply express the beta roll library and perform 
selections. The complexity is that once the binding beta rolls have been collected, we must have 
a way of determining the amino acid sequence of the binding beta rolls as well as have a simple 
way to express them for additional rounds of selection. This requirement is referred to as the 
need for a ―genotype-phenotype linkage‖. This is required because determination of DNA 
sequences is far simpler than determination of protein sequence, so we seek a method by which 
our expressed library proteins are physically linked to their corresponding gene. By far the most 
frequently used solution to this problem are so called ―display techniques‖ whereby the protein is 
synthesized in such a way that it is somehow linked with its corresponding nucleotide sequence. 
Some of these methods include phage display[4, 164], yeast surface display[5], bacterial surface 
display[165], and ribosome display[166]. As can be seen, the name indicates to what the 
expressed protein is linked to. Each of these methods has various positive and negative traits 
related to their technical complexity, possible library size, and compatible proteins such that not 
every method will be appropriate for every scaffold. As ribosome display and bacterial surface 
display are the two methods utilized in this chapter, a more detailed discussion of them follows. 
E. coli cells express a number of outer membrane proteins (OMP’s) which are responsible for 
regulating intracellular conditions through transporting of nutrients and proteins.[167] It has been 
shown that some of these OMP’s can be fused to other proteins such that peptides can be 
displayed on the E. coli cell surface. Examples include the display of β-lactamase as a fusion to 
OmpA[168] and the display of peptides fused to OmpX[169]. By display libraries on the cell 





cytometry, cells expressing mutants which bind can be picked out based on their fluorescent 
intensity. Expressing randomized 15-mer peptides fused to OmpA, it has been shown that high 
affinity binders can be evolved[170]. More recently, the OmpX protein has been circularly 
permuted (to create the protein, CPX) such that both of its termini point out of the cells. This is 
an interesting development as it enables the display of two different peptides simultaneously. 
This CPX construct has been used to identify new streptavidin binders[169] and the construct 
itself was further improved using directed evolution techniques, to create the eCPX protein[171]. 
In Figure 5.3 (from the Daugherty manuscript describing the design of the CPX protein), a 
comparison of OmpX with CPX can be seen. 
One of the main benefits of cell surface display is that enrichment of cells expressing mutants 
that bind can be achieved easily as the cells remain viable throughout the selection process. 
Therefore, binders can simply be collected and allowed to grow more. However, this is also a 
possible drawback of the system. The fact that living cells are used introduces challenges relating 
to clonal selection (where clones are enriched because they are amenable to fast growth as 
opposed to binding) or possibly toxic mutants. Additionally, the size of the library is limited by 





 (note that this is one or two orders of magnitude less than the sequence space for a beta roll 
library described above). 
Most of the display techniques mentioned above are in vivo techniques (e.g. yeast display, 
bacterial display, phage display). Displaying proteins on living cells (or phage) can sometimes be 
problematic as the protein might be toxic to the organism, or the protein may prevent proper 
phage formation which prevents additional rounds of selection. Also, cell-based techniques 





limitation on possible library size. For these reasons, ribosome display is a possibly attractive 
alternative method. Ribosome display is an in vitro technique where the library is expressed and 
remains linked to the ribosome[166]. The method is summarized in Figure 5.4. 
The selection and enrichment principles of ribosome display are the same as those for other 
display techniques. The library is expressed, binders are selected, amplified and enriched over 
multiple rounds. Mutagenesis steps can be added as needed. The process of selection by 
ribosome display consists of six steps (summarized in Figure 5.4): 
1. The library is synthesized and cloned into a ribosome display vector that contains a 
ribosome binding site 
2. The library DNA is transcribed to synthesize library mRNA 
3. The mRNA is added to a translation extract and protein is expressed. The library 
DNA does not contain a stop codon, which results in a ribosome-DNA-protein 
complex forming. A schematic of this complex can be seen in Figure 5.5. 
4. The complexes are incubated on a target plate (e.g. a plate with immobilized 
streptavidin) and non-binding proteins are washed away. 
5. The mRNA of bound complexes is eluted 
6. Reverse transcription is performed to convert the mRNA back to DNA, which can be 
re-cloned in to the ribosome display vector for further selections. 
 
As described above, ribosome display offers a number of benefits over in vivo techniques. 
However, one of the drawbacks of this process is that the large number of in vitro steps can make 





In this chapter, the use of two display techniques is described in an effort to evolve beta roll 
forming peptides which possess calcium-responsive binding to the model protein streptavidin. 
The two techniques attempted are bacterial cell surface display and ribosome display. We 
synthesized two different beta roll libraries: one based on the adenylate cyclase block V beta roll 
characterized earlier in this dissertation and one based on the consensus sequence described in 
the chapter on using beta rolls for bioseparations. Using surface display, we are able to 
demonstrate surface expression of the beta roll and the feasibility of conducting multiple rounds 
of selection using both magnetic beads and flow cytometry. However, no binders were found. 
Using ribosome display, we demonstrate multiple rounds of effective selection and a few 
potential streptavidin binding beta rolls are identified and characterized. 
5.2 Materials and methods 
5.2.1 Beta roll library construction 
Two libraries were synthesized, a consensus library based on the consensus RTX repeat 
sequence and a library based on randomizing the face of the adenylate cyclase block V RTX 
domain (CyaA library). Both libraries were synthesized by ordering two oligonucleotides coding 
for half of the library (IDT). In both libraries, the randomized positions were generated by using 
NNK codons which allow for any amino acid to occur randomly but eliminate one possible stop 






















A schematic of the library construction is shown in Figure 5.6. The resulting sequence is shown 
in Figure 5.7. For surface display and ribosome display, the C-terminal flanking sequence of the 
CyaA block V RTX was then appended onto the library DNA. To amplify the C-terminal flank 
the forward primer RDlib9/C_overlap_F 5’GGCCATGACACGATCCGTATCAACGCGGGGGCG3’ 
was paired with beta1682_SfiI_FLAG_stop_R (for surface display) 
5’TTAAATTTGGCCACCTTGGCCTTATTTATCATCATCATCTTTATAATCGTCCGGATACTGCGC
CATTGC3’ or CcapRHindIII R (for ribosome display), 





primers CyaA_lib_amp_F_XhoI (for surface display) 
5’ATTATATACTCGAGTGGTTCTGCACGCGACGATGTGCGTATCG3’ or RDLib_BamHI_F (for 
ribosome display) 5’ATAATATAGGATCCGGTTCTGCACGCGACGAT3’ with the reverse primer 
RDLib_9C_overlap_R 5’CGCCCCCGCGTTGATACGGATCGTGTCATGGCC3’. The products of 
the cap PCR and the library PCR’s were mixed for an overlap extension PCR using the two 
flanking primers. This product was then ready for cloning into the respective vector, pRDV or 
eCPX_XS, as described below. 
 For surface display experiments, the pB33_eCPX vector from the Daugherty group was used as 
a starting point[170]. The vector was modified by removing a SfiI from the 5’ region of the CPX 
gene and insertion of an XhoI site by amplifying the eCPX gene with forward primer 
eCPX_SfiOut_F 5’TTAATATTGCCAGTCTGGCAAGGGAGGGCAGTCTGGGCAG3’ and reverse 
primer eCPX_XhoIn_R 
5’ATATAATAGGCCACCTTGGCCTTATTATAACTCGAGGAAGACTGTCCAGACTGTCCTCCGCTT
GCAGTACGGCTTTTCTCGGTGTAAGTG3’. This product was recloned into the eCPX vector 
using SfiI overhangs, to generate the vector eCPX_XS. The library product described above was 
then cloned into this vector using an XhoI and SfiI cut site. Controls were also made cloning the 
streptividin binding peptide (SBP) and wild type beta roll sequence into this library. The SBP 
construct was made as a control for streptavidin binding and the wild type control was made so 
that we could confirm that beta rolls can be expressed on the cell surface. To prepare the 
ribosome display library, the pRDV vector was used[172]. The vector and library were both cut 
with BamHI and HindIII and ligated together. The pRDV vector contains the beta-lactamase 





For surface display, a large ligation needed to be performed in order to produce a useful library. 
Therefore, 4 ug of eCPX_XS cut with XhoI and SfiI were prepared and ligated to 200-500 ng of 
library DNA, depending on the yield of insert DNA. Ligation was performed overnight at 16  C. 
After ligation, reaction was cleaned by PCR purification on a Qiagen spin column. Finally, the 
ligation was transformed into electrocompetent Top10 cells (Invitrogen). It should be noted that 
the cell line used for bacterial cell surface display must have the araD139 mutation in order to 
eliminate arabinose metabolism. This is because the system is induced with arabinose and a lack 
of this mutation will severely inhibit surface expression. After electroporation, a small sample of 
the transformation was plated in order to count colonies to estimate library size. The remainder 
was diluted in LB media and grown overnight. The overnight was then pelleted and resuspended 
in LB/glycerol for a glycerol stock. Aliquots were made consisting of 10X library coverage, as 
estimated by colony counting. 
5.2.2 Cell surface display and selection protocol 
To express the surface display library, an aliquot was defrosted and used to start a 5 mL 
overnight in LB supplemented with 50 ug/mL chloramphenicol. 250 uL of the overnight culture 
(or an amount sufficient to provide 10X coverage of the library size, assuming 1 OD600 = 10
9
 
cells) was used to inoculate a 25 mL culture of LB, again supplemented with chloramphenicol. 
Cells were grown at 37  C with shaking at 225 RPM until reaching an OD600 = 0.6. 250 uL of 
20% arabinose solution was then added to the culture for induction and cells were allowed to 
grow for another 4 hours. In the case of streptavidin peptide expression, cells were instead only 
grown for one additional hour at room temperature.  
Upon completion of expression, culture OD was measured and a volume of cells corresponding 
to 10X library coverage (10
9
 cells for a library of 10
8





by centrifugation in a microcentrifuge at maximum speed for two minutes and washed three 
times with TBS (50 mM tris-HCl, 150 mM NaCl, pH 7.5). Streptavidin magnetic beads 
(Invitrogen) were washed three times in TBS as well using a magnetic tube rack instead of 
centrifugation. A number of beads 1/10 the quantity of cells was washed. Cells and beads were 
then combined in 100 uL and incubated for one hour on ice with gentle agitation. Upon 
completion of incubation, cell/bead mixture was washed one to five times depending on the 
stringency desired for the given round of selection. Washed beads were then resuspended in 1 
mL of LB. A small sample was taken and serial dilutions were made and plated for quantifying 
recovery. The 1 mL resuspension was then dilute to 5 mL with LB, 100 ug/mL chloramphenicol 
and 0.2% glucose (to inhibit surface expression). This was grown overnight and used to start the 
culture for the next round. This procedure was repeated as many times as necessary to complete 
the selection experiments as indicated by increasing recovery percentage, typically five to seven 
rounds. A schematic of both the magnetic selection scheme and selection by flow cytometry is 
shown in Figure 5.8 Magnetic and FACS selection schemes for surface displayFigure 5.8.  
For flow cytometry experiments to confirm beta roll expression, 10 uL of cells were added 
directly to 990 uL of TBS buffer, and 1 uL of mouse anti-FLAG antibody (Sigma). This mixture 
was incubated for 30 minutes on ice. Cells were then pelleted and resuspended in 1 mL TBS with 
1 uL of anti-mouse FITC conjugated antibody (Sigma). This reaction was shielded from light 
and incubated on ice for one hour and subsequently pelleted. Pellets were kept on ice until ready 
for flow cytometry experiments. For flow cytometry, cells were resuspened in 1 mL of cold TBS 
buffer and immediately analyzed. For testing binding to streptavidin, streptavidin-phycoerythrin 
(SA-PE) was used. For this reaction, 10 uL of washed cells were diluted in TBS buffer and SA-





case of the streptavidin binding peptide, 1 uL of SA-PE solution was added. For experiments 
testing beta roll binding in the presence of calcium, all antibodies used were first diafiltered from 
their starting buffer (typically delivered in phosphate buffer) into tris buffer in order to avoid 
calcium phosphate precipitation. Gates and filters for flow cytometry were set based on control 
cells. 
Once sufficient rounds of selection were performed, the remaining library was plated on 
chloramphenicol plates. Individual colonies were grown up in analogous manner described 
above for the library and screened via flow cytometry. Clones were separately labeled for FLAG 
to confirm expression and SA-PE to test for streptavidin binding. Clones that were of interest 
were transferred to the pMAL vector for expression as soluble maltose binding protein fusions. 
To do this, cultures of clones of interest were miniprepped (Qiagen) and PCR was performed 
using the primer beta_AvaI_enteroF 
(5’ATATTAAACTCGGGGATGACGATGACAAGGGATCCGGTTCTGCACGC3’) with the reverse 
primer betalib_HindIII_R (5’TTTATTAAAAGCTTTTATTAACGGATCGTGTCATGGCCAC3’) for 
cloning the unflanked beta roll or the previously mentioned CCap_HindIII_R primer for cloning 
the complete beta roll. In either case, the product was cut with AvaI and HindIII and cloned into 
the similar digested pMAL vector. The fusion protein was expressed as previously described[123] 
and characterized using ELISA (described below). 
5.2.3 Ribosome display and selection protocol 
For ribosome display, the protocol of Zahnd et al. was used as a guide[172]. The library was 
prepared as described above and cloned into the pRDV vector using the BamHI and HindIII sites, 
to generated the pRDV_betalib vector. For beta lactamase control expression, the pRDV vector 





using primers T7B (5’ATACGAAATTAATACGACTCACTATAGGGAGACCACAACGG3’) and 
tolAk (5’CCGCACACCAGTAAGGTGTGCGGTTTCAGTTGCCGCTTTCTTTCT3’). The unpurified 
PCR product was then used with the Ambion in vitro transcription kit to synthesize mRNA. The 
protocol from the Ambion manual was followed (a volume corresponding to four reactions was 
used). The reaction was then purified using the Qiagen RNA purification kit and RNA yield was 
qualified by measuring the 260 absorbance and 10 ug aliquots of library RNA were prepared. For 
translation, an RNA aliquot was mixed with 41 ul of Premix solution and 50 ul of S30 extract, 
and diluted up to 110 uL total reaction with RNAse-free water. The reaction was run for 15 
minutes at room temperature and stopped by adding 400 ul of WBT buffer containing 0.5% BSA 
and 12.5 uL/mL heparin. This mixture was subsequently incubated on ice for two minutes, 
pelleted and used for selection experiments.  
For selection experiments, a well from a streptavidin coated plate (Thermo Scientific) was 
washed 5 times with TBS  and the translation product was loaded into the well. The reaction was 
incubated on ice for one hour with gentle shaking. After one hour, wells were washed five times 
and the mRNA was eluted with 100 uL EB supplemented with 50 ug/mL yeast RNA. The eluted 
mRNA was purified using the Qiagen RNeasy mini purification kit. This product was then 
reverse transcribed using the Promega Reverse Transcription kit. For the reverse primer of the 
reverse transcription reaction, the CCap_HindIII_R primer mentioned above was used.  The 
reverse transcription product was amplified This product was PCR amplified using the 
CCap_HindIII_R primer along with the RDLib_BamHI_F primer (also described above) and 
recloned into the pRDV vector with BamHI and HindIII sites. The complete selection and 





After selections were completed, the product of the final library ligation was transformed in E. 
coli cells and plates. Colonies were grown, miniprepped and sequenced. Colonies containing full 
length beta roll sequences, were transferred to the pMAL vector. For this, the T7B forward 
primer and CCap_HindIII_R primers were used to amplify the beta roll gene. This product was 
cut with BamHI and HindIII and cloned into the similar digested pMAL vector. Proteins were 
expressed as previously described and tested for binding using ELISA (described below). 
5.2.4 ELISA protocol 
In order to test potential binders, ELISA were performed on purified maltose binding protein 
fusions to proteins of interest. Streptavidin coated plates (Thermo Scientific) were washed five 
times with TBS supplemented with 0.1% BSA and 0.05% tween-20 (TBST). Then, protein were 
added to the wells at the desired concentration (typically 1, 10, and 100 uM as an initial test) and 
incubated on ice for 1 hour with gentle agitation. After an hour, the solution was removed and 
the wells were washed three times with TBST. Next, a 1000-fold diluted solution of HRP 
conjugated anti-MBP antibody was added to the well. This was incubated for another hour and 
washed once. Finally, ABTS solution (2.2 mg/mL ABTS, 50 mM sodium citrate, pH 4.0) was 
added to each well and the absorbance at 405 nm was tracked as indication of binding. Runs 
were typically performed in parallel to an MBP-SBP sample and MBP-wild type beta roll fusion 
as a positive and negative control for binding. For each step of this process, 200 ul of reaction 





5.3 Results and discussion 
5.3.1 Cell surface display 
In order to confirm proper expression of the beta roll on the E. coli surface, a FLAG tag was 
fused at the C-terminus of the beta roll protein. A schematic of this can be seen in Figure 5.9. 
The FLAG tag is a short peptide sequence which can be readily detected using a fluorescent anti-
FLAG antibody[173]. After four hours of expression post-induction, a very strong FITC signal 
was observed on cells expression the wild type beta roll on the cell surface with the FLAG tag. 
This was compared to a very low signal for uninduced cells. Results of flow cytometry analysis 
on these cells can be seen in Figure 5.10. 
Additionally, as a control, the streptavidin binding peptide was also expressed on the cell surface. 
This was labeled with SA-PE as described and, again, uninduced and induced cells were 
compared. Results of this experiment are shown in Figure 5.11. As can be seen, a very strong 
signal is shown for induced cells indicated strong binding to streptavidin.  
Having confirmed that the beta roll could be effectively expressed on the surface and detected, 
and that our streptavidin binding test worked, we proceeded to conduct selections using 
magnetic-activated cell sorting (MACS). Five rounds of magnetic selection were performed with 
no washes of the bead/cell mixture in the first round and three in subsequent rounds. In order to 
track the effectiveness of selection, after each magnetic selection, recoveries were quantified, 
and FLAG and SA-PE binding assays were performed using flow cytometry. Multiple attempts 
at the full selection cycle were attempted with varying degrees of success. We report here a 





Enrichment data are shown in Figure 5.12. As can be seen, over multiple rounds of selection, an 
increase in the proportion of cells recovered was seen with each round of selection. This was 
seen as a positive sign that the selection scheme was effective and binders were being selected. 
However, to confirm this hypothesis, it was necessary to check for FLAG expression as an 
indication that beta rolls are, in fact, being expressed on the surface of the cells. Unfortunately, it 
can be seen that the FLAG signal drops with each round until no cells remain expressing the tag 
(Figure 5.13). This is a strong indication that beta roll expression is being lost. Upon sequence 
individual clones of the library, it was observed that, in fact, the entire library (after three 
selections) consisted of clones which either contained stop codons or frameshifts. In either case, 
no beta rolls. Further, no change was seen in streptavidin binding, as indicated by flow cytometry 
(Figure 5.14).  
It was hypothesized that these problems stemmed from a clonal selection effect, where non-beta 
roll expressing clones have a significant growth advantage as compared to beta roll expressing 
cells. This was verified by comparing growth rates of beta roll expressing vs. non-beta roll 
expressing cells and by comparing the growth recovery time of cells expressing the large beta 
roll peptide versus cells expressing the short streptavidin binding peptide (data not shown). 
These experiments confirmed that this growth advantage is a very significant effect.  In order to 
attempt to overcome, we attempted a pre-selection with anti-FLAG coated magnetic beads. 
These beads were prepared using the streptavidin magnetic beads and biotinylated anti-FLAG 
antibody, using the protocols provided by Invitrogen. This pre-selection did eliminate the 
problem of loss of FLAG signal over multiple rounds of selection. Unfortunately, instead we 
found all beta roll expressing clones were lost in exchange for clones with large truncations 





After experiencing these challenges with bacterial cell surface display and being unavailable to 
fully overcome the loss of beta roll expression, it was determined that another display technique 
may perhaps be more well suited for beta roll expression. While the beta roll peptide can be 
display on the E. coli surface, it appears that its expression is to detrimental to cell growth rates 
for effective directed evolution experiments. However, it is noteworthy that the flanked beta roll 
is the largest example of a peptide displayed on the cell surface as a CPX fusion. The flanked 
beta roll is 152 amino acids long. On the other hand, the original work which developed this 
construct displayed a library that was 15-mer[169]. So, while directed evolution may not work 
with this construct, surface display of beta rolls may have other useful applications in future 
work. 
5.3.2 Ribosome display 
As an initial test to determine whether or not the ribosome display system would function 
effectively, a test in vitro transcription and translation was performed on the pRDV vector in 
order to synthesize RNA-ribosome-β-lactamase complexes. β-lactamase activity can be assayed 
simply by testing for hydrolysis of nitrocefin and tracking the absorbance at 486 nm. This was 
successful (see Figure 5.15 comparing pRDV to pRDV_betalib). Next, we sought to confirm that 
the full cycle of expression followed by reverse transcription and PCR was successful. This was 
optimized and success was confirmed by gel electrophoresis. 
For selection experiments on the beta roll library, five rounds of selection were performed. For 
every round of selection, five washes were done after binding. Additionally, for the last two 
rounds, a one hour incubation was performed after binding in 1 mg/mL streptavidin solution in 
order to perform an off rate selection step. Samples were subsequently eluted and processed as 





were picked, miniprepped, and sequence. Clones which contained full (or near full) beta roll 
sequences were chosen for further analysis by cloning them into the pMAL vector as described 
in the methods section. Of these 50 clones, 17 were found to contain sequences of interest 
(sequences that were full or near full length, see Table 5.1 for randomized position sequence).  
Table 5.1 Sequences identified by ribosome display 
Clone Sequence 
5.4 VS LP VR KA 
5.8 DH VW GW GN 
5.10 LL EA VE GL 
5.11 SW DT HA KD 
5.15 KV QQ RH SP 
5.20 LC RV SA PA 
5.22 VH KS TL ST 
5.24 SV RG HY DQ 
5.27 MV MS PR ED 
5.31 EG RA VH SC 
5.32 CP YL VL VS 
5.34 SV RG HY T 
5.38 GL VR RV RK 
5.46 RL GG LS PE 
5.47 EG FQ GA KI 
5.51 MR KA PS GS 
5.52 ML LM RW WT 
 
Sequences of the randomized positions for each clone. Each repeat is separated by a space. Clone 
34 lacks an eight amino acid due to a short deletion. 
Once purified, an ELISA using 10 uM of MBP fusions of each of these proteins was performed 
and compared to MBP-SBP and MBP-wild type (MBP-WT) as positive and negative controls, 
respectively. Two clones showed significantly higher signals: 5.31 and 5.34. Both were subjected 
to further characterization. To gain a more detailed understanding of the possible streptavidin 





streptavidin plates. See (Figure 5.16-Figure 5.18). While somewhat inconsistent, the results 
suggest an apparent KD in the high nanomolar or low micromolar range. All selections were 
performed in the absence of calcium. We hypothesized that if no catastrophic mutations occurred 
in the beta roll sequence, addition of calcium would induce clone 31 to form a beta roll, thus 
removing its ability to continue binding streptavidin. We see in Figure 5.17 that there is a 
difference in binding between clone 31 without calcium, versus with calcium. 
Finally, to test the conformation of clone 31 compared to the wild type beta roll, the MBP-clone 
31 fusion tested with ELISAs was cleaved using enterokinase and purified using the same 
methods described in Chapter 2. Circular dichroism analysis was performed both with and 
without calcium and compared to the same test on the wild type (Figure 5.19).  While clone 31 
does not undergo a conformational change as significant as the wild type beta roll, it does appear 
to be calcium responsive and this may be part of the reason that it appears to have different 
streptavidin binding behaviors in the presence or absence of calcium. 
We also tested clone 5.34 for its streptavidin binding behavior. It should first be note that the 
cloned contains a small deletion that removes the eight randomized positions. However, we 
expected that this would not be sufficient to eliminate possible binding behavior. Further, this 
deletion can be removed if needed by basic mutagenesis techniques. As a first test, ELISAs were 
performed comparing clone 34 to SBP and wild type. These results showed strong binding at 
both 10 and 100 uM protein concentrations (data not shown). Next titrations were performed in 
both the nanomolar and micromolar ranges (Figure 5.20 and Figure 5.21). Together, these results 
demonstrate that, like clone 31, clone 34 may also be binding streptavidin with a dissociation 
constant in the 1 uM range. Further work will be necessary to confirm this binding as well as to 





5.3.3 Conclusions and next steps 
The results presented here demonstrate the feasibility of using ribosome display as a technique 
for the selection of RTX domains with the capability of binding to streptavidin. Using the 
technique, we have identified at least two clones (Clone 5.31 and 5.34) that shows possible 
micromolar binding to streptavidin. However, there are some additional steps that will need to be 
taken in order to improve on these results. These additional steps focus on (1) gaining a better 
understanding of the clones which have already been identified as possible binders and (2) 
improving the effectiveness of the selection method employed. 
Thus far, ELISAs have been the primary method utilized to characterize whether or not the RTX 
domains isolated by our selection experiments bind to streptavidin. While effective, ELISAs are 
an indirect method at detecting bind due to their requirement for an HRP-conjugated antibody 
intermediate. This leads to added complication in experiments due to the need to optimize the 
antibody concentration to obtain results of good quality. Additionally, even once optimized, 
ELISAs can only provide apparent binding properties as only the concentration of one of the two 
interacting proteins can be known. In the case of the experiments done here, the concentration of 
the MBP-RTX fusions is known, but we can only obtain rough estimates for the quantity of 
streptavidin immobilized on the plates. And further, the streptavidin is nonspecifically adsorbed 
onto the plates, so it is entirely likely that the epitope to which our beta rolls have been selected 
to bind is obscured by the plate on at least some of the immobilized molecules. For all of these 
reasons, it would be beneficial to use a more direct technique to measure binding. A technique 
that meets these requirements is isothermal calorimetry (ITC). We have performed preliminary 





testing calcium binding to EGTA and have obtained the expected results. With further 
preparation, ITC may be a more efficient manner or testing possible binders. 
As was mentioned in the introduction to this chapter, directed evolution is in fact a combination 
of selection steps and also steps that introduce additional diversity to the library. To engineer 
very strong binders (in the nanomolar range), it has been proposed that multiple cycles of 
selection and mutagenesis must be used.[174] With the RTX domain, we have two methods 
available for increasing diversity that could be attempted. First, a technique to take the existing 
library and add additional mutation to it can be used. A targeted method could be utilized 
whereby the randomized positions are targeted once again. To do this in a specific manner, a 
technique like saturation mutagenesis could be utilized (see [175]). Alternatively, mutations 
could be added in non-specifically using a technique such as error prone PCR. Rather than 
adding in diversity through mutations, one more option would be to use a DNA shuffling 
approach. This could either be done nonspecifically using the Stemmer method ([162]), or 
specifically by identifying restriction sites that could cut the RTX domain between randomized 
positions and then relegate these pieces randomly. We have, in fact, already demonstrated the 
feasibility of both of these techniques in the lab for this library (data not shown). One last 
approach that could work for adding diversity to the library would be to concatenate additional 
repeats to the selected library. Using the same concatenation protocol used in chapter 4, this 
could be achieved fairly easily. By adding another 8 repeats of RTX sequences, the effective 
library size could be increased by an order of magnitude, thus significantly increasing the 
sequence covered and the likelihood of finding stronger binders. This is, in fact, one of the main 





One final step that could be taken to further improve on this work would be to take fuller 
advantage of the calcium binding properties of the RTX domain. In this work, we have 
performed all selections in the absence of calcium. Then, after the fact, calcium was added into 
the binding reaction to see if it would inhibit binding. It was observed that this did, in fact, occur 
(for clone 31). However, the results were not significant. To obtain better results, rational cycling 
of calcium could be included in the actual selections steps. Specifically, one could perform the 
binding step in the absence of calcium and then, for the elution step, simply add calcium and 
collect those ribosome complexes which fall off of the streptavidin. In this way, the selections 






5.4 Figures and tables 
Figure 5.1 Sequence logo for consensus beta roll sequence. 
 





 positions are highly variable and are, therefore, hypothesized to be amenable to 






Figure 5.2 Proposed structure for an evolved beta roll. 
 
A mockup crystal structure of the block V adenylate cyclase toxin beta roll domain. Nine repeats 
of beta roll are shown with the face shaded. The aim of this work is to randomize this face in 






Figure 5.3 Outer membrane proteins for surface display 
 
A schematic of both the natural OmpX protein and the engineered circularly permuted version of 
it, CPX[169]. CPX is modified such that both termini face outside the cell for tethering a 





Figure 5.4 Schematic of ribosome display protocol 
 
 
A summary of the ribosome display protocol. The protocol begins with the DNA library 
amplified from the pRDV vector. The DNA is transcribed to RNA, the RNA is translate into 
protein within the protein/RNA/ribosome complex. This is exposed to the target, RNA is eluted 
off. Then, the RNA is reverse transcribed back to DNA and amplified. The cycle is repeated as 














Figure 5.6 Library generation scheme 
 
A simplified schematic of how the beta roll library was generated. The black lines represent the 
two oligos that were ordered and annealed to each other. At the positions marked by the green 
arrows, randomized nucleotides were included such that the amino acids on the face would be 
randomized. This product was then fused with the C-terminal flank and cloned into the 






Figure 5.7 Sequence of CyaA library 
 
The sequence for the CyaA library on which directed evolution experiments were performed. 
The RTX region consists of the alternating black and dark gray sequence. Randomized positions 






Figure 5.8 Magnetic and FACS selection schemes for surface display 
 
Diagram of magnetic and FACS selection schemes. In both methods, the beta roll is surface 
displayed on E. coli. For magnetic selection, streptavidin coated beads are mixed with cells and 
binders are extracted with a magnet. For FACS selection, cells are mixed with streptavidin-







Figure 5.9 Surface display of beta roll 
 
Diagram of CPX-beta roll-FLAG construct embedded on the E. coli cell membrane. The CPX 
protein runs from the inner membrane to the outer membrane. The beta roll is shown fused to the 







Figure 5.10 FACS data of surface displayed beta roll 
 
Flow cytometry histograms showing FITC flourescence (an indication of FLAG expression) in 
both an uninduced (left peak) and induced (right peak) cell population. It is evident that the 






Figure 5.11 FACS data for surface displayed streptavidin binding peptide 
 
Flow cytometry histograms show PE fluorescence of both an uninduced (left peak) and induced 
(right peak) population expression the streptavidin binding peptide on the surface. Using a 
streptavidin-PE conjugate, binding to streptavidin can be detected and is confirmed by the high 






Figure 5.12 Surface display recovery results 
 
Sample recovery data from five rounds of magnetic selection on the surface displayed beta roll 
library. Over five rounds, recoveries were observed to steadily increase. This is normally an 
indication of enrichment of clones with binding behavior. Unfortunately, in this case, the 






Figure 5.13 Tracking surface display over multiple selections 
 
From top left going across, the FLAG signal of the beta roll library over five rounds of selection. 
In round one, it is seen that the fluorescence signal is high indicating that most of the library is 
expressing surface protein. After round two, the population is divided roughly equally between 







Figure 5.14 Tracking streptavidin binding over multiple selections 
 
Each histogram going from front to back is the PE signal after a round of selection (from first to 
fifth round). As mentioned above, the PE signal is an indication of streptavidin binding. Clearly, 
no detectable binding is present. However, this does not entirely preclude binding, as flow 







Figure 5.15 In vitro expression of beta-lactamase 
 
Beta lactamase is capable of hydrolyzing nitrocefin. Hydrolyzed nitrocefin can be detected by its 
absorbance at 486 nm. Above, as a control for successful invitro expression of beta lactamase, an 
assay is performed to measure nitrocefin hydrolysis. As can be seen, beta lactamase shows a 
positive result (upper curve). As a negative control, expressed beta roll was also tested and only 







Figure 5.16 ELISA to test possible hits 
 
An ELISA comparing clone 31 to the streptavidin binding peptide (SBP) and the wild type beta 
roll (WT). Samples were tested both with and without calcium (solid line and dashed lines, 
respectively). We see that clone 31 shows a slightly higher binding signal without calcium than 
with as well as a higher signal than the WT. However, it does not appear to reach as high of a 






Figure 5.17 ELISA results for 10 uM protein 
 
The ELISA signal only for 10 uM protein samples (same trial as in Figure 5.16). The difference 
between clone with and without calcium and compared to WT is more evident here. + indicates 





Figure 5.18 Additional ELISA experiments 
 
A second trial ELISA on clone 31. In the above graph, OS 31 is the same clone 31 in prevous 
results. Here, we see that clone 31 shows very strong binding at low protein concentration, but it 
seems to trail off as concetnrations go up. The x-axis is protein concentration in uM. 






Figure 5.19 CD spectra of clone 5.31 
 
CD results for clone 5.31. A change in conformation is evident with increasing calcium 
concentration, but this is not the same extent as the change for the wild type. See chapter 2 for 






Figure 5.20 ELISA on clone 5.34 in nM range 
 
ELISA on clone 5.34 focusing on lower protein concentrations. We see that there is a transition 






Figure 5.21 ELISA on clone 34 in uM range 
 
ELISA on clone 5.34 at higher protein concentrations in the uM range. We can see that any 
transition has already taken place and the signal is steady. However, it is clear that clone 34 






6 RTX domains for bioseparations 
Note: A version of this chapter entitled ―A designed, phase changing RTX-based peptide for efficient bioseparations‖ has been submitted to 
Biotechniques as of June 2012. 
OS conceived of and performed all experiments. OS wrote the manuscript. 
6.1  Abstract 
Chromatography is typically the most costly and time consuming step in protein purification 
processes. As a result, alternative methods have been sought for bioseparations. One approach 
has been the use of stimulus-responsive tags which can reversibility precipitate. With an 
appropriate stimulus, target proteins can be efficiently and rapidly purified from complex 
solutions. While effective, these tags tend to require either temperature changes or relatively 
harsh buffer conditions to induce precipitation. Therefore, there is a need for gentler alternatives. 
We have developed a synthetic peptide, based on the natural repeats-in-toxin domain (RTX), 
which undergoes calcium-responsive and reversible precipitation. This tag was coupled to the 
maltose binding protein and was found to be capable of efficiently purifying the fusion protein. 
Next, the maltose binding protein fusion was appended to the green fluorescent protein and to β-
lactamase and we demonstrate that these constructs can also be purified using calcium-induced 
precipitation. Finally, an enterokinase protease site downstream of the precipitation tag was 
cleaved to demonstrate that pure target protein can be obtained by cycling precipitations before 
and after cleavage. This designed RTX sequence is a new stimulus-responsive precipitation tag 







Non-chromatographic purification techniques are of significant interest as chromatography is 
typically the most expensive step in protein purification.[176] Alternative approaches have been 
sought and these methods often rely on targeted precipitation of the protein. One approach is 
metal chelate affinity precipitation, where thermoresponsive copolymers can be used to 
specifically precipitate out poly-histidine tagged recombinant proteins.[177, 178] Another, 
protein based, approach is the use of thermoresponsive elastin-like peptides (ELP’s) that 
precipitate in response to small temperature increases and consist of tandem repeats of the 
sequence VPGXG.[179, 180] ELP’s undergo an inverse phase transition and aggregation, which 
is thought to be driven by the exposure of hydrophobic patches upon heating.[181] To create a 
complete purification system, ELP’s have been coupled to intein domains which have been 
genetically engineered into their minimal self-cleaving units.[182] When coupled, the ELP-intein 
system allows for a simple two stage purification scheme. In the first step, the ELP is triggered 
and the fusion protein is purified. Then, the intein is induced to cleave off the target protein and 
the ELP is again precipitated, leaving behind pure target protein.[121] While effective for many 
purification applications, the necessary heating of samples or the alternative use of high salt 
concentrations [183] can be problematic in many situations. 
Recently, many groups have been exploring repeat scaffolds for protein engineering applications. 
Repeat scaffolds are of great interest as their repetitive, predictable secondary structures make 
them ideal for both studying folding and engineering novel functions.[26, 184] Multiple 
examples exist of repeat scaffolds being engineered for biomolecular recognition, most notably 
the ankyrin repeats.[11] In order to faciliate the engineering of these scaffolds, efforts have been 





peptide unit. Once this unit is identified, multiple repeats can be concatenated as necessary for 
the particular application. Consensus design approaches have been successfully used for a 
number of repeat scaffolds, including ankyrin repeats, tetratricopeptide repeats, and armadillo 
repeats.[9, 25, 30, 47] The ability to alter the size of a scaffold is of particular value when 
engineering molecular recognition in the scaffold, as the interface size can be tuned to the 
particular target. 
In an effort to explore novel scaffolds for protein engineering, we have sought to identify a 
repeat scaffolds which are also stimulus-responsive. Towards this end, we have investigated the 
calcum-responsive repeats-in-toxin (RTX) domain. The RTX domain is found in proteins 
secreted through the bacterial type 1 secretion system.[14] The domain consists of repeats of the 
consensus amino acid sequence GGXGXDXUX, where X is variable and U is a hydrophobic 
amino acid. One of the most well characterized RTX domains is the block V RTX domain from 
the adenylate cyclase toxin (CyaA) of B. pertussis. The domain is intrinsically disordered in the 
absence of calcium and forms a beta roll structure (Figure 6.1Figure 5.1A) in the presence of 
calcium.[15] Of note, the block V RTX domain possesses the property of being reversibly 
calcium-responsive even when expressed separately from the larger protein.[18, 123] Previous 
efforts have been made to use RTX domains in protein engineering efforts, including 
incorporation into mesh networks, design of synthetic RTX peptides, and engineering of cross-
linking RTX domains that enable hydrogel formation. [21-23, 185]  
Our original objective in this work was to develop a consensus design for RTX domains. 
Specifically, we identified the frequency of amino acids at each position of the nine amino acid 
repeat unit from a set of native RTX-containing proteins (Figure 6.1B). This led to identification 





constructs consisting of 5, 9, 13, or 17 repeats of the consensus unit. Upon purification of a 
number of these constructs, we observed that many of them precipitate in the presence of 
calcium. Therefore, we decided to explore the possibility for using these consensus beta roll tags 
(BRT’s) as a tool for protein bioseparations, similar to the ELP-based systems. We first 
demonstrate the purification of a maltose binding protein (MBP)-BRT fusion as a proof of 
principle. Then, this MBP-BRT construct is fused to the green fluorescent protein (GFP) and β-
lactamase to demonstrate the feasibility of purifying two additional proteins. Finally, a specific 
protease is used to cleave the BRT from MBP-BRT construct to show that target proteins can be 
fully purified using this methodology.  
6.3 Materials and Methods 
6.3.1 Cloning  
Four different sized MBP-BRT fusions were prepared consisting of 5, 9, 13, or 17 repeats of the 
consensus RTX sequence (named BRT5, BRT9, BRT13, and BRT17). In order to generate the 
DNA fragment for BRT9, three oligonucleotides were synthesized: cons_beta_1, cons_beta_2, 


















was performed and a clean product was obtained and gel extracted. This fragment was digested 
with AvaI and HindIII and cloned into the similarly digested pMAL_c4E vector to generated 
pMAL_BRT9.  
To generate the BRT5 construct, pMAL_BRT9 was used as a template for PCR with the primers 
cons1_AvaI_F and cons5_BseRI_HindIII_R (5’-
TTTTTAATAAGCTTGAGGAGTATTATTAATACAGCGTGTCGTTACCG-3’). This product 
was digested with AvaI and HindIII and cloned into the pMAL_c4E vector producing 
pMAL_BRT5. 
BRT13 was produced by concatenation of four additional repeats to the insert of pMAL_BRT9. 
Concatenations were achieved using a recursive ligation technique similar to those previously 
described.[150, 151] This four repeat insert was amplified using primers cons1_BtsCI_F (5’-
ATTAAAAAGGATGATGGCGGTGCGGG-3’) and cons4_BseRI_HindIII_R (5’-
TTTTTAATAAGCTTGAGGAGTATTATTAATACAAAGTGTCGTTACCTGCTC-3’). This 
product was digested with BtsCI and HindIII and cloned into pMAL_BRT9 cut with BseRI and 





reverse primer cons8_BseRI_HindIII_R (5’-
TTTTTAATAAGCTTGAGGAGTATTATTAATAGAGGGTATCGTTACCCGC-3’) was used 
instead of cons4_BseRI_HindIII_R. 
The emGFP gene was amplified from Invitrogen pRSET/emGFP vector using primers 
GFP_BseRI_F (5’-
AATATATAGAGGAGATAATAATATATGAGTAAAGGAGAAGAACTTTTCACTGGAGT-
3’) and GFP_HindIII_R (5’-
TATTATAAAGCTTTTATTTGTATAGTTCATCCATGCCATGTGTAAT-3’). The β-
lactamase gene was amplified from the pMAL_c4E vector using primers betalac_BseRI_F (5’-
AATATATAGAGGAGATAATAATATATGAGTATTCAACATTTCCGTGTCGC-3’) and 
betalac_HindIII_R (5’-TATTATTAAGCTTTTATTACCAATGCTTAATCAGTGAGGCACC-
3’). Both of these inserts were digested with BseRI and HindIII and cloned into similarly 
digested pMAL_BRT17 to yield pMAL_BRT17_GFP and pMAL_BRT17_betalac. All 
oligonucleotides were ordered from IDT. 
6.3.2 Expression and Purification.  
For expression and cloning, Invitrogen Omnimax T1 E. coli cells were used. For expression of 
all constructs, 1 L cultures of TB supplemented with 100 ug/mL ampicillin and 0.2% glucose 
were inoculated with 10 mL of overnight culture. Cultures were grown at 37° C with shaking at 
225 RPM to an approximate OD600 of 0.5 and induced with 0.3 mM IPTG. All cultures except 
pMAL_BRT17_GFP were grown for an additional two hours and harvested. 
pMAL_BRT17_GFP was transferred to a shaker at 25° C and allowed to grow for an additional 





Cells were harvested after expression and resuspended in 1/20 culture volume of 50 mM tris-HCl, 
pH 7.4 for precipitation purification. For amylose resin purification, cells were resuspended in 
1/20 culture volume of MBP column buffer (20 mM tris-HCl, 200 mM NaCl, 1 mM EDTA, pH 
7.4). In both cases, cells were subsequently lysed via sonication using 15 second pulses for a 
total of 150 seconds. Lysate was then clarified by centrifugation at 15000g for 30 minutes. For 
amylose resin purification, clarified lystate was diluted with five volumes of column buffer and 
purified as previously described.[123]  
For precipitation purification, clarified lysate was added to a concentrated calcium stock as 
indicated by the calcium concentration in the data presented. For example, for precipitation of 
MBP-BRT lysate in 100 mM CaCl2, 950 uL of clarified lysate was added to 50 uL of 2 M CaCl2 
solution. The sample was promptly mixed by gentle pipetting and allowed to sit at room 
temperature for two minutes. The sample was then centrifuged at maximum speed in a 
microcentrifuge for two minutes. The supernatant was carefully removed and the pellet was 
resuspended in the same tris buffer by gentle pipetting. The turbid solution was centrifuged and 
washed for two additional cycles. For the final step, the pellet was resuspended in tris buffer with 
a concentration of EGTA equivalent to the original calcium concentration. Gentle pipetting was 
sufficient to cause the sample to redissolve as confirmed by observation and the lack of a 
precipitate upon subsequent centrifugation.  





6.3.3 Recovery, Activity and Fluorescence Assays.  
Recovery of MBP-BRT17 both by amylose resin purification and precipitation was determined by 




 was used as 
determined by the ProtParam tool on ExPASy. 
GFP recoveries were estimated by comparing fluorescence emission intensity at 509 nm with 
excitation at 487 nm. 100-fold dilutions of both clarified lysate and purified protein were made 
for fluorescence measurements. Purified proteins were resuspended in the same volume as the 
lysate from which they were extracted, so signals were compared directly. 
For estimation of β-lactamase recovery, protein was added to a nitrocefin solution and the 
absorbance at 486 nm was tracked corresponding to the hydrolysis of nitrocefin. 500 uL of 
nitrocefin solution was prepared by placing three nitrocefin disks (Fluka) in 450 uL 50 mM tris-
HCl, pH 7.4 and 50 uL DMSO. In each sample well, 50 uL of this solution were mixed with 90 
uL of the same tris buffer and 10 uL of protein sample. For each sample tested, serial dilutions 
from 1X to 1000X were prepared from lysate and purified protein. Initial rates were determined 
by measuring the change in absorbance at 486 nm over the first 20% of the change in signal 
between the starting absorbance and the end absorbance. The same nitrocefin stock solution was 
used for all samples to account for variations in concentration. 
All spectroscopic measurements were performed using a SpectraMax M2 (Molecular Devices). 
6.4 Results and Discussions 
In order to identify a consensus RTX sequence, a database of RTX containing proteins was 
constructed by a search of the UniProt database for hemolysin-type calcium binding domains. 





positions was determined (Figure 6.1B). From this result, the repeat sequence GGAGNDTLY 
was identified as an RTX consensus sequence. A variety of synthetic RTX domains of different 
lengths (5, 9, 13, and 17 repeats) were prepared as fusions to the C-terminus of MBP. These 
lengths were chosen based on the natural variability in the lengths of RTX domains. These BRT 
constructs were named BRT5, BRT9, BRT13, and BRT17, with subscripts denoting the number of 
repeats. Unexpectedly, we observed that upon the addition of calcium to the purified BRT17 
construct, there was significant precipitation, which was reversed upon the addition of the 
chelating agent, EGTA. 
In order to more thoroughly characterize the precipitation behavior, cells were induced to express 
the four different MBP-BRT constructs. Clarified cell lysates were prepared from these four 
cultures and were then titrated with calcium to assess precipitation behavior. Briefly, 1 mL of 
clarified cell lysate was mixed with calcium chloride solution at the indicated concentrations, 
clarified by centrifugation, and the mass of the pellet measured (Figure 6.2). Due to possible 
variations in cell growth rates and densities, all cultures were started from saturated overnight 
cultures and induced simultaneously. Both BRT13, and BRT17 precipitated when calcium 
concentrations exceeded 25 mM. Some precipitation was observed from BRT5 and BRT9 lysate, 
similar to what was observed with control cell lysate. Addition of an equivalent concentration of 
EGTA allowed the pellets to quickly redissolve upon gentle pipetting. While both BRT13, and 
BRT17 precipitated out of solution, it was observed that the BRT17 formed a pellet that was easier 
to clarify and was selected for further examination. Two additional constructs were prepared by 
fusing MBP-BRT17 to the N-terminus of GFP and β-lactamase (named MBP-BRT-GFP and 





The folding of RTX domains into the beta roll is highly calcium specific. Therefore, we were 
interested in whether the precipitation behavior observed was also calcium-specific. To test this, 
MBP-BRT-GFP was purified on an amylose resin and diafiltered into salt-free tris buffer. 
Diafiltration was necessary as proteins are purified in high salt buffer during the amylose resin 
purification step and it was observed that BRT precipitation was reduced in high ionic strength 
conditions. This is consistent with previous observations that calcium affinity of RTX domains is 
reduced with increased salt concentration.[129]   Solutions of various salts were added to  a final 
concentration of 100 mM. The samples were then gently mixed by pipetting, allowed to sit for 
five minutes, and centrifuged at top speed in a microcentrifuge for 2 minutes. Tubes were then 
inverted and the presence of a pellet at the top was indicative of precipitation (Figure 6.3). BRT 
precipitation was observed to be calcium-specific, with near complete precipitation of MBP-
BRT-GFP (as indicated by the remaining color in solution) in calcium and no precipitation was 
observed upon addition of other salts. While this behavior does not establish the formation of a 
beta roll structure, it does indicate that at least one property of beta roll formation is still present 
in these consensus constructs. 
For all three constructs tested (MBP-BRT17, MBP-BRT-GFP, and MBP-BRT-β-lac), calcium 
concentrations greater than 25 mM were found to cause precipitation of the fusion protein. To 
assess the ideal calcium concentrations, all three constructs were precipitated from 1 mL of 
clarified cell lysate in 25, 50, 75, and 100 mM calcium chloride. Pellets were washed in salt-free 
tris buffer three times and ten times. Pellets did not dissolve until exposed to an equivalent 
concentration of EGTA after the final wash and were resuspended in their original volume. The 
100 mM CaCl2 samples were found to not fully redissolve, so only lower CaCl2 concentrations 





lower CaCl2 concentrations) as confirmed by SDS-PAGE (data not shown).  All three constructs 
were subsequently purified by precipitation with 75 mM CaCl2 and SDS-PAGE was performed 
for three (Figure 6.5) and ten washes (Figure 6.4). The additional washes did not appear to 
improve the purification, so further quantification and recovery measurements were performed 
on samples washed only three times. To confirm scalability, the analogous protocol was also 
performed on 50 mL lysate, and comparable results were obtained (data not shown). 
We next sought to quantify the recovery and functionality of the purified proteins after 
precipitation. To assess the recovery of MBP-BRT17, we used the theoretically determined 
extinction coefficient to estimate concentration by absorbance at 280 nm.[186] Results from 
purifying the construct on an amylose resin were compared to BRT precipitation. For MBP-
BRT-GFP, recoveries were calculated as the percentage of fluorescence signal (ex. 487 nm, em. 
507 nm) of purified sample compared to lysate (which was normalized against control lysate). 
MBP-BRT-β-lac recoveries were calculated using activity measured by tracking the absorbance 
at 486 nm for the hydrolysis of nitrocefin. Results of these trials are shown in Table 6.1. For 
MBP-BRT, calcium precipitation performed comparably to or better than amylose resin 
purification. For MBP-BRT-GFP, we observed near complete recovery of fluorescent signal for 
all three calcium concentrations. Finally, the β-lactamase recovery was not as high, but the use of 
the BRT tag yielded more activity than what was achieved using the standard amylose resin for 
purification. 
To increase the utility of this tag, it may be beneficial to couple the BRT system with a cleavage 
tag to cleave the protein of interest and precipitate the BRT. The pMAL_c4E vector contains a 
cleavable enterokinase site between the MBP and BRT. Therefore, as a proof of principle, we 





After cleavage, CaCl2 was again added to the supernatant and the pellet was separated.  Nearly 
pure target protein was achieved and higher purity could be obtained with additional washes. To 
further improve this sytem, the protease used could be fused to the precipitating BRT (to remove 
trace protease after cleavage) or a self-cleaving intein could be incorporated.  
It is not clear why these consensus RTX constructs precipitate, whereas the wild-type 
sequences do not. We do observe a correlation between length and precipitation (Figure 6.2), so 
size likely plays a role. We recently investigated the impact of altering the number of RTX 
repeats in the native block V CyaA RTX domain of B. pertussis but no significant size effect was 
observed and, further, a C-terminal capping was required for calcium-responsiveness. (PEDS 
submitted, June 2012) A few previously reported efforts have been aimed at designing synthetic 
RTX domains.  Scotter et al. created synthetic domains consisted of 4 RTX repeats and Lilie et 
al. created domains consisting of 8 repeats.[22, 145] The peptides create by Lilie et al. were 
weakly calcium responsive, while those of Scotter et al. were only lanthanum responsive and 
formed partially insoluble filaments in the presence of lanthanum. In general, it is thought that 
beta sheets can be prone to aggregation and nature uses various techniques to enhance solubility. 
[187] Thus it seems likely that some of the deviations from the consensus sequences found in 
native RTX domains function to enhance solubility of the beta roll structures.  These effects are 
lost in the consensus sequences, however the resulting reversible precipitation is valuable for 
bioseparations applications.  It is interesting that the BRT sequence is only responsive to calcium, 
which suggests that beta roll structures could be forming during the precipitation process as 
opposed to a non-specific salting-out effect.  Further investigation will be required to better 





experiments can be performed to identify critical residues for precipitation. Additionally, 
precipitates can be tested amyloidgenic character. 
The technique described here offers a new method that could be useful in a range of applications 
similar to those reported for which ELPs, such as recombinant protein purification, creation of 
stimulus responsive biomaterials and controlled release. The BRT tag possesses certain 
advantages over ELPs since precipitation is simple and the BRT is significantly smaller in size. 
The, BRT17 tag precipitates in as little as 25 mM calcium chloride at room temperature compared 
with larger ionic strength and higher temperature increases required for ELP precipitation. The 
protocol described here can be performed in only a few minutes from lysate to purified fusion 





6.5 Figures and tables 
Table 6.1 Recovery data for three constructs tested 
  MBP-BRT MBP-BRT-GFP MBP-BRT-β-lac 
Calcium,  mM fold vs. resin fold vs. resin Fluorescence fold vs. resin Activity 
25 0.83 ± 0.05 1.1 ± 0.04 91 ± 4% 3.0 ± 0.04 7.4 ± 1.2% 
50 1.7 ± 0.29  1.1 ± 0.03 98 ± 3% 4.4 ± 0.15 10 ± 3.4% 
75 2.0 ± 0.27 1.2 ± 0.06 97 ± 6% 4.5 ± 0.14 11 ± 3.2% 
 
 ―Fold vs. resin‖ denotes protein quantity recovered relative to amylose resin for equivalent 
loading amount. For MBP-BRT-GFP and MBP-BRT-β-lac, fluorescence and activity are the 






Figure 6.1 Beta roll structure and sequence logo 
 
(a) Crystal structure of beta roll domain from metalloprotease of S. marcescens. (PDB: 1SAT), 
(b) Amino acid frequencies for single beta roll repeat identifying consensus sequence 
GGAGNDTLY. Height of the letter corresponds to proportion of sequences containing the 






Figure 6.2 Role of BRT length in precipitation 
 
Mass of precipitated pellet versus calcium chloride concentration and BRT size. Results for 







Figure 6.3 Ion specifity of BRT precipitation 
 
Purified MBP-BRT-GFP was mixed with 100 mM of the compound indicated, and centrifuged to 
collect any pellet. The tube was then inverted such that precipitated protein remained on top. The 






Figure 6.4 SDS-PAGE results for purification of three constructs tested 
 
Numbers are standard size in kDa. Expected molecular weights for MBP-BRT-GFP, MBP-β-lac, 
and MBP-BRT are 83.4, 88.6, and 57.1 kDa, respectively. (a) Purification of MBP-BRT-GFP. 
Lane 1 is standard, 2 is clarified lysate, and lane 3 is purified fusion protein. (b) Same samples 
for purification of MBP-BRT-β-lac. (c) Purification and enterokinase cleavage of MBP-BRT. 







Figure 6.5 SDS-PAGE results after three washes 
 
SDS-PAGE gels of recoveries after three washes of the calcium-induced precipitate. For all three 
panels, lane 1 is purified protein, lane 2 is clarified lysate, and lane 3 is standard. Panels are as 








7 Summary of work and future directions 
7.1 Summary 
In this work, we have documented the process by which an interesting natural protein motif is 
identified, characterized, and arduously molded into a bioengineering scaffold. Scaffolds are, in 
many ways, the fundamental unit of protein engineering work. Due to the immense (and, as of 
today, mostly insurmountable) difficulty of designing proteins de novo, we are forced to begin 
with naturally existing proteins and alter them to fit our requirements. We identified the beta roll 
forming RTX domain as possible new scaffold and have shown how different approaches can be 
used to gain a detailed understanding of the domains behavior. Using this understanding, we 
have demonstrated two different applications of this new scaffold. 
In chapter 1 of this work, we provided an overview of the concept of bioengineering scaffolds. 
Particularly, we focused on scaffolds for engineering novel biomolecular recognition. We 
reviewed some of the more widely used scaffolds such as antibodies, designed ankyrin repeats, 
tetratriocopeptides, and fibronectin domains (see review by Binz et al. for detailed discussion[7]). 
Next, repeat scaffolds were addressed and the benefits of such scaffolds, including their 
predictable secondary structure and modularity. We discussed some of the approaches used for 
working with these scaffolds, focusing on consensus design and the concept of end capping. 
Finally, we identified the need for stimulus responsive repeat scaffolds and proposed that the 
beta roll domain may be a possible answer. While beta rolls have not been known naturally to be 
involved in biomolecular recognition, their structural similarity to leucine rich repeats, which are 
widely involved in such interactions (see[19, 20]), was taken as a strong indication that it would 





efforts to study the RTX domain and explore the possibility of developing it into a new tool for 
bioengineers. 
Prior to this work, the most well characterized RTX domain was the block V RTX domain from 
the adenylate cyclase toxin of B. pertussis (see [18]). Bauche et al. showed that this domain was 
calcium-responsive in the presence of its natural flanking sequences. In chapter 2, we began with 
this domain and made a variety of truncations to the flanking sequence in order to identify the 
minimal flank required for beta roll formation. It was found that only the natural C-terminal 
flank was required. Further, we demonstrated that other proteins could also act as flanks enabling 
beta roll formation, as long as they were on the C-terminus. Together, these results showed that 
beta roll formation is driven by entropic stabilization of the C-terminus of the RTX peptide. 
There was also some indication that naturally flanked beta rolls behave different than 
alternatively flanked beta rolls, and this observation helped guide our subsequent work. 
The ability to tether a peptide to a solid substrate is useful in a variety of applications, 
particularly for biosensors or chromatography applications. We envisioned that once a beta roll 
was engineered to bind to a target, it could be immobilized and used one of these applications. 
Therefore, in chapter 3, a quartz crystal microbalance was used to determine if RTX domains can 
still form the beta roll when immobilized. We find that not only does the beta roll still form when 
flanked with the natural C-terminal group, but that immobilization on either terminus without the 
flank also enabled folding. This provided us with further evidence of the hypothesis that entropic 
stabilization of the RTX domain is the main driving force of folding. However, we again 
observed that, in the absence of the native flanking group, folding proceeded with lower 





To this point, all of our characterization work had focused on the flanking groups of the RTX 
domain; be it native flank, alternative protein flank, or solid substrate. However, we had not yet 
studied the behavior of the actual RTX repeats. There were two issues that were of particular 
interest to us. First, we sought an explanation for our observation that while alternative caps can 
allow beta roll formation, the native flank results in the best calcium binding cooperativity and 
affinity. We hypothesized that this was related to the presence of ―non-standard‖ repeats present 
near the terminus. Second, we had an interest in exploring the modularity of RTX repeats. As 
mentioned above, other repeat scaffolds are highly desirable for their modularity. That is, the 
ability to concatenate multiple units to create a binding interface of any size that is desired. With 
these two questions in mind, chapter 4 focused on studying the modularity of RTX repeats and 
the role of non-standard repeats. We found that repeats were indeed modular and that adding or 
removing repeats did not significantly harm calcium binding behavior. However, the presence of 
non-standard repeats near the terminus was critical, and moving them was found to be 
catastrophic to beta roll formation. 
Overall, our characterization efforts summarized in chapter 2-4 provided groundwork for efforts 
to develop beta rolls with useful functionality. Moving towards applications, we now had a good 
sense of how to enable beta roll formation and what properties of the beta roll could be 
engineered (particulary the length and the cap) and which properties needed to remain unaltered 
(non-standard repeats at the C-terminal region). At this point, we began efforts towards 
engineering of beta rolls with biomolecular recognition capabilities and consensus design of beta 
rolls. 
Chapter 5 described our efforts at engineering beta rolls with biomolecular recognition 





ribosome display. While surface display presented a number of challenges, ribosome display did 
yield some positive results. We were able to identify a set of beta roll with possible binding to 
strepavidin. Specifically, we found one beta roll that appears to bind streptavidin in a calcium-
dependent fashion and does shown some conformational change in response to calcium. 
Unfortunately, the conformational change was not as extensive as what was observed in earlier 
chapters with the native beta roll and binding experiments were not entirely conclusive. Despite 
some drawbacks, we were able to demonstrate the feasibility of these techniques and some 
proposed future directions are outlined in the final section of this chapter. 
We concluded this work with an unexpected application of beta rolls. Towards the goal of 
consensus design, we took the beta roll consensus sequence and appended it to the native C-
terminal flank. Based on our earlier findings, we expected that this construct would undergo a 
predictable calcium-responsive conformational change. Surprisingly, it turned out to reversibly 
precipitate in the presence of calcium. In chapter 6, we described our efforts to use this result to 
turn the beta roll into a bioseparations tag. Using the consensus beta roll, we show that we can 
create beta roll tags (BRTs) that can purify a variety of proteins in an efficient and rapid manner. 
7.2 Future directions 
While much has been accomplished in this work, there will always be further areas for 
innovation and progress. To conclude this dissertation, we will consider a few different areas that 
merit further investigation in order to advance our knowledge of the RTX domain and, by 





7.2.1 Explore alternative RTX proteins as scaffolds 
The majority of this work has focused on the block V RTX domain from the adenylate cyclase 
toxin. However, there are many proteins that contain RTX domains and it is not clear this 
particular domain is unique in anyway. Other RTX domains have been studied to differing 
extents. While many past efforts to engineering RTX domains have been unsuccessful, the RTX 
domains studied in these past research works should be reconsidered in light of the discovering 
made here regarding inducing beta roll formation.  
An RTX domain from P. aeruginosa alkaline protease was used as a starting point for creating 
synthetic beta roll proteins. However, the products formed unexpected filaments and were not 
calcium responsive [23]. Or, there is the work by Lilie et al. where an 18-mer peptide of the 
repeat GGSGNDNLS was produced, but only folded in the presence of high concentrations of 
PEG [22]. In both of these cases, one wonders what would occur if a C-terminal flanking group 
was added to these two RTX domains. As a final example of past work that can be expanded on 
based on our work, the beta roll from the metalloprotease of S. marcescens has been used as a 
calcium switch in a designed network, and has the added advantage of having a crystal 
structure[16, 21]. Here, it would be interesting to study the effect of increasing the number of 
RTX repeats (the metalloprotease beta roll consists of only 5 RTX units). 
Not only can past RTX engineering work be reconsidered, but new RTX domains for study can 
be identified. We have shown in chapter 4 that while additional repeats can be added to the CyaA 
RTX domain, there is some harm caused to its conformational change. If a large RTX domain is 
sought, it may be a better approach to identify a longer natural beta roll as a starting point. In 
chapter 4, we proposed one such example (the leukotoxin of A.  actinomycetemcomitans), but 





7.2.2 Optimization of BRTs for bioseparations 
The results presented in chapter 6 demonstrate a very promising application for synthetic RTX 
domains. While the technology is already at a useful point, there are areas where further 
enhancements can be made. 
The first area that optimization may be possible is by adjusting the length of the BRT. In chapter 
6, lengths ranging from 5 to 17 repeats were tested. There is a clear transition from 9 to 13 
repeats where precipitation does not occur to where it does occur. However, we also noticed that 
while both 13 and 17 repeats precipitate, 17 forms a more manageable pellet. Ease of separating 
the pellet from the supernatant is one critical aspect of successfully using this technology. 
However, there is another equally important requirement. In chapter 6, we showed that an 
equivalent concentration of EGTA was required to redissolve the pellet. This is acceptable, but 
not the ideal case. In the ideal case, simple resuspension of the pellet in calcium-free buffer 
would suffice. Along these lines, we have observed that an MBP-BRT8-GFP construct actually 
does precipitate in response to calcium. This is interesting for two reason. First, it is surprising in 
that the MBP-BRT9 construct does not precipitate. Second, this construct is interesting because 
while it precipitates, we were unable to redissolve it with any amount of EGTA. This leads us to 
hypothesize that additional repeats may be helpful in encourage redissolution of the pellet. 
Therefore, a future direction to take this work may be to create constructs with more repeats of 
BRTs. 
The second area that this work could be further improved is through the identification of a better 
system for cleaving the protein from the BRT tag to which it is fused for precipitation. In chapter 
6, we used an enterokinase site to demonstrate the feasibility of cleaving off the tag. This was 





present in the final purified sample. Therefore, ideally a self-cleaving intein domain would be 
used instead or a method would be present for easily removing and reusing the enterokinase (or 
other protease). The self-cleaving intein could be used analogously to the previously described 
ELP-intein system[152]. As far as using a separate protease, one option would be to 
recombinantly express the enterokinase as a BRT fusion.  The methods for expressing 
enterokinase recombinantly in E. coli are well established, so it would likely be straightforward 
to modify these system to include the BRT. [190] In this way, the BRT-enterokinase could be 
added to the precipitation purified fusion protein, cleaving with BRT-enterokinase and the 
remaining BRT could be precipitated out of solution along with the BRT-enterokinase. Further, 
BRT-enterokinase could be recovered from the pellet and possibly recycled. 
The above represent a small sampling of some of the potential future directions for this work. It 
will be up to future graduate students to continue to develop this promising bioengineering 
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